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The mouse AtT-20/D16-16 anterior pituitary tumour cell line was 
employed as a model system for the study of the mechanisms mediating 
calcium ion-stimulated adrenocorticotropin (ACTH) secretion. The present 
study indicates that calcium ion-stimulated ACTH secretion from AtT-20 
cells is mediated by a GTP-binding protein which is present in a variety of 
other cell types and has been dubbed Ge (for reviews see Gomperts, 
1990; Lindau & Gomperts, 1991). In AtT-20 cells the nature of Ge remains 
elusive with the selective heterotrimeric GTP-binding protein activator 
AIF(3 -5 ) proving not to be a useful pharmacological tool under the 
conditions employed in the present study. Ge present in this cell line does 
however display characteristics consistent with it being a heterotrimeric 
GTP-binding protein. The results of this study would also suggest that in 
AtT-20 cells Ge is insensitive to both pertussis toxin and cholera toxin.
Both cyclic AMP-dependent protein kinase (PKA) (Guild, 1991) and 
protein kinase C (PKC) (Guild & Reisine, 1987; Reisine, 1989) have been 
implicated in the regulation of calcium ion-stimulated ACTH secretion from 
AtT-20 cells. Results from the present study suggest that calcium ion/Ge- 
stimulated ACTH secretion from AtT-20 cells is not mediated by PKA, PKC 
or any other kinase but is in fact mediated by a phosphatase. PKC appears 
to provide a direct stimulus to secretion, which is independent of calcium 
ion/Ge-stimulated secretion, in contrast to PKA which is unable to stimulate 
secretion by itself but seems to play a modulatory role with regard to both 
calcium ion/Ge- and PKC-stimulated secretion.

ISIRESSJiESPQMSE
The 19th century physiologist Claude Bernard first suggested that 
the constancy of the internal milieu is critical for a free and independent 
existence (Bernard, 1878). The preservation of this internal environment, 
which was later termed and is now commonly referred to as homeostasis 
(Cannon, 1929), requires continuous adaptation to external and internal 
stimuli, or stressors, by means of a wide range of physiological changes 
throughout the body which are generally referred to as the stress response. 
The stress response is mediated by the hypothalamus, a small region of 
the brain which initiates two main stress response pathways (for reviews 
see Fisher, 1989; Johnson et al., 1992). The first pathway produces an 
immediate set of physiological changes termed the alarm reaction or fight 
or flight response. The alarm reaction is a complex of responses initiated 
by hypothalamic stimulation of the sympathetic division of the autonomic 
nervous system. These responses are fast, mobilising the resources of the 
body for immediate physical activity, however they are also short lived. The 
second pathway is termed the resistance reaction which, unlike the alarm 
reaction, is mediated by a number of hypothalamic hormones and is a 
more long term response. The actions of these hypothalamic hormones 
include the release of adrenocorticotropic hormone (ACTH) from 
corticotrophs of the anterior pituitary (for reviews see Aguilera, 1994; 
Antoni, 1986; Jones & Gillham, 1988). ACTH in turn is the dominant, if not 
sole, physiological regulator of the secretion of glucocorticoids, in particular 
corticosterone, from the zona fasciculata of the adrenal cortex (for review 
see Dallman, 1985) which subsequently act upon every cell in the body to 
cause alterations in differentiated function (for review see Munck et al., 
1984). A knowledge of how ACTH release from the anterior pituitary is 
regulated is therefore of importance in the understanding of how the body
mounts a co-ordinated response to stressors and is the focus of the 
present study.
2 THE PITUITARY
The fully developed pituitary or hypophysis is an amalgam of 
hormone-producing glandular cells (the adenohypophysis) and neural cells 
with secretory function (the neurohypophysis). Endocrine cells of the 
adenohypophysis, or anterior pituitary gland, synthesise, store and secrete 
a group of tropic hormones from a number of specialised secretory cells;
ACTH from corticotrophs, thyroid stimulating hormone (TSH) from 
thyrotrophs, gonadotropins (luteinizing hormone (LH) & follicle-stimulating I
hormone (FSH)) from gonadotrophs, somatotropin (growth hormone, GH) |
from somatotrophs and prolactin from lactotrophs. Two hormones, 
antidiuretic hormone (arginine-vasopressin, AVP) and oxytocin, are 
synthesised by neurones in the hypothalamus but are stored and secreted 
by the neurohypophysis or posterior pituitary gland.
In order to understand the regulation of hormone release from the 
anterior pituitary a brief knowledge of the anatomy of the pituitary gland as 
a whole is useful (for review see Porter et al., 1974). The anterior 
endocrine portion of the pituitary develops from an upward outgrowth of 
ectodermal cells from the roof of the oral cavity (Rathke's pouch). This 
pouch eventually pinches off and becomes separated from the oral cavity 
by the sphenoid bone of the skull which forms a hollow around the pituitary 
which is termed the sella turcica, the lumen being reduced to a small cleft.
The posterior neural portion of the pituitary develops from a downward I
outgrowth of ectoderm from the brain in the floor of the third ventricle, with
Ji
The blood supply to this consortium of neural and endocrine tissue 
is complex and is also represented in figure 1. In the posterior pituitary the 
neural tissue of the infundibular process derives its blood supply from the 
capillary plexus of the inferior hypophyseal artery into which posterior 
pituitary hormones are released. These hormones subsequently drain into 
the posterior hypophyseal veins for distribution to the systemic circulation. 
The neural tissue of the median eminence is supplied largely by the 
superior hypophyseal artery. The capillary plexus emanating from this 
artery forms a set of long portal veins that carry the blood downward into 
the anterior pituitary. There these portal veins give rise to a second 
capillary plexus that supplies the endocrine cells with the majority of their 
blood supply, into which anterior pituitary hormones are secreted, which is 
then drained off into the anterior hypophyseal veins for distribution to the 
systemic circulation. The anterior pituitary receives its remaining blood 
supply via a set of short portal veins originating in the capillary plexus of 
the inferior hypophyseal artery, which carry posterior pituitary hormones. 
There is therefore little or no direct blood supply to cells of the 
adenohypophysis.
J
the lumen of this pouch being obliterated interiorly as the sides fuse. 
Superiorly the lumen remains contiguous with the third ventricle. The upper 
portion of this neural stalk expands to invest the lower portion of the 
hypothalamus and is termed the median eminence. In the anterior pituitary 
of some species, a third, well defined intermediate lobe is also included, 
but in humans is rudimentary. In lower vertebrates this lobe secretes 
melanocyte stimulating hormones (MSHs). A schematic diagram of these 
anatomical arrangements is displayed in figure 1 .
HYPOTHALAMUS
MEDIAN
EMINENCE
' no(7
SUPERIOR 
HYPOPHYSEAL ARTERY
HYPOPHYSEAL 
PORTAL VEINS
POSTERIOR
PITUITARY
INFERIOR
HYPOPHSEAL
ARTERY
■li I ANTERIOR
PITUITARY
SPHENOID
BONE
Figure 1 Diagram of the pituitary gland showing Its division Into the 
adenohypophysis (anterior pituitary) and the neurohypophysis (posterior 
pituitary). (Adapted from Tortora & Grabowski, 1992).
Hormone secretion from both the anterior and posterior pituitary is 
primarily under the control of the hypothalamus. This small region of the 
brain is the major integrating link between the nervous system and 
endocrine system receiving and integrating numerous inputs, both neural 
and hormonal, excitatory and inhibitory. The relationships between the 
posterior pituitary and the hypothalamus and the anterior pituitary and the 
hypothalamus, however, are entirely different. The posterior pituitary 
represents a collection of axons whose cell bodies lie in two well defined 
clusters of the hypothalamus, the supraoptic and paraventricular nuclei. 
Peptide hormones are synthesised in the cell bodies of the hypothalamic 
neurones and travel down their axons in neurosecretory granules to be 
stored in the nerve terminals lying in the posterior pituitary. Thus secretion 
from the posterior pathway is under the control of a neural pathway. Upon 
stimulation the granules release their contents into the capillary plexus of 
the inferior hypophyseal artery and ultimately the peripheral circulation (for 
review see Douglas, 1974 a). In contrast to the posterior pituitary, the 
anterior pituitary is a collection of endocrine cells regulated by blood borne 
stimuli originating from neural cells of the hypothalamus. Cell bodies of 
particular hypothalamic neurones, termed hypophysiotropic neurones, 
synthesise releasing and inhibiting hormones (including cortlcotrophin 
releasing factor-41 (ORF-41) and AVP, discussed in detail below) which 
travel down their axons only as far as the median eminence where they are 
stored as neurosecretory granules in the nerve terminals. Upon stimulation 
the releasing or inhibiting hormones are released into the median 
eminence and enter the primary capillary plexus of the superior 
hypophyseal artery. They are transported along the long portal veins and 
exit from the second capillary plexus to reach their specific endocrine 
target. These cells respond by modulating their release of their tropic 
hormones into the same second capillary plexus through which they
ultimately reach the peripheral circulation. This unusual capillary to 
capillary connection allows the releasing and inhibiting hormones to be 
delivered immediately and directly to the anterior pituitary at relatively high 
concentrations, completely bypassing the systemic circulation (for review 
see Riskind & Martin, 1989).
3 RSQUIATIQN QF AQTM RELEASE
ACTH secretion from anterior pituitary corticotrophs is now known to 
be largely under the control of stimulatory corticotropin-releasing factors, 
which are secreted from the hypothalamus in response to a central 
circadian rhythm, coupled with a tonic inhibition conferred by 
glucocorticoids by means of a negative feedback mechanism (for reviews 
see Aguilera, 1994; Antoni, 1986; Jones & Gillham, 1988).
The discovery of the portal blood supply between the hypothalamus 
and the anterior pituitary (Popa & Fielding, 1930) together with the 
observation that the direction of flow was from the hypothalamus to the 
anterior pituitary (Green & Harris, 1949) gave the first indications of the 
functional importance of the hypothalamus over the release of tropic 
hormones from the anterior pituitary. In a series of classic experiments 
Harris subsequently demonstrated that placing an impenetrable barrier 
across the cut ends of the portal vessels led to a permanent disruption of 
anterior pituitary function (Harris, 1955). Such observations led Harris to 
propose the neurohumoral hypothesis which predicted that the 
hypothalamus releases specific neurohormones, including a corticotropin- 
releasing factor (or factors), into the portal blood supply of the median 
eminence which, upon reaching the anterior pituitary, stimulates the
release of a number of tropic hormones including ACTH (Harris, 1955). 
This hypothesis was quickly followed by the demonstration that a 
corticotropin-releasing factor (or factors) existed (Guillemin, 1955; Saffran 
& Schally, 1955), however it was more than 25 years later before Vale and 
co-workers purified the first corticotropin-releasing factor and characterised 
it as a 41 amino acid peptide which was subsequently named corticotropin 
releasing factor-41 (ORF-41) (Vaie et at., 1981). CRF-41 is now known to 
be contained in hypophysiotropic neurones which send axonal projections 
from the hypothalamus to the median eminence to control the release of 
pituitary hormones. 90 % of these CRF-41 containing hypophysiotropic 
neurones are located in the parvicellular subdivisions of the hypothalamic 
paraventricular nucleus (PVN) (Bruhn et aL, 1984). CRF-41 containing 
neurones are also present in a second neuronal pathway which projects 
from the magnocellular neurones of the PVN, the supraoptic and the 
accessory magnocellular nuclei of the hypothalamus (Antoni, 1986).
ACTH secretion from anterior pituitary corticotrophs is now known to 
be under the control of a number of other corticotropin-releasing factors, 
the most important of which is the hypothalamic nonapeptide arginine- 
vasopressin (AVP). Although this peptide was first proposed as a 
candidate for a corticotropin-releasing factor as early as the 1950s (Martini 
& Morpurgo, 1955; McCann, 1957) it was not until the discovery of CRF-41 
that this theory was proved conclusively. Since the discovery of CRF-41 it 
has been shown in preparations derived from rats, primates and humans 
that although AVP is a minor stimulant to ACTH secretion it does potentiate 
the stimulatory effect of CRF-41 upon ACTH secretion in a synergistic 
manner (Abou-Samra et a i, 1987; Gillies et al., 1982; Millan et al., 1987; 
Rivier et al., 1984; Rivier & Vale, 1983). In ovine preparations the opposite 
is true, AVP is the dominant hormone and CRF-41 is facilitative with regard
8to evoked ACTH release (Familary et aL, 1989; Liu etaL, 1990), however 
this appears to be the exception. The importance of AVP as a corticotropin 
releasing factor is emphasised by the finding that this peptide is also 
present in the parvicellular CRF-41 containing pathway to the median 
eminence. There is evidence to suggest that AVP may co-localise with up 
to 50 % of the CRF-41 containing neurones of the parvicellular pathway not 
only in the same axons but also in the same neurosecretory granules 
(Whitnall et a/., 1985). A number of other corticotropin-re leasing factors 
released into the median eminence which are of particular relevance to the 
present discussion include angiotensin II (Capponi et a/., 1982; Sobel & 
Vagnucci, 1982), catecholamines (Giguere ef a/., 1981; Vale & Rivier, 
1977) and vasoactive intestinal polypeptide (VIP) (Reisine et aL, 1982). It 
has been proposed that different stressors may evoke the release of 
specific mixes of ACTH secretagogues in the median eminence (Plotsky et 
aL, 1985) which may go some way to explaining the need for this variety of 
ACTH secretagogues.
ACTH secretion from anterior pituitary corticotrophs is also 
regulated by a number of inhibitory factors, the dominant one being 
glucocorticoids by means of a negative feedback mechanism. 
Glucocorticoids inhibit ACTH secretion directly at the level of the pituitary 
corticotroph and also at different sites in the brain including the PVN and 
the hippocampus (Dallman etaL, 1987; DeKloet, 1991). The primary site of 
feedback inhibition under basal conditions is the hippocampus which 
contains the high affinity type I steroid receptors which are sensitive to non­
stressed levels of circulating glucocorticoids (DeKloet, 1991, Sapolsky & 
Jacobson, 1991). Lower affinity type II receptors constitute the major 
proportion of receptors found in the pituitary and PVN which become 
occupied with stress induced levels of glucocorticoids (ReuI & DeKloet,
1985). A number of other agents have been implicated in the inhibition of 
ACTH secretion from anterior pituitary corticotrophs including, of relevance 
to the present discussion, the hypothalamic neuropeptide somatostatin 
(somatotropin release inhibitory factor, SRIF) (Luini eta!., 1986; Reisine & 
Guild, 1985; Reisine et ai, 1988).
4 SECRETORY PATMWA.Y.
(i) Protein sorting & processing
Proteins can be released from specialised secretory cells by means 
of two major routes, that of the regulated secretory pathway and that of the 
constitutive secretory pathway (for review see Burgess & Kelly, 1987). The 
majority of secretory proteins secreted from eukaryotic cells originate in the 
rough endoplasmic reticulum (RER) in the form of a peptide precursor. 
Secretory proteins are transferred from the RER to the cis -Golgi network 
(OGN) and from one Golgi stack to the next, in shuttle vesicles, finally 
reaching the frans-Golgi network (TGN) (figure 2 ) (Klausner, 1989; Pfeffer 
& Roth man, 1987; Rothman & Orci, 1992). At this point proteins to be 
secreted by means of the regulated secretory pathway are actively sorted 
into dense core secretory granules in contrast to delivery into constitutive 
secretory vesicles which proceeds by default (Griffiths & Simons, 1986). 
Release from the constitutive pathway is a continuous process, limited only 
by the availability of the product, therefore release from this pathway is 
regulated at the most proximal of levels, that of biosynthesis (Mains & 
Eipper, 1981; Tartakoff & Vassalli, 1978). In contrast secretion via the 
regulated pathway is stimulated by secretagogues which occurs at the 
level of exocytosis itself, the most distal step in the pathway, and allows for
\(§)
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Figure 2 The regulated and constitutive secretory pathways.
OGN, c/s-Golgi network; TGN, trans-Golgi network. (Adapted from Halban
& Irminger, 1994).
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the rapid and massive discharge of proteins stored in dense core secretory 
granules at the physiologically appropriate moment (Palade, 1975).
The peptide precursor found in corticotrophs is pro-opiomelanocortin 
(POMC) which is processed to form a number of peptides including ACTH. 
POMO is processed by a membrane bound conversion endoproteases to 
form ACTH, p-lipotropic hormone (lipotropin) and POMC (1-74) (figure 3). 
p-lipotropic hormone in turn can be partially cleaved by a second related 
endoprotease, which in comparison is poorly expressed, to produce p- 
endorphin and y-lipotropic hormone (for reviews see Halban & Irminger, 
1994; Loh etaL, 1991).
(ii) Fusion machinery
Over recent years the general mechanisms of eukaryotic 
intracellular transport and in particular the proteins controlling vesicle 
docking and fusion have been greatly elucidated (for review see Rothman,
1994). Initially Rothman and co-workers identified a number of soluble 
mammalian proteins involved in intra-Golgi transport using a run down- 
reconstitution approach (for review see Rothman & Orci, 1992). One of the 
first proteins to be identified by this method was A/-ethylmaleimide- 
sensitive fusion protein (NSF) which was purified by its ability to 
reconstitute transport through the Golgi after blockade by the alkylating 
agent A/-ethylmaleimide (NEM) (Block et aL, 1988). The ability of NSF to 
reconstitute vesicular transport was however shown to be dependent upon 
additional cytosolic factors, in particular a group of proteins which later 
became known as the soluble NSF attachment proteins (SNAPs). SNAPs 
are now known to be a family of three proteins named a-, p- and y-SNAP 
which were purified by their ability to reconstitute NSF-dependent transport
11 1 t
POMC (1-74) JP Beta-LPH
Figure 3 POMC processing in the anterior pituitary. Solid arrows 
indicate efficient cleavage whereas broken arrows indicate partial 
cleavage. ACTH, adrenocorticotropic hormone; Beta- LPH, p-lipotropic 
hormone (lipotropin); JP, joining peptide; POMC, pro-opiomelanocortin. 
(Adapted from Halban & Irminger, 1994).
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through the Golgi (Clary & Rothman, 1990) and were subsequently shown 
to mediate NSF binding to the membrane (Clary etaL, 1990). Employing 
an immunoprécipitation approach using brain membranes a number of 
membrane associated proteins involved in vesicle docking and membrane 
fusion have been identified including three SNAP receptors (SNAREs) 
which have subsequently been named syntax!n, synaptobrevin and SNAP- 
25 (Sollner et aL, 1993). These three proteins are now known to be targets 
for the botulinum neurotoxins (Montecucco & Shiavo, 1994), potent 
inhibitors of neurotransmission, thus implicating NSF and SNAPs in 
regulated exocytosis at the synapse. Functional evidence also exists for 
the involvement of NSF and SNAPs in regulated exocytosis at the synapse 
(Debello et aL, 1995) and also in chromaffin cells (Morgan & Burgoyne, 
1995 a). It therefore appears that a "fusion complex", comprising 
membrane bound SNAREs bound to cytosolic SNAPs which in turn bind 
cytosolic NSF, has some role in vesicle docking and membrane fusion. 
Additional information comes from the observation that this fusion complex 
has an intrinsic ATPase activity conferred by NSF (Tagaya et aL, 1993) 
which contains two ATP binding sites (Wilson etaL, 1989). This ATPase 
activity appears crucial to some aspect of vesicle docking and membrane 
fusion since after ATP hydrolysis this complex of proteins dissociates 
(Wilson etaL, 1992).
These and other observations led Rothman and co-workers to 
formulate the SNARE hypothesis (Sollner et aL, 1993), a schematic 
diagram of which is displayed in figure 4. This model predicts that SNAREs 
present on the vesicle membrane (v-SNAREs), of which synaptobrevin is 
an exampie, interact with their equivaient on the target membrane (t- 
SNAREs), of which syntax!n and SNAP-25 are examples, forming a 
complex to which one or more SNAPs can bind. Inactive cytosolic NSF can
v-SNAREO F - t-SNARE
UNDOCKED
VESICLE
DOCKED
VESICLE
NSF SNAPs
PREFUSION
STATE
ATP HYDROLYSIS 
&
COMPLEX DISASSEMBLY
Figure 4 SNARE hypothesis. ATP, adenosine 5'-triphosphate; NSF, 
/V-ethylmaieimide-sensitive fusion protein; SNAPs, soluble NSF 
attachment proteins; t-SNARE, target membrane associated SNAP 
receptor; v-SNARE, vesicle membrane associated SNAP receptor. 
(Adapted from Sollner etaL, 1993).
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then also bind to this complex, via interaction with one or more SNAPs, 
resulting in an activation of this protein and therefore ATP hydrolysis. This 
ATPase activity according to Rothman "creates a fusion active 
conformation which facilitates bilayer fusion" (Rothman, 1994). This model 
is an attempt to explain how some of the key proteins known to participate 
in membrane docking and fusion may interact to regulate this process at a 
number of stages throughout both the regulated and constitutive secretory 
pathways. In the case of the regulated pathway a "fusion clamp" is 
included in the hypothesis, a protein which under resting conditions would 
prevent the full formation of the fusion complex. Upon activation by second 
messengers this clamp would however be removed and membrane fusion 
allowed to proceed in a manner similar to that of constitutive secretion.
Although the SNARE hypothesis may prove with time to be an 
oversimplification (Morgan & Burgoyne, 1995 b) it does highlight the 
advances made over recent years in the understanding of the general 
machinery controlling vesicle docking and membrane fusion. In contrast 
the mechanisms which mediate the effects of extracellular secretagogues 
upon the final stages of the regulated secretory pathway remain, 
particularly in non-neuronal secretory cells, only partially understood. This 
is certainly true of the regulated ACTH secretion from the anterior pituitary 
corticotroph despite many studies being carried out to this end (Antoni, 
1986; Axelrod & Reisine, 1984). The broad aim of this study was therefore 
to further elucidate the intracellular mechanisms which mediate the effects 
of corticotropin-releasing factors upon the regulated ACTH secretory 
pathway.
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5 AtI:2Q CELLS
(i) Corticotroph model system
Corticotrophs have been estimated to represent only 3-10 % of the 
cell population of the anterior pituitary (Westlund et aL, 1985). The major 
drawback, therefore, of any preparation derived from normal anterior 
pituitary tissue is the heterogeneity of this cell population, which makes 
experiments conducted at an intracellular level difficult. As a result many 
studies investigating the intracellular mechanisms mediating regulated 
ACTH secretion in response to corticotropin-releasing factors have been 
carried out in using the AtT-20 anterior pituitary tumour cell line which 
provides a homogeneous population of ACTH secreting corticotrophs 
(Axelrod & Reisine, 1984). The AtT-20 ceil line was therefore adopted as a 
corticotroph model system in the present study. As can be seen in figure 5, 
the POMC cleavage patterns in anterior pituitary corticotrophs and in AtT- 
2 0  cells closely resemble each other and as a result both secrete a similar 
array of proteins (for reviews see Halban & Irminger, 1994; Loh et aL, 
1991).
(ii) Derivation
Transplantable mouse pituitary ACTH-secreting tumours, which 
retain differential function after serial transfer, were first developed by Furth 
upon exposure of mice to ionising radiation from an atomic detonation 
(Furth, 1955). One such tumour contained about twice the normal 
adrenotropic hormone (ACTH) content and was designated AtT-20 
(Adrenotropic lumour # 2Û) (Cohen & Furth, 1958). AtT-20 cells were 
subsequently adapted to tissue culture (Yasumura, 1968) by the method of
AH i i
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Figure 5 POMC processing In AtT-20 cells in comparison to the 
anterior pituitary. Panel A represents protein processing in AtT-20 cells 
whereas panel B represents protein processing in the anterior pituitary. 
Solid arrows indicate efficient cleavage whereas broken arrows indicate 
partial cleavage. ACTH, adrenocorticotropic hormone; Beta- LPH, p- 
lipotropic hormone (lipotropin); JP, joining peptide; POMC, pro­
opiomelanocortin. (Adapted from Halban & Irminger, 1994).
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alternate animal and cell culture passage (Buonassisi etaL, 1962). Briefly 
hormone producing tumours were cultured and after various times injected 
into mice and tumours arising from these injected cultures checked for 
hormonal activity, put back into culture and the whole process repeated.
This process allows only those tumour cells which survive culture g
conditions to contribute to subsequent tumours and appears to give rise to #
cells with increased growth and enhanced hormonal activity in culture.
After completion of this process a cell line of ACTH-secreting cells, 
designated D-1 (üai-iti-l), which grows as floating aggregates was finally 
isolated and cloned (Yasumura, 1968; Yasumura & Sato, 1967). Three 
variant cell lines, including the AtT-20/D16v (variant) cell line, were 
subsequently isolated from the D-1 cell line (Yasumura, 1968). Each of 
these variant cell lines grew as a monolayer and were re-cloned by the 
single-cell plating technique (Puck, 1959). This AtT-20/D16v mouse 
anterior pituitary cell line has since provided a simplified model system in 
which to study POMC processing and subsequent storage and secretion 
of ACTH (for review see Halban & Irminger, 1994). Because of possible 
heterogeneity within this AtT-20/D16v cell line a number subclones were 
derived from single cells and isolated, one of which was chosen, by virtue 
of its high p-endorphin immunoreactivity, for further experimentation and |
designated AtT-20/D16-16 (Sabol, 1980). This AtT-20/D16-16 subclone 
shows identical morphology to that of the AtT-20/D16v cell line (Sabol,
1980).
Sabol and co-workers (Hook etaL, 1982), upon isolating the D16-16 
subclone, demonstrated that CRF-41 stimulates ACTH release from these 
cells in a similar manner to CRF-41-stimulated ACTH release from primary 
cultures of anterior pituitary cells (Turkelson etaL, 1981 ; Vale et aL, 1981).
It was therefore concluded that AtT-20/D16-16 cells may serve a useful
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model system for the study of the cellular and molecular actions of CRF-41 
in the regulation of secretion and synthesis of ACTH from the normal 
corticotroph. Due to its greater degree of homogeneity the AtT-20/D16-16 
cell line has since been used extensively as a model system in the 
investigation of ACTH secretion from the normal corticotroph in response 
to a number of different secretagogues (Axelrod & Reisine, 1984) and as a 
result was the particular subclone employed as a model system for the 
normal corticotroph in the present study.
(ill) Morphology
Many of the studies carried out in the comparison of the regulated 
and constitutive secretory pathways employed the AtT-20 model system 
which also promoted an understanding of the morphology of these cells, a 
photo-micrograph of which is displayed in figure 6 . AtT- 2 0  cells are 
approximately 15 |im long (Richardson, 1978) and as can be seen these 
cells exhibit a polarised morphology with dense-core secretory granules 
accumulating in the tips of processes extending from the cell. When AtT-20 
cells are stimulated with secretagogues they increase in size become 
flatter and the tips of these processes enlarge and accumulate ACTH 
(Buckley & Kelly, 1985; Burgess et aL, 1985; Kelly etaL, 1983; Matsuuchi 
etaL, 1988; Tooze & Burke, 1987).
6 CALCIUM IONS AS CENTRAL REGULATORS OF ACTH SECRETION
First messengers, including hormones, interact with specific 
receptors at the cell surface initiating a cascade of molecular events that 
underlies trans-membrane signalling or signal transduction. In many cases
Figure 6 A photo-micrograph of AtT-20/D16-16 cells.
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stimulation of these receptors results in activation of effector proteins such 
as enzymes or ion channels which mobilise chemical second messengers 
that in turn initiate characteristic actions within the cell, a concept first 
proposed by Sutherland and co-workers (Sutherland & Rail, 1958). 
Evidence from a variety of studies established calcium ions as one such 
second messenger, including the work of Douglas who first suggested that 
changes in cytosolic calcium ions may be a necessary and sufficient trigger 
to hormone secretion (Douglas, 1968 & 1974 b). Calcium ions are now 
established as one of the most important second messengers in a variety 
of systems (for review see Glapham, 1995) and have been shown to 
directly stimulate a secretory response from a variety of speciaiised 
secretory cells (Gomperts, 1990; Knight & Scrutton, 1986; Lindau & 
Gomperts, 1991) including AtT- 2 0  cells (Guild, 1991; Luini & DeMatteis,
1988).
Calcium ions are central to the actions of both CRF-41 and AVP. 
The actions of CRF-41 and AVP are both thought to be mediated by 
second messenger generation, activation of distinct kinases which 
reversibly add a phosphate onto specific target proteins and in turn 
stimulate calcium ion entry into the cell (a detailed account of the evidence 
for which is given below). The reversible addition of a phosphate by a 
kinase was first elucidated as a regulatory mechanism 40 years ago 
(Fischer & Krebs, 1955) and is now recognised as one of the most 
common means of regulating the function of signal transducing proteins in 
eukaryotic cells (for reviews see Goldsmith & Cobb, 1994; Pawson, 1994; 
Taylor etaL, 1993). There are two major classes of protein kinases; those 
which transfer a phosphate onto a tyrosine residue and those which do so 
onto a serine or threonine residue (Krebs & Beavo, 1979). Two prominent 
serine/threonine-specific kinases, which are activated by second
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messenger action and play a central role in signal transduction, are the 
adenosine 3" : 5' cyclic monophosphate (cyclic AMP)-dependent protein 
kinase (PKA) (for reviews see Francis & Corbin, 1994; Taylor etaL, 1990; 
Walsh & Van Patten, 1994) and the calcium ion and phospholipid activated 
protein kinase C (PKC) (for reviews see Dekker & Parker, 1994; Hug & 
Sarre, 1993; Nishizuka, 1995). PKA and PKC have been implicated in 
mediating the abilities of CRF-41 and AVP respectively to raise the 
cytosolic free calcium ion concentration (a detailed account of the evidence 
for which is given below).
(i) Corticotropin reieasing factor-41 & cyclic AMP-dependent 
protein kinase activation
PKA was first described by Lamer and co-workers as a cyclic AMP- 
dependent glycogen synthase kinase that, in the presence of MgATP, 
transferred the y-phosphate of ATP to serine and threonine residues on 
many cellular enzymes (Friedman & Lamer, 1963; Rosell-Perez & Lamer, 
1964). Not long after, this enzyme was purified and permanently named as 
PKA (Walsh et aL, 1968). PKA is now known to be present in ail 
mammalian tissues and is responsible for the phosphorylation and 
regulation of a wide variety of proteins which are involved in a wide variety 
of cellular functions (Francis & Corbin, 1994; Taylor et aL, 1990; Walsh & 
Van Patten, 1994). Cyclic AMP is generated from ATP by agents which 
activate adenylate cyclases, a family of eight isozymes, which are now 
known to be multiply regulated by variety of factors including guanosine 5'- 
triphosphate (GTP)-binding proteins (discussed in detail below), PKC and 
calcium ions (Cooper et aL, 1995; Iyengar, 1993; Tang & Gilman, 1992). 
Cyclic AMP is degraded by hydrolysis to adenosine 5'-monophosphate 
(AMP) by a large family of different cyclic nucleotide phosphodiesterases
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which appear to be differentially expressed and regulated in different cell 
types (Beavo & Reifsnyder, 1990).
The effect of CRF-41 upon anterior pituitary corticotrophs has been 
the focus of many studies and as a result it is now well established that the 
effects of this peptide are mediated largely through the activation of PKA 
and subsequent elevation of cytosolic free calcium ion levels (Axelrod & 
Reisine, 1984). CRF-41-stimulates ACTH secretion from anterior pituitary 
corticotrophs via activation of specific GTP-binding protein linked receptors 
(Aguilera et al., 1987) which have seven transmembrane spanning 
domains (Chen eta!., 1993, Perrin et a!., 1993). The ability of CRF-41 to 
stimulate ACTH secretion has been shown to be mediated by cyclic AMP 
generation, via activation of adenylate cyclase, both in AtT-20 cells (Litvin 
eta!., 1984; Miyazaki eta!., 1984) and in rat anterior pituitary corticotrophs 
(Aguilera et al., 1983). Other agents which increase the cellular content of 
cyclic AMP such as forskolin, a plant diterpene capable of activating 
adenylate cyclase (Seamen & Daly, 1981; Seamen et al., 1981), and 8 - 
bromo cyclic AMP, a membrane permeant cyclic AMP analogue (Hei et at., 
1991 ; Meyer & Miller, 1974; Sandberg ef al., 1991), have also been shown 
to stimulate ACTH secretion from both AtT-20 cells (Axelrod & Reisine, 
1984; Heisler & Reisine, 1984; Litvin etal., 1984; Miyazaki eta!., 1984) and 
rat anterior pituitary corticotrophs (Aguilera et al., 1983). These findings 
suggest that elevation of cellular cyclic AMP content and subsequent 
activation of PKA may be an important step in the stimulation of ACTH 
secretion by CRF-41. In addition catecholamines (Reisine etal., 1983) and 
VIP (Reisine etal., 1982) both stimulate ACTH secretion from AtT-20 cells, 
the effects of which are thought to be mediated by cyclic AMP 
accumulation and PKA activation (Miyazaki et al., 1984) further
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emphasising the importance of PKA in the stimulus-secretion coupling 
pathway of this cell line.
Extracellular calcium ions have been shown to be necessary for the 
stimulation of ACTH secretion from AtT-20 cells by secretagogues which 
generate cyclic AMP, however extracellular calcium is not required for 
cyclic AMP accumulation (Axelrod & Reisine, 1984, Miyazaki etal., 1984). 
Furthermore CRF-41, forskolin and 8 -bromo-cycIic AMP also elevate 
cytosolic calcium ion concentrations in AtT-20 cells (Guild et al., 1986, 
Guild & Reisine, 1987; Luini etal., 1985; Reisine & Guild, 1985). Since 
agents which raise the cytosolic calcium ion concentration, such as calcium 
ionophores, had been shown to stimulate ACTH secretion from AtT-20 
cells (Richardson, 1983), it was postulated that cyclic AMP and subsequent 
PKA activation influence ACTH secretion via an interaction with the 
calcium messenger system. This was later shown to be the case with the 
finding that cyclic AMP, via activation of PKA, is able to increase the 
cytosolic free calcium ion concentration of AtT-20 cells by stimulating the 
entry of extracellular calcium ions by the activation of voltage-dependent 
calcium channels (Reisine & Guild, 1987, Reisine, 1989).
(it) Arglnine-vasopressin & protein kinase C activation
PKC was originally discovered by Nishizuka and co-workers on the 
basis of its activation by calcium ions, phospholipids and diacylglycerol 
(DAG) (Castagna et al., 1982; Inoue et al., 1977; Takai et al., 1979). 
Because of these requirements PKC is generally thought to be activated in 
the cell by signal transduction cascades that produce DAG. PKC is also a 
major receptor for the tumour promoting phorbol esters, which activate 
PKC in a similar fashion to DAG (Gschwendt etal., 1991), therefore
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phorbol esters have been used extensively as a pharmacological tool to 
investigate the functions of PKC. Mainly through the use of phorbol esters 
it has been demonstrated that PKC is involved in a variety of diverse 
processes and, in common with PKA, phosphorylates a wide range of 
substrates (for reviews see Dekker & Parker, 1994; Hug & Sarre, 1993; 
Nishizuka, 1995). It soon became clear that PKC is not a single entity 
however and is now known to consist of a number of PKC isozymes 
(Huang et al., 1986). At present the ever increasing mammalian PKC 
family consists of 1 2  closely related polypeptides designated a, p i, p2 » Y, 8 , 
e, Ç, T|, 0, I ,  X, and p (Dekker & Parker, 1994). Some isozymes are 
widespread in their distribution whereas others are restricted to a small 
number of tissues. In general only a certain subset of PKC isozymes are 
present in a particular cell (Dekker & Parker, 1994; Hug & Sarre, 1993). 
The PKC family can be subdivided by means of their dependence upon 
calcium ions into the calcium-dependent or conventional PKCs (cPKCs) 
and the calcium-independent or novel PKCs (nPKCs) (Ohno et al., 1991). 
The a, p and y isozymes belong to the cPKC subfamily and the Ô, e, r\, 0 
and p belong to the nPKC subfamily. A third emerging subfamily, 
designated atypical PKCs (aPKCs) comprising the Ç isozyme and the 
related i and X isozymes appear not to be regulated by phorbol esters or 
DAG (Akimoto etal., 1994; Nishizuka, 1988; Selbie etal., 1993). There is 
evidence however to suggest that members of this third subfamily are 
regulated by phosphatidyl inositol (3,4,5)-triphosphate (PIP3) (Nakanishi et 
al., 1993; Singh et al., 1993). All isoforms also appear to require the 
membrane phospholipid phosphatidyl serine (PS) as a cofactor for their 
activation (Dekker & Parker, 1994; Hug & Sarre, 1993; Nishizuka, 1995). 
DAG is generated by a number of signal transduction cascades including 
that initiated by activation of phospholipase C (PLC). This enzyme upon 
stimulation cleaves phosphatidyl inositol (4,5) bisphosphate (PIP2 ). a minor
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membrane phospholipid, to produce two second messengers, DAG and 
phosphatidyl inositol-(3,4,5)-triphosphate (IP3 ) (Divecha & Irvine, 1995). 
PLC can be activated by a variety of stimuli including GTP-binding 
proteins, a mechanism through which some hormones are thought to act 
(Exton, 1994).
There is now evidence to suggest that the hypothalamic 
neuropeptide AVP stimulates ACTH secretion from anterior pituitary 
corticotrophs at least partly by the activation of PKC and the elevation of 
the cytosolic free calcium ion concentration. The investigation of the 
intracellular mechanisms mediating the actions of AVP were initially 
hampered by the fact that although AtT-20 cells do posses a AVP receptor 
it is not a functional one (Lutz-Burcher etal., 1987) therefore the effects of 
AVP upon ACTH secretion have only been investigated in heterogeneous 
anterior pituitary preparations. As a result these mechanisms are poorly 
understood in comparison to those of CRF-41. This peptide however is 
known to act upon membrane bound receptors belonging to the Vi subtype 
similar to the AVP receptors found on smooth muscle and the liver, 
although pharmacological and structural differences are now known to be 
present between this pituitary Vi receptor (designated Vib) and the liver 
and vascular Vi receptor (designated Via) (Antoni, 1987; Jard etal., 1986; 
Lolait & Brownstein, 1994; Lolait et al., 1992; Morel et al., 1992). The 
actions of the Vi receptor subtype are generally known to be mediated by 
PLC activation (Jard etal., 1987) and indeed AVP has since been shown 
to activate PLC in anterior pituitary corticotrophs which therefore results in 
the generation of DAG and subsequent PKC activation as well as the 
generation of IP3 (Bilezikjian etal., 1987 a & b; Guillon et al., 1987; Oki et 
al., 1990; Raymond et al., 1985). The importance of PKC in the ACTH 
stimulus-secretion coupling pathway in anterior pituitary corticotrophs is
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emphasised by the finding that the effects of angiotensin II are also 
mediated by activation of PLC (Guillon et a!., 1987) and subsequent 
activation of PKC (Abou-Samra etal., 1986), Although AtT-20 cells do not 
respond to AVP, lithium, an inhibitor of a particular phosphatase involved in 
the recycling of DAG and IP3 to PIP2 (Hallcher & Sherman, 1980), has 
been shown to be an effective secretagogue in AtT-20 cells indicating that 
phosphatidyl inositol metabolism is also an important second messenger 
pathway in the regulation of ACTH secretion from this cell line as well as 
the normal corticotroph (Reisine & Zatz, 1987; Zatz & Reisine, 1985). In 
addition activators of PKC have been shown to stimulate ACTH release 
from these cells indicating that this enzyme is also an important regulator 
of ACTH secretion from AtT-20 cells as well as the normal corticotroph 
(Reisine & Guild, 1987; Reisine & Zatz, 1987; Zatz & Reisine, 1985).
In common with CRF-41 the ability of AVP to stimulate a secretory 
response is thought to be mediated, at least partly, by the elevation of the 
cytosolic free calcium ion concentration. AVP has been shown to stimulate 
a biphasic release of ACTH from normal anterior pituitary corticotrophs, an 
initial spike, which may be mediated by IP3 stimulated calcium ion 
mobilisation from intracellular stores, followed by what is in comparison a 
sustained response, mediated by the generation of DAG and subsequent 
PKC activation (Oki et al., 1990). Studies employing the AtT- 2 0  cell line 
have also demonstrated that the ability of PKC to stimulate ACTH secretion 
is due to an elevation of the cytosolic free calcium ion concentration. 
Activators of PKC appear to inhibit potassium channels resulting in a 
depolarisation of the cell which in turn activates voltage-dependent calcium 
channels allowing calcium ions to enter the cell (Reisine & Guild, 1987; 
Reisine, 1989).
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7 MECHANISMS MEDIATING CALCIUM IQN-STMULATED ACTH 
SECRETION
Although it is clear that elevation of the cytosolic free calcium ion 
level is an important trigger to ACTH secretion and is central to the actions 
of both CRF-41 and AVP the mechanisms by which calcium ions in turn 
stimulate secretion are poorly understood. The aim of this study was to 
further the understanding of the mechanisms which mediate the effects of 
calcium ions upon ACTH secretion from anterior pituitary corticotrophs 
using the AtT-20 cell model system. There is evidence to suggest that a 
well established family of transducing proteins, termed GTP-binding 
proteins, may mediate the ability of calcium ions to stimulate secretion from 
a number of specialised secretory cells (Gomperts, 1990; Lindau & 
Gomperts, 1991) including ACTH secretion from AtT-20 cells (Guild, 1991 ; 
Luini & DeMatteis, 1988 & 1990). There is also some evidence to suggest 
that PKA and PKC, which mediate, at least partly, CRF-41- and AVP- 
stimulated ACTH secretion respectively, in addition to raising the cytosolic 
free calcium Ion concentration may also regulate secretion by actions in the 
stimulus-secretion coupling pathway distal to changes in cytosolic free 
calcium ion concentrations (Guild, 1991; Guild & Reisine, 1987; Reisine,
1989). This study therefore focused upon the involvement of these two 
kinases and GTP-binding proteins and their involvement in calcium ion- 
stimulated ACTH secretion from AtT-20 cells.
(i) GTP-binding proteins
The observation by Rodbell, Birnbaumer and co-workers that a 
guanine nucleotide, GTP, was required for hormonal activation of 
adenylate cyclase (Rodbell etal., 1971) ultimately resulted in the discovery
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of a large, diverse and ubiquitous superfamily of GTP-binding and 
hydrolysing proteins which have been implicated in the regulation of a wide 
variety of cellular functions (for reviews see Bourne et al., 1990 & 1991; 
Kaziro et al., 1991). All GTP-binding proteins, however, have certain 
features in common including the ability to bind and hydrolyse GTP and the 
ability to undergo two alternate conformations (figure 7). The GTP-bound 
form is an active conformation in which the protein can recognise and 
interact with target molecules. Upon hydrolysis of the bound GTP to GDP 
and inorganic phosphate, by an intrinsic GTPase activity, the conformation 
is shifted to the inactive GDP-bound form. The conversion of the GDP- 
bound form to the GTP-bound form is achieved by the exchange of the 
bound GDP with external GTP. The GTP-binding protein also passes 
through a transient "empty” state upon releasing GDP during which no 
guanine nucleotide is bound. Since GTP-hydrolysis is irreversible the cycle 
is unidirectional. GTP binding proteins are now known to constitute a large 
superfamily of proteins which can be largely categorised by means of their 
subunit composition into a number of families including heterotrimeric and 
monomeric GTP-binding proteins both of which have been implicated in 
various aspects of the secretory process (Ferro-Novick & Novick, 1993; 
Nuoffer& Balch, 1994; Pfeffer, 1992).
Heterotrimeric GTP-binding proteins, or classical GTP-binding 
proteins, consist of an a subunit (36-52 kDa) which binds and hydrolyses 
GTP, as well as a p (35-37 kDa) and a y subunit (6-10 kDa) (for reviews 
see Gilman, 1987; Hepler & Gilman, 1992; Neer, 1995; Taylor, 1990). 
Mammals have over 20 different GTP-binding protein a  subunits, 16 gene 
products, some with alternatively spliced isoforms. Five p subunits are 
known which display between 53 and 90 % sequence homology in contrast 
to the six known y subunits which display little sequence homology (Neer,
■ o
Figure 7 GTP-binding protein cycle. GDP, guanosine 5'- 
diphosphate; GTP, guanosine 5 -triphosphate; P;, inorganic phosphate.
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1995). Heterotrimeric GTP-binding proteins are generally subdivided by 
means of the amino acid sequence of their a  subunit into four major 
subfamilies designated Gg, Gj, Gq and G 12 which display between 56 and 
95 % sequence homology (Hepler & Gilman, 1992; Neer, 1995).
In contrast monomeric GTP-binding proteins, or ras -related GTP- 
binding proteins, consist of a single 20-25 kd subunit (for reviews see Hall, 
1990; Takai et a/., 1992). The ras oncogene is known to encode a 21 kDa 
protein that specifically binds and hydrolyses GTP (Barbacid, 1987). The 
designation of the ras gene product as a GTP-binding protein, and 
subsequently as the prototypical small GTP-binding protein, was made with 
the discovery that it displayed regions of homology with the a  and y 
subunits of heterotrimeric GTP-binding proteins (Hurley etal., 1984). The 
ever increasing ras -superfamily of GTP-binding proteins currently contains 
over 60 proteins which can be divided by means of their amino acid 
sequence homology into the ras, rho, rab, ran and arf subfamilies (Hall, 
1990; Takai etal., 1992).
Heterotrimeric GTP-binding proteins are well characterised with 
regard to activation by membrane bound receptors (for reviews see 
Gilman, 1987; Hepler & Gilman, 1992; Neer, 1995; Taylor, 1990). The 
GTPase cycle of heterotrimeric GTP-binding proteins is depicted in figure 
8. In the GDP-bound conformation, the a-subunit (Ga) binds the p and y 
subunits (Gpy), which function as a dimer, to form a heterotrimer that binds 
to the receptor. Both Ga and GPy subunits are capable of binding to the 
receptor. Activation of receptors on the plasma membrane by extracellular 
ligands induces a conformation change in the receptor which in turn 
induces a conformational change in Ga which results in a decreased 
affinity of the GTP-binding protein for GDP. As a result Ga releases GDP,
GDP
GDP
\
/
GDP
Figure 8 Heterotrimeric GTP-binding protein cycle. A, agonist 
(extracellular ligand) ; E, effector; GDP, guanosine 5’-diphosphate; GTP, 
guanosine 5'-triphosphate, Pj, inorganic phosphate; R, receptor. (Adapted
from Kaziro etal., 1991).
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tightly associated with Ga, and because the concentration of GTP in cells 
is much higher, the leaving GDP is replaced with GTP. This leads to the 
dissociation of the receptor from the GTP-binding protein which in turn 
dissociates into the activated state of Ga-GTP and GPy. The dissociated 
Ga the goes on to activate target molecules. There is evidence to suggest 
that many GPy subunits are also capable of activating target molecules (for 
reviews see Birnbaumer, 1992; Sternweis, 1994). This activated state lasts 
until the bound GTP is hydrolysed to form GDP by the intrinsic GTPase 
action of Ga. Now Gpy, which has a high affinity to Ga-GDP, can associate 
to form the Gapy-GDP complex, terminating the actions of both Ga and 
Gpy and priming the system to respond again.
Monomeric GTP-binding proteins also cycle between an inactive 
GDP-bound conformation and an active GTP-bound conformation. This 
cycle has been postulated to be modulated by a several families of 
regulatory proteins (for reviews see Boguski & McCormick, 1993; Bokoch & 
Der, 1993; Feig, 1994). The GDP/GTP exchange reaction is extremely 
slow and is facilitated by a family of regulatory proteins referred to as 
guanine-nucleotide exchange factors (GEFs). This point in the cycle is also 
negatively regulated by GDP dissociation inhibitors (GDIs). One major 
difference between monomeric and heterotrimeric GTP-binding proteins 
lies in the intrinsic GTPase activity of monomeric GTP-binding proteins. 
The intrinsic GTPase activity of monomeric GTP-binding proteins is < 0.01 
min-1 compared to that of heterotrimeric GTP-binding proteins which is 3-5 
min-1. This GTPase activity of monomeric GTP-binding proteins is 
therefore catalysed by another family of regulatory proteins termed 
GTPase activating proteins (GAPs) and may also be inhibited by GDIs.
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The technique of cell permeabilisation has been employed 
extensively over recent years to elucidate the late stages of the stimulus- 
secretion coupling pathway of many specialised cell types. This technique 
is one which permits the composition of the cytosol to be manipulated 
allowing the complicating influences of membrane bound events to be 
bypassed. The ability of calcium ions to stimulate secretion from a variety 
of specialised cell types has been demonstrated using permeabilised cell 
preparations (Knight & Scrutton, 1986) including ACTH secretion from 
permeabilised AtT-20 cells (Guild, 1991; Luini & DeMatteis, 1988). GTP- 
binding proteins are well established as transducing proteins linking cell 
surface receptors to effector proteins (Bourne etal., 1990 & 1991 ; Kaziro et 
al., 1991) however more recently evidence has been obtained, again using 
this technique, to suggest that GTP-binding proteins may play more than 
one role in the stimulus-secretion coupling pathway. The finding by 
Gomperts and co-workers that GTP analogues were capable of stimulating 
a secretory response from permeabilised neutrophils by an action which 
was independent of receptor-linked events (Barrowman et al., 1986) 
prompted the suggestion that a GTP-binding protein, subsequently 
designated Ge (Gomperts et al., 1986), is also Involved at a late stage of 
the stimulus-secretion coupling pathway. It is now thought that calcium ion- 
stimulated secretion from a number of specialised secretory cell types is 
mediated by this GTP-binding protein (Gomperts, 1990; Lindau & 
Gomperts, 1991). Initial findings from this (Guild, 1991) and other 
laboratories (Luini & DeMatteis, 1988 & 1990) using the non-hydrolysable 
GTP analogue guanosine 5'-0-(3-thiotriphosphate) (GTP- y -S) have 
suggested that such a GTP-binding protein may mediate the effects of 
changes in the cytosolic free calcium ion concentration upon ACTH 
secretion from AtT-20 cells. In addition ACTH secretion is inhibited by a 
heterotrimeric GTP-binding protein which mediates the effects of SRIF and
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also acts at a late stage in the stimulus secretion coupling pathway. This 
GTP-binding protein can be regarded as the inhibitory equivalent to Ge and 
has therefore been dubbed Gei (Luini & DeMatteis, 1988 & 1990).
The first aim of this study was to confirm that previously observed 
effects of GTP- y-S  upon ACTH secretion from permeabilised AtT-2 0  cells 
(Guild, 1991 ; Luini & DeMatteis, 1988 & 1990) were due to activation of Ge 
and to further characterise Ge-stimulated ACTH secretion. In addition it 
was hoped to determine, using a number of pharmacological tools, whether 
this stimulatory GTP-binding protein, which mediates the effects of calcium 
ions upon ACTH secretion, displays characteristics consistent with it, in 
common with Gei, being a heterotrimeric GTP-binding protein or whether it 
displays characteristics which suggest it may be a monomer or perhaps an 
as yet uncharacterised GTP-binding protein.
(ii) Cyclic AMP-dependent protein kinase & protein kinase 0
The technique of cell permeabilisation has also been used to further 
investigate the mechanisms mediating cyclic AMP-regulated ACTH 
secretion. By this approach it has been demonstrated that cyclic AMP has 
a second action In the regulation of ACTH secretion from AtT-20 cells. 
Cyclic AMP has no effect upon ACTH secretion from permeabilised AtT-20 
cells in the absence of cytosolic free calcium ions however it potentiates 
the ability of cytosolic free calcium ions to stimulate ACTH secretion (Guild, 
1991). This synergistic interaction seems to suggest that cyclic AMP may 
also interact with the calcium ion messenger system at a stage distal to 
changes in cytosolic calcium ion concentrations. Thus it appears that cyclic 
AMP, and therefore PKA, has at least two sites of action in the ACTH 
stimulus-secretion coupling pathway of anterior pituitary corticotrophs both
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of which involve an interaction with the calcium ion messenger system. 
PKA appears capable of increasing the cytosolic free calcium ion 
concentration and also of modulating the ability of a particular cytosolic free 
calcium ion concentration to stimulate ACTH secretion.
There is also evidence to suggest that PKC may also have a point of 
regulation in the ACTH stimulus-secretion coupling pathway which is 
unrelated to the elevation of cytosolic free calcium ion levels. As already 
discussed PKC is capable of stimulating ACTH secretion by an elevation of 
the cytosolic free calcium ion concentration due to an inhibition of 
potassium channels which in turn results in a depolarisation and an 
activation of voltage-dependent calcium channels (Guild & Reisine, 1987; 
Reisine, 1989). This action however is quickly followed by the inhibition of 
the voltage-dependent calcium channel and as a result the rise in cytosolic 
free calcium ion concentration observed in response to activation of PKC is 
a transient one (Guild & Reisine, 1987; Reisine, 1989). In contrast the 
evoked secretory response is persistent and long outlasts the changes in 
cytosolic free calcium ion concentrations (Guild & Reisine, 1987; Reisine, 
1989) a situation quite unlike that observed with PKA-stimulated ACTH 
secretion. This may suggest that PKC, in common with PKA, may also 
have additional actions in the ACTH stimulus-secretion coupling pathway 
distal to changes in the concentration of cytosolic free calcium ions. The 
second main aim of this study was to determine using the permeabilised 
cell preparation whether PKC does indeed have a point of regulation in the 
ACTH stimulus-secretion coupling pathway which is unrelated to the 
elevation of cytosolic calcium ion concentration. The role of PKC at this late 
stage of the stimulus-secretion coupling pathway would then be compared 
to that of PKA.
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&0BJECT1YES
It Is clear that the second messenger pathways mediating the 
effects of CRF-41 and AVP, as well as a variety of other secretagogues, 
upon ACTH secretion from anterior pituitary corticotrophs are complex. As 
detailed above the effects of CRF-41 and AVP are largely mediated by 
PKA and PKC respectively which in turn evoke ACTH secretion by raising 
the cytosolic free calcium ion concentration, regarded as the central trigger 
to hormone secretion. These mechanisms are relatively well understood, 
however this is not the case with regard to the mechanisms which mediate 
the effects of calcium ions upon the secretory apparatus. The aim of this 
study was therefore to investigate the mechanisms mediating calcium ion- 
stimulated ACTH secretion from anterior pituitary corticotrophs using the 
AtT-20 anterior pituitary cell line as a model system.
Initial results from the present study confirmed previous findings 
which suggested that Ge mediates calcium ion-stimulated ACTH secretion 
from AtT - 2 0  cells (Guild, 1991). As previously mentioned both 
heterotrimeric and monomeric GTP-binding proteins have been implicated 
in various aspects of the secretory process (Ferro-Novick & Novick, 1993;
Nuoffer & Balch, 1994; Pfeffer, 1992) and as a result both represent 
candidates for the GTP-binding protein Ge- Having confirmed the existence 
of this protein in AtT-20 cells it was also an aim of this study to gain 
evidence to suggest whether or not this GTP-binding protein belongs to the 
heterotrimeric or monomeric family of GTP-binding proteins. A number of 
pharmacological agents affecting GTP-binding protein function have been 
identified which display a degree of selectivity towards heterotrimeric, as 
opposed to monomeric, GTP-binding proteins. These include aluminium 
fluoride (AIF(3-5 )) which is capable of activating heterotrimeric GTP-binding
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proteins by binding to GDP and mimicking the y-phosphoryi group of GTP 
and thus converting the protein to the active conformation (Higashijima et 
a i, 1991). Monomeric GTP-binding proteins appear in contrast to be 
insensitive to AIF(3 ,5 ) (Kahn, 1991). Another is the amphiphilic 
tetradecapeptide mastoparan which has a wide variety of actions which are 
largely attributed to the activation of heterotrimeric GTP-binding proteins 
(Higashijima et a i, 1988 & 1990; Weingarten, 1990). In addition the 
bacterial exotoxins pertussis toxin (PTX) from Bordetella pertussis and 
cholera toxin (CTX) from Vibrio cholerae both posses mono ADP-ribosyl 
transferase activity. PTX has the capacity to transfer the ADP-ribose 
moiety of the cofactor p-nicotinamide adenine dinucleotide (NAD) onto a 
specific cystine residue of the a  subunit of certain members of the G; 
subfamily of heterotrimeric GTP-binding proteins which prevents activation 
of these proteins by their endogenous activators. CTX is also capable of 
transferring the ADP-ribose moiety from NAD in this case to a particular 
arginine residue on the a  subunit of members of the Gg subfamily of 
heterotrimeric GTP-binding proteins resulting in a persistent activation of 
these proteins due to an inhibition of their intrinsic GTPase activity 
(Yamane & Fung, 1993). It was therefore decided to investigate the 
possibility that Ge may be a heterotrimeric GTP-binding protein by means 
of a pharmacological approach employing these and other related agents.
Having established that a GTP-binding protein mediates the effects 
of calcium ions another aim of this study was to determine what mediates 
the effects of G© upon ACTH secretion. As outlined above there is 
evidence to suggest that PKC (Guild & Reisine, 1987; Reisine 1989) has at 
least one additional action in the regulation of ACTH secretion from AtT-20 
cells which is unrelated to the elevation of the cytosolic free calcium ion 
concentration. These studies were carried out in intact AtT-20 cells and as
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a result the evidence for such an action is therefore indirect. In the present 
study it was however possible to investigate this suggestion further using 
permeabilised cells which allow a more direct approach. The second main 
aim of this study was therefore to confirm this suggestion, again using a 
number of pharmacological agents, that PKC has a point of regulation in 
the stimulus-secretion pathways of AtT-20 cells which is distal to changes 
in the cytosolic free calcium ion concentration. Such an approach proved 
successful in the study of PKA-mediated regulation of calcium ion- 
stimulated ACTH secretion from AtT-20 cells (Guild, 1991). This study 
suggested that PKA may have a point of regulation in the ACTH stimulus- 
secretion coupling pathway of AtT-20 cells which is distal to changes in the 
cytosolic free calcium ion concentration. It was therefore also an aim of the 
present study to gain further evidence to implicate PKA at a stage in the 
ACTH stimulus-secretion coupling pathway distal to changes in the 
cytosolic free calcium ion concentration.
Results from the present study did indeed confirm that PKC, as well 
as PKA, does have a post calcium ion-point of regulation in the ACTH 
stimulus-secretion coupling pathway. One possibility which could not be 
ruled out is that one or other of these kinases may mediate the effects of 
this GTP-binding protein. Other explanations include the possibility that 
PKC or PKA may modulate calcium ion-stimulated ACTH secretion or 
alternatively these kinases may stimulate a secretory response which is 
completely independent of calcium ion/Ge-stimulated secretion. The nature 
of these post-calcium ion points of regulation was therefore also 
investigated. It was also hoped to gain evidence to suggest whether PKC 
and PKA act at this late stage in the stimulus-secretion coupling pathway 
by similar or distinct mechanisms.
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As previously mentioned PKC is now known to describe a family of 
closely related polypeptides (Dekker & Parker, 1994). Having established 
that PKC has more than one point of regulation in the ACTH stimulus- 
secretion coupling pathway the possibility that different isozymes contribute 
to ACTH secretion at different points of the stimulus-secretion coupling 
pathway was also investigated. A number of agents have been reported to 
selectively activate particular PKC isozymes (Ryves etal., 1991), therefore 
a pharmacological approach was again adopted. In particular whether or 
not different isozymes act at pre- or post-calcium site was determined. This 
was made possible once again by the use of permeabilised AtT-20 cells in 
which the cytosolic free calcium ion concentration can be controlled.
Taken together it was hoped that the various aspects of this study 
could suggest some possible mechanisms by which calcium ions, well 
established as the central trigger to exocytosis in AtT- 2 0  cells, stimulate 
ACTH secretion. By gaining a greater knowledge of these late stages of 
the secretory pathway it may be possible to understand to a greater extent 
why corticotropin-releasing factors, in particular CRF-41 and AVP, interact 
in the manner that they do to regulate ACTH secretion.
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1 CULTUBEJQF AtT-20 CELLS
Cells of the mouse AtT-20/D16-16 anterior pituitary cell line were 
grown and subcultured in a growth medium of Dulbecco's modified Eagle's 
medium (DMEM) containing glucose (4.5 g| i) supplemented with foetal 
calf serum ( 1 0  % v:v), penicillin ( 1 0 0  units ml-i) and streptomycin ( 1 0 0  pg 
ml-i). The cells were cultured as a monolayer in 80 cm^/ 260 ml flasks 
(Nunc, Gibco, Paisley, U.K.). Passaging required a flask of 80-90%  
confluent cells from which the growth medium was decanted and the cells 
liberated from the surface of the flask by incubation with trypsin-EDTA (0.5 
g trypsin and 0.2 g EOTA per litre of modified Pucks saline A) at 37 °C. 
The action of this trypsin solution was terminated by the addition of 5 ml of 
fresh growth medium. Cells to be used in ACTH release experiments from 
intact cells were plated in 24-well (16 mm diameter) multiwell plates 
(Costar, U.S.A.) at a initial density of 1 0  ^ cell per well in a final volume of 2 
ml per well and used 5-7 days after subculturing upon reaching 80-90 % 
confluency. The cells were grown at 37 °C with 10 % carbon dioxide in air 
and 96 % humidity. Cells to be used in used in ACTH release and cyclic 
AMP accumulation experiments from electrically-permeabilised cells were 
plated in 80 cm2 / 260 ml flasks at an initial density of approximately 2  
million cells per flask in a final volume of 20 ml. The cells were grown at 
37 °C with 10 % carbon dioxide in air and 96 % humidity and were used for 
experimental procedures 7-9 days after subculturing upon reaching 80-90 
% confluency. Routinely 1 0 - 2 0  million cells were harvested from each 
flask. These procedures were carried out in aseptic conditions in a Gelai re 
laminar air flow hood. The growth medium and constituents as well as the 
trypsin-EDTA solution were kept sterile and manipulated using sterile 10 ml 
serological pipettes (Falcon, A. & J. Beveridge, Edinburgh, U.K.).
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2 MEASUREMENT OF ACTH SECRETION FROM INTACT AtT-20 
CELLS 
(i) Ceil preparation
The growth medium was removed, cells adhering to the substrate in 
each well were washed 3 times with 1 ml of Dulbecco's modified Eagle's 
medium supplemented with 0.1 % (w;v) bovine serum albumin (fraction V) 
(DMEM/BSA) then incubated for 1 h in 1 ml of fresh DMEM/BSA at 37 °C 
in 10 % carbon dioxide in air and 96 % humidity.
(ii) Experimental procedure
The DMEM was decanted and replaced with 1 ml of fresh DMEM / 
BSA supplemented with the appropriate drugs. Zero time samples were 
removed at this point, centrifuged (1 0 ,0 0 0  g, 2 0  s) and the supernatants 
removed. The remaining samples were incubated for the appropriate 
period at 37 °C in 10 % carbon dioxide in air and 96 % humidity. 
Incubations were terminated by removing the DMEM/BSA bathing the 
cells, centrifugation of these samples (1 0 ,0 0 0  g, 20 s) and removal of the 
supernatant. The ACTH content of the supernatants were measured by 
radioimmunoassay (RIA). In each experiment sextuplicate samples were 
run for each condition.
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3 i /iJEASUREMENT O f-ACThl,. SECRETION EROM PERMEABILISED 
AtT:2Q CELLS
(I) Cell preparation
The growth medium was decanted and the cells washed in 1 0  ml of 
a balanced salt solution of the following composition (mM): NaC1145, KOI 
5.6, CaCIa 2 , MgCIa 0.5, glucose 5.6, HEPES 5, sodium ascorbate 0.5, pH 
7.4, containing 0.1 % (w:v) bovine serum albumin (BSA). Cells were 
liberated from the surface of the flask by incubation with trypsin-EDTA (0.5 
g trypsin and 0.2 g EDTA per litre of modified Pucks saline A) at 37 °C. 
The actions of this trypsin solution were terminated by adding the original 
growth medium and the balanced salt solution back into each flask. The 
cells were washed twice by centrifugation (200g, 5 min, room temperature) 
and resuspension in the balanced salt solution, then counted by means of 
a Coulter Counter and resuspended at a density of 1 million cells m|-i and 
incubated for 30 min at 37°C. After this time the cell suspension was 
centrifuged (200g, 5 min, room temperature) and the cell pellet washed 
twice by centrifugation (200g, 5 min, room temperature) and resuspension 
in a standard permeabilisation medium of the following composition (mM): 
potassium glutamate 129, PIPES (potassium salt) 2 0 , glucose 5, 
adenosine 5'-triphosphate (ATP) 5, EGTA 5, pH 6 .6  containing 0.1 % (w:v) 
BSA. Finally after resuspension at a density of 40 million cells ml“i in the 
standard permeabilisation medium the cells were electrically-permeabilised 
by subjection to intense electric fields of brief duration (Knight & Baker, 
1982).
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(ii) Eiectrical permeabiiisation
AtT-20 cells were permeabilised using apparatus similar to that first 
described by Knight & Baker (1982), a schematic diagram of which is 
shown in figure 9. Cells suspended at a density of 40 million cells ml-i in 
the basic permeabilisation medium were exposed to electric fields of brief 
duration by discharging a capacitor through the cell suspension. The 2 pF 
capacitor was charged to a known voltage by a 0-3 kV high voltage power 
supply, isolated from the source, and discharged through a cell suspension 
of 1 ml between two platinum electrodes 1 cm apart at room temperature. 
Routinely cell suspensions were exposed to 10 discharges each of 3 kV 
cm’ .^ The effectiveness of these parameters were confirmed using the 
nuclear stain ethidium bromide which is normally impermeable to cells and 
fluorescent only when in contact with nucleic acid. This stain can therefore 
be used as an indicator of cell permeability. Cells were subjected to the 
standard permeabilisation parameters and subsequently stained with 
ethidium bromide (10 pg/ml) as well as the cellular stain acridine orange (3 
pg/ml). Control AtT-20 cells are displayed in figure 10 while AtT-20 cells 
exposed to the electric fields are displayed in figure 11 both in the 
presence of an ethidium bromide/acridine orange mixture and viewed by 
means of a Leitz Dialux 20 fluorescence microscope. Of the cells exposed 
to the above permeabilisation parameters more than 98 % appear to be 
permeabilised compared to less than 5 % of the control cells. Cells 
subjected to the standard permeabilisation parameters remained 
permeable to the same extent for up to two hours.
Reversing
Switch
Perspex Block Metal
Electrodes
Cell Suspension
Capacitor
High Voltage Supply
Figure 9 Schematic representation of the apparatus used to 
expose cell suspensions to brief electric fields. (Adapted from Knight &
Baker, 1982).
Figure 10 Control AtT-20 cells In the presence of ethidium bromide 
/ acridine orange. Cells are viewed by means of a fluorescence 
microscope in the presence of ethidium bromide / acridine orange as 
described. When in the presence of nucleic acid the nuclear stain ethidium 
bromide will fluoresce red however under normal circumstances stained by 
acridine orange the cells will fluoresce green.
Figure 11 Permeabillsed AtT-20 ceils In the presence of ethldlum 
bromide / acrldlne orange. Cells were exposed to 10 discharges each of 
3 kV cm-1 and viewed by means of a fluorescence microscope in the 
presence of ethidium bromide / acridine orange as described. When in the 
presence of nucleic acid the nuclear stain ethidium bromide will fluoresce 
red however under normal circumstances stained by acridine orange the
cells will fluoresce green.
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(iii) Experimental procedure
Calcium-stimulated ACTH secretion. Permeabillsed cells were 
suspended at a density of 1 0  ^ cells ml"  ^ in a series of permeabiiisation 
buffers designed to establish and maintain free calcium ion concentrations 
over the range of IO'^m to 1 0 '^M. At this point zerotime samples were 
centrifuged (200 g, 5 min, 4 °C) and samples of the supernatant stored for 
subsequent measurement of ACTH content. The remaining cell 
suspensions were incubated at 37 °C in the presence and absence of the 
appropriate drugs for the appropriate incubation period at which point the 
incubations were terminated by centrifugation ( 2 0 0  g, 5 min, 4 °C) and 
samples of the supernatant stored for subsequent measurement of ACTH 
content by radioimmunoassay. In each experiment sextuplicate samples 
were run for each condition.
Calcium-independent ACTH secretion. Permeabillsed cells were 
suspended at a density of 1 0  ^ cells mh^ in a permeabiiisation buffer 
designed to establish and maintain a free calcium ion concentration of 1 0 '
9m (effectively zero calcium). At this point zerotime samples were 
centrifuged (200 g, 5 min, 4 °C) and samples of the supernatant stored for 
subsequent measurement of ACTH content. The remaining cell 
suspensions were incubated at 37 °C in the presence and absence of the 
appropriate drugs for the appropriate incubation period at which point the 
incubations were terminated by centrifugation (2 0 0  g, 5 min, 4 °C) and 
samples of the supernatant stored for subsequent measurement of ACTH 
content by radioimmunoassay. In each experiment sextuplicate samples 
were run for each condition.
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(iv) Permeabiiisation buffers
A series of calcium-EGTA permeabiiisation buffers were employed 
to establish and maintain a range of free calcium ion concentrations within 
the cytosol of permeabillsed cells (Portzehl et ai, 1964). Various quantities 
of 1 M calcium chloride and 1 M magnesium chloride solutions were added 
to a basic permeabiiisation medium of the following composition (mM): 
glutamate 129, PIPES 20, glucose 5, ATP 5, EGTA 5, pH 6 .6 , containing 
0.1 % (w:v) BSA to give the required calcium concentration over the range 
of 1 nM to 1 mM and a magnesium concentration of 1 mM when in 
equilibrium with 5 mM EGTA and 5 mM Mg ATP (both present in the basic 
permeabiiisation medium) at pH 6 .6 . The exact quantities of calcium 
chloride and magnesium chloride (standard 1 M stock solutions) added to 
1 0 0  ml of basic medium were calculated by a computer programme written 
on the basis of programmes for hand held calculators (Fabiato & Fabiato,
1979; Perrin & Sayce, 1967) and are displayed in table 1. A cytosolic free 
calcium ion concentration of lO'^M was considered to be essentially 
calcium ion free and was adopted for experiments carried out in the 
effective absence of cytosolic free calcium ions. The calcium concentration 
of these buffers was checked using a calcium sensitive electrode (Russel 
pH Limited) which was calibrated by means of a series of calcium 
standards with known free calcium ion concentrations over the range of 1 0 "
9m - 1 0 ‘^M, the composition of which are shown in table 2 , as previously 
described (Tsien & Rink, 1980). A calibration curve was constructed in 
order to convert electrode potential readings obtained by the electrode into 
a measure of the free calcium ion concentration of the permeabiiisation 
buffers. A typical calcium electrode calibration curve is shown in figure 12.
[free Ca2+] (log M) -9 -8 -7 -6 -5 -4 -3
CaClg (pi / 100 ml) 0 2 .0 19.7 146.0 405.0 516.0 734.0
MgCl2 (pi / 100 ml) 531.0 530.0 530.0 529.0 525.0 510.0 411.0
Table 1 Calcium chloride and magnesium chloride composition 
of permeabiiisation buffers. The indicated quantities of calcium chloride 
(CaCIa) and magnesium chloride (MgClg) (standard 1 M solutions) were 
added to 1 0 0  ml of basic medium as described to produce a series of 
permeabiiisation buffers with the indicated free calcium ion concentration.
[free Ca2+J 
(Log M)
[CaCIa]
(mM)
Ligand 
(10 mM)
[KCI]
(mM)
pH buffer 
(10 mM)
pH
-3 1 none 98 MOPS 7.30
-4 5 NTA 90 HEPES 7.39
-5 5 NTA 90 TAPS 8.42
- 6 5 HEEDTA 90 HEPES 7.70
-7 5 EGTA 90 MOPS 7.29
- 8 5 EGTA 90 HEPES 7.80
-9 0 EGTA 1 0 0 HEPES 7.80
Table 2 Composition of calcium electrode calibrating solutions.
Each different calibrating solution contained 10 mM of the specified pH 
buffer and 10 mM of the specified calcium ligand (except 1 mM calcium 
which contained no ligand). The pH of each solution was brought to the 
desired level by titration with potassium hydroxide. The final Cl" 
concentration was always 100 mM. NTA, nitrilotriacetic acid.
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Figure 12 A representative calcium electrode standard curve. Curve 
shows electrode potential readings from calcium electrode calibrating 
solutions containing the indicated concentrations of free calcium ions. The 
results are expressed as the means from duplicate determinations; s.e. 
mean shown by the vertical bars. Absence of error bars indicate that they
lie within the symbol.
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4 ACTH RADIOIMMUNOASSAY
The ACTH content of experimental samples was initially determined 
by a radioimmunoassay based upon a method previously described by 
Hook et al, (1982). This assay relies upon the competition between ACTH, 
present in experimental samples, and radioactively labelled ACTH to a 
fixed quantity of ACTH antibody. The greater the quantity of unlabelled 
ACTH present the smaller the amount of labelled ACTH will be bound to 
the antibody, that is to say there is an inverse relationship. To each 100 pi 
of experimental sample containing unknown amounts of ACTH, 100 pi of 
rabbit anti-human ACTH serum was added at a final dilution of 1:40 000 in 
an ACTH-RIA buffer of the following composition; 0 .0 2  M barbital buffer, 
pH 8 .6 , containing 0.3% (w:v) BSA and 0.2 % (v:v) 2-mercaptoethanol.
This ACTH antiserum dilution also contained 0 .0 2  % normal rabbit serum.
200 pi of [1251] ACTH was also added to each sample, diluted with ACTH- 
RIA buffer to give approximately 10 000 counts min*i in each sample. The 
reagents were allowed to equilibrate by overnight incubation (16-24 h) at 
4°C after which time the antibody-ACTH complex was precipitated by 
addition of a second antibody, donkey anti-rabbit immunoglobulin G. 1 0 0  pi 
of this second antibody, at a dilution of 1:20 in ACTH-RIA buffer was added 
to each sample and again incubated overnight (16-24 h). The precipitate 
was pelleted by centrifugation (3200 g , 30 min, 4°C). The supernatant 
which contains unbound ACTH was removed by aspiration and the 
radioactivity associated with the pellet was determined by a Packard Cobra 
II auto gamma counter. Each sample was assayed in duplicate.
The amount of ACTH in each sample was quantified by constructing 
a standard curve using known concentrations of human ACTH 1-39. This 
hormone was diluted in ACTH-RIA buffer to give 100 pi aliquots containing
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varying amounts of human ACTH 1-39 ranging from 0-5000 picogrammes, 
the expected range of hormone secretion. These standard ACTH dilutions, 
again in duplicate, were subjected to the same protocol as the 
experimental samples. By comparing each count in the standard curve to a 
sample containing only [i25j]_ACTH the percentage of the [125|].a c t H 
bound to the ACTH antiserum was calculated. Non specific [i25j].ACTH 
binding was calculated by means of a sample containing [125|]_ACTH and 
200 pi ACTH-RIA buffer and was taken into consideration in calculating the 
percentage [125|]-a c TH bound. By plotting the percentage of [125|]-ACTH 
bound against the ACTH concentration the standard curve was obtained. 
A typical standard curve for this ACTH-RIA is shown in figure 13. A new 
standard curve was constructed with each set of experimental samples. 
Therefore by knowing the amount of radioactivity associated with each 
experimental sample the percentage of the [125|]-a c t h  bound can be 
calculated and by means of the standard curve converted to a measure of 
ACTH present in each experimental sample.
For unknown reasons the ACTH radioimmunoassay initially 
employed became highly variable. The ACTH content of experimental 
samples was therefore measured by an alternative radioimmunoassay 
based upon the previously described method of Antoni et a!. (1983) which 
proved to be more reliable. To each 100 pi of experimental sample, 
containing unknown amounts of ACTH, 100 pi of rabbit anti human ACTH 
serum was added to give a final dilution of 1: 32000 in a modified ACTH- 
RIA buffer of the following composition; 0.05 M sodium phosphate, 6  % 
(w:v) polyethylene glycol 8000, 0.1% (w:v) BSA, 0.1% (v:v) triton-X 100, 
2.5 mM EDTA, pH 7.4. This ACTH-antiserum dilution also contained 0.02 
% (v:v) normal rabbit serum. 1 0 0  pi of [125|]-acth was also added to each
sample, diluted with modified ACTH-RIA buffer to give approximately 10
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Figure 13 A representative ACTH radioimmunoassay standard 
curve using the original protocol. Standard concentrations of ACTH 
were incubated in the presence of [^25|]-acth as described. The results 
are expressed as the means from duplicate determinations; s.e. mean 
shown by the vertical bars. Absence of error bars indicate that they lie
within the symbol.
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0 0 0  counts min-'i in each tube. The reagents were allowed to equilibrate by 
overnight incubation (16-24 h) at 4°C. The antibody-ACTH complex was 
precipitated by addition of a second antibody, donkey anti-rabbit 
immunoglobulin G. 100 \i\ of this second antibody, diluted in ACTH-RIA 
buffer at a dilution of 1:10 containing 0.5% (v:v) normal rabbit serum, was 
added to each sample and further incubated at room temperature for 3 h 
after which time 1 ml of 3% (w:v) polyethylene glycol 6000 was added to 
each tube. The precipitate was pelleted by centrifugation (3200 g , 30 min, 
4°C). The supernatant which contains unbound ACTH was removed by 
aspiration and the radioactivity associated with the peilet was determined 
by a Packard Cobra II auto gamma counter. Each sample was assayed in 
duplicate. The amount of ACTH in each experimental sample was 
quantified by constructing a standard curve by the same method as 
previously described using however the modified ACTH-RIA buffer. A 
typical standard curve for this modified ACTH-RIA is shown in figure 14.
5 MEASUREMENT OF CYCLIC AMP ACCUMULATION FROM 
PERMEABILISED AtT-20 CELLS
AtT-20 cells were prepared and electricaily-permeabilised as 
previously described. Permeabilised cells were then suspended at a 
density of 1 0 ® cells mh"! in a standard permeabiiisation medium designed 
to establish and maintain a free calcium ion concentration of lO'^M 
(effectively zero calcium) supplemented with the appropriate drugs. The 
medium was also supplemented with the phosphodiesterase Inhibitor 1- 
isobutyl 3-methylxanthine (IBMX, 10’®M). At this point zero time samples 
were centrifuged (1 0 ,0 0 0  g ,20  s) and samples of the supernatant stored 
for subsequent measurement of cyclic AMP content. The cell suspensions
oz3Om
X
o<
%
30
1 10 100 1000 10000
ACTH, (pg)
Figure 14 A representative ACTH radioimmunoassay standard 
curve using the modified protocol. Standard concentrations of ACTH 
were incubated in the presence of C^sij-agTH as described. The results 
are expressed as the means from duplicate determinations; s.e. mean 
shown by the vertical bars. Absence of error bars indicate that they lie
within the symbol.
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were incubated at 37 °C for the appropriate incubation period at which 
point the incubations were terminated by centrifugation (1 0 ,0 0 0  gf, 2 0  s) 
and samples of the supernatant removed and stored for subsequent 
measurement of cyclic AMP content. In each experiment sextuplicate 
samples were run for each condition.
6 CYCLIOAMP. RADlOiimUHO ASSAY
The cyclic AMP content of experimental samples was determined by 
a radioimmunoassay based upon a method previously employed to 
measure cyclic GMP accumulation (McCartney & Cramb, 1993). Again this 
assay relies upon a competition between cyclic AMP, present in 
experimental samples, and a radioactively labelled cyclic AMP derivative to 
a fixed quantity of cyclic AMP antibody. To each 100 pi of experimental 
sample, containing an unknown amount of cyclic AMP, 250 pi of rabbit 
cyclic AMP anti-serum was added at a final dilution of 1 : 5 000 in a cyclic 
AMP-RIA buffer of the following composition; 50 mM sodium acetate, pH 
4.75, containing 0.5 % (w:v) BSA. Cyclic AMP antiserum was prepared by 
the method of Rich man etal. (1980) and was the gift of Dr Gordon Cramb, 
University of St Andrews. 100 pi [f25|]-succinyl cyclic AMP tyrosyl methyl 
ester ([f25|]_scAMP-TME) was also added to each sample diluted with 
cyclic AMP-RIA buffer to give approximately 10 000 counts min'f. The 
reagents were allowed to equilibrate by overnight incubation (16-24 h) at 4 
°C. The antibody-cyclic AMP complex was precipitated by the addition of 
ice cold 96 % ethanol, vortexing and incubation at room temperature for 30 
min The resulting precipitate pelleted by centrifugation ( 2 0 0 0  g , 30 min, 4 
°C). The supernatant was removed by aspiration and the radioactivity
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associated with the pellet determined by a Packard Cobra II auto gamma 
counter. Each sample was assayed in duplicate.
The amount of cyclic AMP in each sample was quantified by 
constructing a standard curve using cyclic AMP diluted in cyclic AMP-RIA  
buffer to give 100 pi aliquots containing 0.0625 - 32 pmol cyclic AMP. 
These standard cyclic AMP dilution's, again in duplicate, were subjected to 
the same protocol as the experimental samples. By comparing each count 
in the standard curve to a sample containing only [f25|].scAMP-TME the 
percentage of the [f25j]-ScAMP-TME bound to the antibody was 
calculated. Non-specific [^2S|]_scAMP-TME binding was determined by 
means of a sample containing [‘l25|]_scAMP-TME and 350 pi cyclic AMP- 
RIA buffer and was taken into consideration when calculating the 
percentage [f25|]-ScAMP-TME bound. By plotting the percentage of the 
[125|]_s c AMP-TME  bound to the antibody against the cyclic AMP  
concentration the standard curve was obtained. A typical standard curve 
for this cyclic AMP-RIA is shown in figure 15. A new standard curve was 
constructed with each set of experimental samples. Therefore by knowing 
the amount of radioactivity associated with the pellet of each experimental 
sample the percentage of the [f25|]-ScAMP-TME bound to the antibody 
can be calculated and by means of the standard curve can be converted to 
an accurate measure of cyclic AMP present in each experimental sample.
7 iODINATIONS
[1251] labelled ACTH for radioimmunoassay use was produced using 
the lodo-gen reagent (1,3,4,6-tetrachloro-3a,6a-diphenyl glycouril) which 
was first described as a reagent for iodination by Fraker and Speck (1978).
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Figure 15 A representative cyciic AMP radioimmunoassay standard 
curve. Standard concentrations of cyclic AMP were incubated in the 
presence of [f25|]_succinyl cyclic AMP tyrosyl methyl ester as described. 
The results are expressed as the means from duplicate determinations; 
s.e. mean shown by the vertical bars. Absence of error bars indicate that
they lie within the symbol.
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5 mg of lodo-gen was diluted in 25 ml of chloroform and divided into 50 \x\ 
aliquots (i.e. 10 ng lodo-gen/tube). The tubes were placed in a water bath 
at 37°C and evaporated to dryness allowing the tubes to become coated 
with lodo-gen. Standard human ACTH 1-39 was diluted in a 0.5 M sodium 
phosphate buffer pH 6.0-7.4 to give a final ACTH concentration of 6 x 10' 
®M. 40 jxl of this ACTH was added to an iodogen coated tube along with 
approximately 1 mCi of Na [125|] and allowed to react for 30 min at room 
temperature. During this time the reagent iodi nates exposed tyrosine 
residues by an oxidative reaction. The reaction was halted by adding 1 ml 
of 0.1 % (v:v) trifluoroacetic acid. An octyl C8  amprep column (Amersham, 
Buckinghamshire, U.K.) was prepared by washing with 4 ml methanol 
followed by 4 ml distilled water, the iodinated ACTH sample added and 
washed again with 6 ml 0.1 % (v:v) trifluoroacetic acid. 2 ml of 10, 20, 30, 
40, 50, and 60 % (v:v) acetonitrile each containing 0.1 % (v.v) 
trifluoroacetic acid were passed through the cartridge in turn and the six 
eluted samples containing varying amounts of iodinated ACTH collected. 1 
ml of methanol was added to each of these samples. The amount of 
radioactivity incorporated into each eluted sample was determined by 
counting a fraction of each sample in a Packard Cobra II auto gamma 
counter. The 30-40 % acetonenitrile solutions produced the eluted samples 
which gave the highest degree of radioactivity incorporation and therefore 
optimum results in the radioimmunoassay. A typical elution profile is 
displayed in figure 16. [I25|]-succinyl cyclic AMP tyrosyl methyl ester was 
produced by a similar method and was the gift of Dr Gordon Cramb, 
University of St Andrews.
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Figure 16 a c TH elution profile. ACTH was iodinated and eluted
from an octyl C8  cartridge (Amersham) by the indicated concentration of 
acetonitrile as described. The results are expressed as the mean ±  s.e. 
mean from three separate iodinations. Absence of error bars indicate that
they lie within the columns.
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a^IAnsnCALANALYSlS
In each experiment sextuplicate determinations at each 
experimental condition were made and each experiment was repeated 
three times on different days. ACTH secretion is expressed as the mean ±  
s.e. mean. Statistical significance was determined by means of either a 
paired t-test or in cases of multiple comparisons an ANOVA test with 
Scheffe's F-test post hoc analysis.
.9-MAIERiALS-& ABBREVIATIONS
The following substances (with their sources) were used: Dulbecco’s 
modified Eagle's medium containing glucose 4.5 gl'i (DMEM), foetal calf 
serum, normal rabbit serum, penicillin (5000 units/ml)/ streptomycin (5000 
jig/ml) and trypsin-EDTA (0.5 g trypsin and 0.2 g EDTA per litre of modified 
Pucks saline A) from Gibco, Paisley, U.K.; adenosine 3' : 5' cyclic 
monophosphate (cyclic AMP), adenosine 5'-triphosphate (ATP), aluminium 
chloride, barbital (sodium salt), bovine serum albumin (BSA) (fraction V) , 
cholera toxin (CTX), EDTA (ethylenediamine-tetraacetic acid), forskolin, 
glutamate (monopotassium salt), EGTA (ethylene glycol-bis(P-aminoethyl 
ether) N, N, N ‘, N '-tetra acetic acid), HEEDTA (N- 
hydroxyethylethylenediaminetriacetic acid), HEPES (N-[2-hydroxyethyl] 
piperazine-N'-[2-ethanesulfonic acid]), 1 -isobutyl 3-methylxanthine (IBMX), 
mastoparan (lle-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-lle-Leu- 
NH2 ), 2-mercaptoethanol, MOPS (3-[N-morpholino]propanesulfonic acid), 
p-nicotinamide adenine dinucleotide (NAD), nitrilotriacetic acid (NTA), 
pertussis toxin (PTX), 4a phorbol, phorbol 12, 13-dibutyrate (PDBu),
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phorbol 12,13-didecanoate (FDD), phorbol 12-myristate 13-acetate (PMA), 
polyethylene glycol 8000, PIPES (piperazine-N-N'-bis-[2-ethanesulfonic 
acid]), potassium fluoride, sodium fluoride, sodium phosphate 
(monosodium phosphate), TAPS (N-tris[hydroxymethyl]methyl-3 - 
am inopropanesulfon ic  ac id ), and Triton X -10 0  (t-
octylphenoxypolyethoxyethanol) from Sigma, Poole, U.K.; calyculin A, 
chelerythrine chloride, 1 2 -deoxyphorbol 13-phenylacetate 2 0 -acetate 
(dPPA), 1,2-dioctanoyl-sn-glycerol (DOG), 1-oleoyl-2-acetyl-sn-glycerol 
(OAG) and thymeleatoxin (TMX) from L.C. Laboratories distributed by 
Calbiochem-Novabiochem, Nottingham, U.K.; guanosine 5 '-0 -(2 - 
thiodiphosphate) (GDP- p -S) and guanosine 5'-0-(3-thiotriphosphate) 
(GTP- Y -S) from Boehringer Mannheim, Lewes, U.K.; mas-7 (Ile-Asn-Leu- 
Lys-Ala-Leu-Ala-Aia-Leu-Ala-Lys-Ala-Leu-Leu-NHg), C ortico troph in
releasing factor (CRF-41, human / rat), mas-17 (Ile-Asn-Leu-Lys-Ala-Lys- 
Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NHa) and [D-trp8 ]-somatostatin (SRIF) 
from Peninsula Laboratories, Belmont, U.S.A.; anti-rabbit immunoglobulin 
G was the gift of the Scottish Antibody Production Unit, Carluke, U.K.; 
human ACTH antiserum and standards were the gift of the National 
Hormone and Pituitary programme, N.I.A.D.D.K., N.I.H., U.S.A.; cyclic 
AMP antiserum and standards and [I25|]_succinyl cyclic AMP-tyrosyl 
methyl ester ([^25j].scAMP-TME) were the gift of Dr Gordon Cramb, 
University of St Andrews, U.K.; lodo-gen reagent from Pierce & Warriner, 
Chester, U.K.; radioisotopes from Dupont, Stevenage, U.K. All other 
chemicals were of analar grade and readily commercially available.
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JLAIi.lMyj£aTlGATLO[i. INTO THE INVOLVEMENT OF GTP-BlNDlNfi 
PRQIEINS, MEPiAntlG.. CALCIUM IQIiiSTiMULATEP AG IH  
SE.CREIlQtif RGM AtT-20 CELLS
(i) Effects of calcium ions upon the late stages of the ACTH 
secretory pathway of AtT-20 cells
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells, over a period of 30 min, in a concentration-dependent manner 
becoming significantly greater than control secretion (defined here and 
subsequently as ACTH secretion in standard permeabiiisation medium in 
the absence of added secretagogues) at concentrations above 10'^M with 
an EC5 0  of 1.6 ± 0 .3  x 10"®M (figure 17). A 30 min incubation period has 
previously been shown to be suitable for the investigation of calcium ion- 
stimulated ACTH secretion from permeabilised AtT-20 cells (Guild, 1991) 
and therefore was adopted for all experiments investigating calcium ion- 
stimulated ACTH secretion, A free calcium ion concentration of 10"^M was 
found to be maximal with regard to ACTH secretion. ACTH secretion in 
response to a free calcium ion concentration of lO'^M was 218 ±  17 pg/10^ 
cells/30 min compared to control secretion which was 50 ±  3 pg/1Q5 
cells/30 min.
(ii) Effects of GTP- y -S upon the late stages of the ACTH secretory 
pathway of AtT-20 cells
The involvement of GTP-binding proteins in the late stages of the 
ACTH secretory pathway in AtT-20 cells was investigated using the non- 
hydrolysable GTP analogue GTP- y -S. A suitable incubation period for the 
investigation of GTP- y-S upon ACTH secretion from permeabilised AtT-20
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Figure 17 Effect of calcium ions upon ACTH secretion from 
permeabilised AtT-20 cells. Permeabilised cells were incubated for 30 
min as described in the methods in a series of calcium/EGTA buffers such 
that the indicated cytosolic free calcium ion concentration resulted and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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cells was initially determined, ACTH was secreted in a time-dependent 
manner from permeabilised AtT-20 cells in standard permeabiiisation 
medium in the absence of added secretagogues becoming significant after 
60 min (figure 18). GTP- y-S  (lO'^M) enhanced this control secretion in a 
time-dependent manner becoming significantly greater than control 
secretion after 20 min (figure 18). Secretion in response to GTP- y-S  after
30 min was 60 ± 2  pg/IO^ cells compared to a control secretion which was 
40 ±  2 pg/105 cells after the same time period. A standard incubation 
period of 30 min was chosen for all subsequent experiments in which GTP- 
y-S-stimulated ACTH secretion from permeabilised AtT-20 cells was being 
investigated. GTP- y -S stimulated ACTH secretion from permeabilised 
AtT-20 cells in standard permeabiiisation medium in a concentration- 
dependent manner becoming significantly greater than control secretion at 
concentrations above lO’^M (figure 19). ACTH secretion in response to 
GTP- y -S (lO'^M) was 98 + 8 pg/IO^ cells/30 min compared to control 
secretion which was 33 + 3 pg/10^ cells/30 min. The ability of GTP- y-S to 
stimulate ACTH secretion in standard permeabiiisation medium, which 
contains effectively no calcium ions, suggests that a GTP-binding protein 
(or proteins) contributes to ACTH secretion from AtT-20 cells at a stage in 
the stimulus-secretion coupling pathway at a stage distal to changes in 
cytosolic calcium ion levels. In the present study higher concentrations of 
GTP- y -8 proved too expensive therefore complete concentration 
response curves were unfortunately not obtained.
Having established that calcium ions and GTP- y-S  both stimulate 
ACTH secretion from permeabilised AtT-20 cells the possibility that they do 
so via a common mechanism, i.e. by the activation of a GTP-binding 
protein, was investigated by studying the effects of these two 
secretagogues in combination. Calcium ions stimulated ACTH secretion
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Figure 18 Time course of GTP- y -S-stimuiated ACTH secretion 
from permeabilised AtT-20 cells. Permeabilised cells were incubated for 
the indicated time periods as described in the methods in standard 
permeabiiisation medium in the presence (♦ )  or absence (■) of GTP- y-S  
(IQ-^M) and ACTH secretion measured by radioimmunoassay. The results 
are expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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Figure 19 Effect of GTP- y -S upon ACTH secretion from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabiiisation medium for 30 min 
supplemented with the indicated concentration of GTP- y-S and ACTH 
secretion measured by radioimmunoassay. The results are expressed as 
the mean ±  s.e. mean from three separate experiments.
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from permeabilised AtT-20 cells in a concentration-dependent manner 
becoming significantly greater than control secretion at concentrations 
above iO'^M (figure 20). GTP- y - S (10-5M) significantly stimulated ACTH 
secretion in standard permeabiiisation medium (free calcium ion 
concentration of 10‘^M), however in contrast was unable to enhance ACTH 
secretion observed in response to a free calcium ion concentration of 10* 
(figure 20), ACTH secretion in standard permeabiiisation medium was 
57 + 6 pg/10^ cells/30 min in the absence of GTP- y -S compared to 159 ±  
5 pg/105 cells/30 min in the presence of GTP- y-S. ACTH secretion in a 
free calcium ion concentration of lO'^M was 216 ±  29 pg/10^ cells/30 min 
in the absence of GTP- y -S compared to 208 ±  18 pg/10^ cells/30 min in 
the presence of GTP- y -S. These results demonstrate that GTP- y -S is 
able to stimulate ACTH secretion from permeabilised AtT-20 cells in the 
effective absence of calcium ions however is unable to enhance calcium 
ion-stimulated ACTH secretion from permeabilised AtT-20 cells. This 
convergence may suggest that the effects of calcium ions and GTP- y -S 
are mediated by a common mechanism i.e. the GTP-binding protein Ge-
(iii) Mechanisms mediating calcium ion- and Ge-stimuiated ACTH 
secretion from AtT-20 cells
Chelerythrine chloride is a potent and selective inhibitor of PKC 
(Herbert et al., 1990) which was employed in the present study to 
investigate the possibility that activation of PKC mediates calcium ion- and 
GTP- y -S-stimulated ACTH secretion from permeabilised AtT-20 cells. 
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 cells in 
a concentration-dependent manner becoming significantly greater than 
control secretion at concentrations above 10'®M (figure 21). This calcium 
ion-stimulated secretion was not significantly different in the presence and
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Figure 20 Effect of GTP- y -S upon calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in a series of 
calcium/EGTA buffers such that the indicated cytosolic free calcium ion 
concentration resulted in the presence (♦ )  and absence (■) of GTP- y-S  
(10'5M) and ACTH secretion measured by radioimmunoassay. The results 
are expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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Figure 21 Effect of cheierythrine chloride upon calcium ion- 
stimulated ACTH secretion from permeabilised AtT-20 cells.
Permeabilised cells were incubated for 30 min as described in the methods 
in a series of calcium/EGTA buffers such that the indicated cytosolic free 
calcium ion concentration resulted in the presence { ♦ )  and absence (■) of 
cheierythrine chloride (lO'^M) and ACTH secretion measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments. Absence of error bars indicate that they
lie within the symbol.
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absence of cheierythrine chloride (lO'^M) (figure 21). ACTH secretion in 
response to a free calcium ion concentration of 10‘^M was 213 ±  32 pg/IO® 
cells/30 min in the absence of cheierythrine chloride compared to 193 ±  21 
pg/10^ cells/30 min in the presence of cheierythrine chloride. GTP- y -S 
stimulated ACTH secretion from permeabilised AtT-20 cells in standard 
permeabilisation medium in a concentration-dependent manner becoming 
significantly greater than control secretion at concentrations above 10*®M 
(figure 22). This GTP- y -S-stimulated ACTH secretion cells was also not 
significantly different in the presence and absence of cheierythrine chloride 
(lO'^M) (figure 22). ACTH secretion in response to GTP- y-S  (10"‘^ M) was 
248 ±  37 pg/105 cells/30 min in the absence of cheierythrine chloride 
compared to 246 ±  72 pg/10^ cells/30 min in the presence of cheierythrine 
chloride. Results from the present study indicate that cheierythrine chloride 
(lO'^M) is capable of completely inhibiting the effects of PKC activators in 
AtT-20 cells under similar conditions (a detailed account of this positive 
control can be found on p73) therefore the inability of cheierythrine chloride 
to inhibit calcium ion- and GTP- y -S-stimulated secretion suggests that 
neither of these secretagogues stimulate ACTH secretion from 
permeabilised AtT-20 cells via activation of PKC.
As discussed above the enzyme responsible for the generation of 
cyclic AMP, adenylate cyclase, can be regulated by calcium ions and by 
GTP-binding proteins (Cooper etaL, 1995; lyenger, 1993; Tang & Gilman, 
1992). In addition the present study demonstrated that GTP- y-S  (10’^M) 
was capable of stimulating cyclic AMP accumulation (table 3). The 
possibility that the effects of calcium ions and GTP- y -S upon ACTH 
secretion from permeabilised AtT-20 cells were mediated by activation of 
adenylate cyclase and subsequent generation of cyclic AMP was 
investigated. Cyclic AMP (10’^M) had no significant effect upon ACTH
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Figure 22 Effect of cheierythrine chioride upon GTP- y  -S- 
stimulated ACTH secretion from permeabilised AtT-20 cells.
Permeabilised cells were incubated for 30 min as described in the methods 
in standard permeabilisation medium in the presence of the indicated 
concentration of GTP- y-S in the presence ( ♦ )  and absence (■) of 
cheierythrine chloride (10‘5M) and ACTH secretion measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments. Absence of error bars indicate that they
lie within the symbol. ,
CYCLIC AMP ACCUMULATION 
(pmol/105 CELLS/30 MIN)
CONTROL 1.3±1.0
G TP-y -S(10-4M) 15.0 ±3 .5
Table 3 Effect of GTP- y-S upon cyclic AMP accumulation from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of GTP- y-S (lO-^M) as indicated and cyclic 
AMP accumulation measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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secretion from permeabilised AtT-20 cells in standard permeabilisation 
medium over a period of 30 min (figure 23). ACTH secretion was 90 ±  16 
pg/1Q5 cells/30 min in the presence of cyclic AMP compared to control 
ACTH secretion which was 68 ±  11 pg/IO^ cells/30 min. In addition the 
effects of agents, the effects of which are already known to be mediated by 
cyclic AMP, upon ACTH secretion were investigated. The diterpene 
forskolin, from the roots of Coleus forskohlii is a potent activator of 
adenylate cyclase and is thus capable of stimulating the generation of 
cyclic AMP (Seamen et a!., 1981; Seamon & Daly, 1981). As discussed 
above the effects of CRF-41 upon ACTH secretion are also mediated by 
cyclic AMP generation. Forskolin (lO'^M) (figure 24) and CRF-41 (lO'^M) 
(figure 25) both significantly stimulated cyclic AMP accumulation from 
permeabilised AtT-20 cells in standard permeabilisation medium in the 
presence of IBMX (lO'^M) over a period of 30 min. In contrast forskolin 
(10'^M) (figure 26) and CRF-41 (10‘^M) (figure 27) both had no significant 
effect upon ACTH secretion from permeabilised AtT-20 cells in standard 
permeabilisation medium over a period of 30 min. Thus it appears that 
cyclic AMP and agents which stimulate ACTH secretion by raising cyclic 
AMP levels are unable to stimulate ACTH secretion from permeabilised 
AtT-20 cells in standard permeabilisation medium. It can therefore be 
assumed that calcium ion- and GTP- y -S-stimulated ACTH secretion from 
permeabilised AtT-20 cells are not mediated by the generation of cyclic 
AMP and subsequent activation of PKA and that these agents must 
stimulate ACTH secretion from AtT-20 cells by a different mechanism of 
action.
GTP- y -S-stimulated ACTH secretion from permeabilised AtT-20 
cells was found to be independent of ATP, normally present in the 
permeabilisation medium at a concentration of 5 x lO'^M. GTP- y -S
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Figure 23 Effect of cyclic AMP upon ACTH secretion from 
permeabilised AtT-20 ceils. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of cyclic AMP (10 '^ M) as indicated and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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Figure 24 Effect of forskolin upon cyclic AMP accumulation from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of forskolin (10'^M) as indicated and cyclic 
AMP accumulation measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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Figure 25 Effect of CRF-41 upon cyclic AMP accumulation from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of CRF-41 (10'^M) as indicated and cyclic 
AMP accumulation measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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Figure 26 Effect of forskolin upon ACTH secretion from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of forskolin (tO'^M) as indicated and ACTH 
secretion measured by radioimmunoassay. The results are expressed as 
the mean ±  s.e. mean from three separate experiments.
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Figure 27 Effect of CRF-41 upon ACTH secretion from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence and absence of CRF-41 (lO-'^M) as indicated and ACTH 
secretion measured by radioimmunoassay. The results are expressed as 
the mean ±  s.e. mean from three separate experiments.
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stimulated ACTH secretion from permeabilised AtT-20 cells in standard 
permeabilisation medium in a concentration-dependent manner (figure 28) 
becoming significantly greater than control secretion at concentrations 
above 10'®M. Omitting ATP from the permeabilsation medium had no 
significant effect upon this GTP- y -S-stimulated ACTH secretion at every
concentration of the guanine nucleotide investigated (figure 28). ACTH 
secretion in response to GTP- y -8 (lO’^M) was 96 ±  12 pg/IO^ cells/30 
min in the presence of ATP compared to 91 ± 1 5  pg/10® cells/30 min in 
the absence of ATP. Since ATP is a requirement for kinase activation (for 
reviews see Goldsmith & Cobb, 1994; Pawson, 1994; Taylor et at., 1993) 
this again suggests that GTP- y -S-stimulated ACTH secretion is not 
mediated by a kinase.
The protein phosphatase inhibitor calyculin A (Ishihara et a!., 1989) 
was employed in the present study to test the possibility that the effects of 
cytosolic free calcium ions and GTP- y-S  upon ACTH secretion from AtT- 
20 cells are mediated by a phosphatase. Initially increasing concentrations 
of the phosphatase inhibitor upon calcium ion- and GTP- y -S-stimulated 
ACTH secretion from permeabilised AtT-20 cells were investigated. 
Calcium ions (lO'^M) and GTP- y -S  (lO'^M) both stimulated ACTH 
secretion over 30 min from permeabilised AtT-20 cells (figure 29) which in 
both cases was significantly greater than control ACTH secretion. Calyculin 
A had no significant effect upon control ACTH secretion from 
permeabilised AtT-20 cells however did inhibit calcium ion (lO’^M)- and 
GTP- y -S (10-4M)-stimulated ACTH secretion in a concentration- 
dependent manner (figure 29) becoming significant at 10'®M in the case of 
GTP- y -S and 10-^M in the case of calcium ions. Secretion in response to 
GTP- y -S (lO’^M) was 102 + 7 pg/IO^ cells/30 min in the absence of 
calyculin A compared to 61 ±  2 pg/10^ cells/30 min in the presence of
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Figure 28 Effect of GTP- y-S upon ACTH secretion from 
permeabilised AtT-20 cells in the presence and absence of ATP.
Permeabilised cells were incubated for 30 min as described in the methods 
in the presence of the indicated concentration of GTP- y-S  either in 
standard permeabilisation medium which contains ATP (5 x IQ-^M) (■) or 
permeabilisation medium containing no ATP (♦ )  and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments.
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Figure 29 Effect of calyculin A upon calcium ion- and GTP- y  -S- 
stimulated ACTH secretion from permeabilised AtT-20 cells.
Permeabilised cells were incubated for 30 min as described in the methods 
in the indicated concentrations of calyculin A in the absence of added 
secretagogues (■) and in the presence of GTP- 7 - S (IQ-'iM) (♦ )  both in 
standard permeabilisation medium and also in the presence of calcium 
ions (lO'^M) (#) and ACTH secretion measured by radioimmunoassay. 
The results are expressed as the mean ±  s.e. mean from three separate
experiments.
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calyculin A (10'^M). Secretion in response to calcium ions (10 % )  was 109 
i  19 pg/10^ cells/30 min in the absence of calyculin A compared to 60 ±  3 
pg/IO^ cells/30 min in the presence of calyculin A (10 % ). A calyculin A 
concentration of 10 %  was chosen as standard for all subsequent 
experiments investigating the effects of the phosphatase inhibitor upon 
stimulated ACTH secretion.
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells in a concentration-dependent manner becoming significantly greater 
than control secretion at concentrations above 10*®M (figure 30). Calyculin 
A (10 % )  significantly inhibited calcium ion-stimulated ACTH secretion to 
the extent that there was no significant difference between control 
secretion and secretion in response to any free calcium ion concentration 
investigated (figure 30). Secretion in response to calcium ions (lO’^M) was 
123 ± 6  pg/105 cells/30 min in the absence of calyculin A compared to 42 ±  
4 pg/105 cells/30 min in the presence of calyculin A, GTP- y-S  stimulated 
ACTH secretion from permeabilised AtT-20 cells in a concentration- 
dependent manner becoming significantly greater than control secretion at 
concentrations above 10"% (figure 31). Calyculin A (10‘^M) significantly 
inhibited GTP- y -S-stimulated ACTH secretion to the extent that there was 
no significant difference between control secretion and secretion in 
response to any concentration of GTP- y -S investigated (figure 31). 
Secretion in response to GTP- y-S (lO'^M) was 135 ±  15 pg/10  ^ cells/30 
min in the absence of calyculin A compared to 84 ±  10 pg/10^ cells/30 min 
in the presence of calyculin A. The ability of calyculin A to inhibit calcium 
ion- and GTP- y -S-stimuiated ACTH secretion from permeabilised AtT-20 
cells appears to suggest that the effects of these two secretagogues are 
mediated by a phosphatase.
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Figure 30 Effect of calyculin A upon calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in a range of 
calcium/EGTA buffers such that the indicated concentrations of calcium 
resulted in the absence (■) and presence ( ♦ )  of calyculin A (IQ-'^M) and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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Figure 31 Effect of calyculin A upon GTP- y  -S-stImulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in standard 
permeabilisation medium supplemented with the indicated concentration of 
GTP- y-S in the absence (■) and presence {♦ )  of calyculin A (IQ-^M) and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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2 AN INVESTIGATION INTO THE NATURE OF THE GTP-BINDING 
PJLQIEINJIEDIATING CALClUMiQN-STIMUlATEP ACTH SECRËILQN 
FROM A IIt2Q CELLS
(I) Effects of aluminium fluoride upon the late stages of the ACTH
secretory pathway of AtT-20 cells
Aluminium fluoride (AIF(3 -5 )) is capable of activating heterotrimeric 
GTP-binding proteins by binding to GDP and mimicking the y-phosphoryl 
group of GTP and thus converting the protein to the active conformation 
(Higashijima et al., 1991). Monomeric GTP-binding proteins appear in 
contrast to be insensitive to AIF(3 -5 ) (Kahn, 1991). The effects of AIF(3 -5 ), 
provided in the present study by the combination of potassium or sodium 
fluoride with aluminium chloride, were initially investigated upon cyclic AMP 
accumulation in order to obtain effective parameters for heterotrimeric 
GTP-binding protein activation. AIF(3 -5 ) should be able to generate cyclic 
AMP by an action on the heterotrimeric GTP-binding protein Gs which is 
known to regulate adenylate cyclase (lyenger, 1993). The effects of 
aluminium chloride (5 x lO'^M), potassium fluoride (1 ,5 ,10  & 20 x 10'% ) 
and sodium fluoride (1,5, 10 & 20 x 10’% )  upon cyclic AMP accumulation 
in standard permeabilisation medium in the presence of IBMX (10'% ) over 
a 90 min incubation period were investigated. Sodium fluoride (1,5, 10 & 
20 X lO'^M) and potassium fluoride (1, 5, 10 & 20 x lO'^M) both had no 
significant effect upon cyclic AMP accumulation from permeabilised AtT-20 
cells (figure 32). However aluminium chloride (5 x lO'^M) in combination 
with potassium fluoride was able to stimulate cyclic AMP accumulation 
from permeabilised AtT-20 cells becoming significant at potassium fluoride 
concentrations of 5 x 10 '%  and above (figure 32). The combination of 
aluminium chloride (5 x 10'^M) and sodium fluoride also produced an
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Figure 32 Effect of AIF(3_5) upon cyclic AMP accumulation from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 90 min 
supplemented with IBMX (10'% ) and the indicated concentration of 
sodium fluoride or potassium fluoride in the presence (shaded columns) or 
absence (open columns) of aluminium chloride (5 x 10'^M) and cyclic AMP 
accumulation measured by radioimmunoassay. The results are expressed 
as the mean ±  s.e. mean from three separate experiments.
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enhancement of cyclic AMP production, however this was not statistically 
significant. Cyclic AMP accumulation in response to aluminium chloride (5 
X 10‘^M) in combination with potassium fluoride (2 x 10'^M) was 10.5 ±  0.7 
pmol/10^ cells/90 min compared to control cyclic AMP accumulation 
(defined here and subsequently as cyclic AMP accumulation in standard 
permeabilisation medium, in the presence of IBMX (lO'^M), in the absence 
of added secretagogues) of 2.0 ±  0,4 pmol/10^ cells/90 min. The 
combination of aluminium chloride (5 x 10 '% ) and potassium fluoride (2 x 
10 '% ) was subsequently adopted as standard for further experiments in 
which the effects of AIF(3 -5 ) were being investigated.
Having established effective parameters for the activation of GTP- 
binding proteins by AIF(3_s) the effects of AIF(3 -5 ) upon ACTH secretion 
from permeabilised AtT-20 cells were subsequently investigated over 
various time periods. Control ACTH from AtT-20 cells became significant 
after 30 min (figure 33). The addition of potassium fluoride (2 x lO'^M) 
inhibited control ACTH secretion becoming significantly lower than control 
secretion after 20 min (figure 33). The addition of aluminium chloride (5 x 
lO’^M) had no significant effect upon control secretion and was also 
unable to enhance secretion observed in response to potassium fluoride 
(figure 33). Control secretion after 30 min was 144 ±  6 pg/10^ cells which 
was reduced to 106 ± 2  pg/10^ cells in the presence of potassium fluoride. 
Secretion in response to AIF(3 -5 ) was 93 ±  6 pg/10  ^ cells. It therefore 
appears that potassium fluoride inhibits ACTH secretion from 
permeabilised AtT-20 cells, an inhibition which AIF(3 -5 ) is unable to 
overcome.
The ability of GTP- y-S to stimulate ACTH secretion in the presence 
of AIF(3 -5 ) was investigated in order to determine whether or not Ge-
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Figure 33 Time course of the effects of AIF(3-5) upon ACTH 
secretion from permeabilised AtT-20 ceils. Permeabilised cells were 
incubated for the indicated time periods as described in the methods in 
standard permeabilisation medium in the absence of added substances 
(■), in the presence of potassium fluoride (2 x 1Q-2M) (♦ ) , aluminium 
chloride (5 x 10“5M) ( • )  or AIF(3 -5 ), provided by the combination of 
potassium fluoride (2 x tO'^M) and aluminium chloride (5 x 1Q-5M) (A), and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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stimulated secretion was possible under these conditions, GTP- y-S  (10' 
significantly stimulated ACTH secretion from permeabilised AtT-20 
cells which was significantly greater than control ACTH secretion (figure 
34). Aluminium chloride (5 x lO'^M) alone had no significant effect upon 
control ACTH secretion or GTP- y -S-stimulated ACTH secretion (figure 
34). Potassium fluoride (2 x lO'^M) alone significantly inhibited GTP- y-S - 
stimulated ACTH secretion (figure 29). Control ACTH secretion was 
significantly inhibited in the presence of AIF(3 .5 ), provided by the 
combination of potassium fluoride (2 x lO'^M) and aluminium chloride (5 x 
lO'^M) (figure 34). GTP- y -S in the presence of AIF{3 -5 ) was unable to 
stimulate ACTH secretion above that observed in response to AIF(3 .5 ) 
alone (figure 34). Control ACTH secretion was 51 ± 3  pg/10^ cells/30 min 
in the absence of GTP- y -S compared to 150 + 14 pg/10^ cells/30 min in 
the presence of GTP- y-S. In the presence of AIF(3 -5) ACTH secretion was 
1 1 + 5  pg/105 cells/30 min in the absence of GTP- y-S  (10'^ h/1) compared 
to 18 + 7 pg/105 cells/30 min in the presence of GTP- y -S (lO'^M). It is 
clear that activation of G@ in the presence of AIF(3_s) does not result in 
ACTH secretion and therefore AIF(3_5 ) seems not to be a useful tool with 
regard to the investigation of Ge in AtT-20 cells.
(ii) Effects of mastoparan upon the late stages of the ACTH
secretory pathway of AtT-20 cells
The amphiphilic tetradecapeptide mastoparan has a wide variety of 
actions which are largely attributed to the activation of heterotrimeric GTP- 
binding proteins (Higashijima et ai, 1988 & 1990; Weingarten, 1990). This 
peptide was also employed in the present study, again in order to 
investigate the possibility that the GTP-binding protein which mediates 
calcium ion-stimulated ACTH secretion from AtT-20 cells may be a
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Figure 34 Effect of Al F(3.$) upon GTP- y  -S-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in standard 
permeabilisation medium supplemented as indicated with GTP- y - 8 (10- 
4M), aluminium chloride (5 x lO-^M), and both GTP- y- S and aluminium 
chloride as indicated in the presence (shaded columns) and absence (open 
columns) of potassium fluoride (2 x lO'^M) and ACTH secretion measured 
by radioimmunoassay. The results are expressed as the mean ±  s.e. mean
from three separate experiments.
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heterotrimeric GTP-binding protein. Mastoparan stimulated ACTH 
secretion from intact AtT-20 cells over 2 h becoming significantly greater 
than control secretion (defined here and subsequently as secretion in 
DMEM/BSA in the absence of added secretagogues) at concentrations 
above 10"®M (figure 35). ACTH secretion in response to mastoparan (10- 
5M) was 550 ±  65 pg/well/2 h compared to control secretion which was 303 
±  42 pg/well/2h. In order to determine if mastoparan directly activates the 
GTP-binding protein Ge the effects of this peptide were investigated in 
permeabilised AtT-20 cells.
A suitable incubation period for the investigation of mastoparan 
upon ACTH secretion from permeabilised AtT-20 cells was initially 
determined. Control ACTH secretion became significant after 60 min 
(figure 36). Mastoparan (10 % )  significantly stimulated ACTH secretion 
from permeabilised AtT-20 cells in a time-dependent manner becoming 
significantly greater than that of control secretion after 10 min (Figure 36). 
Secretion In response to mastoparan after 30 min was 104 ±  6 pg/IO^ cells 
compared to a control secretion of 40 ±  3 pg/10  ^cells. Thirty minutes was 
chosen as the standard incubation period for all subsequent experiments in 
which mastoparan-stimulated secretion from permeabilised AtT-20 cells 
was being investigated. Mastoparan stimulated ACTH secretion in 
standard permeabilisation medium in a concentration-dependent manner 
becoming significantly greater than control secretion at concentrations 
above 10 %  (figure 37). ACTH secretion in response to mastoparan (10- 
5M) was 359 ±  25 pg/10^ cells/30 min compared to control ACTH secretion 
which was 42 ±  10 pg/10  ^cells/30 min. Again in the present study higher 
concentrations of mastoparan proved too expensive therefore complete 
concentration response curves were unfortunately not obtained.
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Figure 35 Effect of mastoparan upon ACTH secretion from intact 
AtT-20 celis. Intact cells were incubated as described in the methods in 
(DMEM/BSA) for 2 h supplemented with the indicated concentration of 
mastoparan and ACTH secretion measured by radioimmunoassay. The 
results are expressed as the mean ±  s.e. mean from three separate
experiments.
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Figure 36 Time course of mastoparan-stimuiated ACTH secretion 
from permeabllised AtT-20 cells. Permeabilised cells were incubated for 
the indicated time periods as described in the methods in standard 
permeabilisation medium in the presence (♦ )  or absence (■) of 
mastoparan (lO'^M) and ACTH secretion measured by radioimmunoassay.
The results are expressed as the mean ±  s.e. mean from three separate 
experiments. Absence of error bars indicate that they lie within the symbol.
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Figure 37 Effects of mastoparan and upon ACTH secretion from 
permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
supplemented with the indicated concentration of mastoparan and ACTH 
secretion measured by radioimmunoassay. The results are expressed as 
the mean ±  s.e. mean from three separate experiments. Absence of error 
bars indicate that they lie within the symbol.
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Mastoparan-stimulated ACTH secretion from permeabilised AtT-20 
cells was reversed by the stable GDP analogue GDP- p -S. This guanine 
nucleotide is used as a means of inhibiting GTP-binding protein activation 
by virtue of its ability to compete with GTP for the guanine nucleotide 
binding site, and once bound to maintain the GTP-binding protein in the 
inactive conformation. Mastoparan stimulated ACTH secretion from 
permeabilised AtT-20 cells in standard permeabilisation medium in a 
concentration-dependent manner becoming significantly greater than 
control secretion at concentrations above lO'^M (figure 38). GDP- p -S (10- 
^M) significantly reduced mastoparan-stimulated ACTH secretion from 
permeabilised AtT-20 cells (figure 38). Secretion evoked by mastoparan 
(10'^M) was reduced from 340 ±  9 pg/IO® cells/30 min in the absence of 
GDP- p -8 to 211 + 23 pg/105 cells/30 min in the presence of GDP- p -S.
The effects of two mastoparan related peptides upon ACTH 
secretion from permeabilised AtT-20 cells were also investigated. The 
mastoparan analogue mas-7 has been reported to be a highly effective 
GTP-binding protein activator whereas the mastoparan analogue mas-17 is 
unable to activate GTP-binding proteins (Higashijima et al., 1990). 
Mastoparan and mas-7 both stimulated ACTH secretion, in standard 
permeabilisation medium, in a concentration-dependent manner becoming 
significantly greater than control secretion at concentrations above lO'^M 
(Figure 39). ACTH secretion in response to mas-7 (lO'^M) was 430 ±  13 
pg/IO^ cells/30 min compared to 291 ±  11 pg/IO^ cells /30 min obtained in 
response to mastoparan (lO’^M). In contrast, mas-17 (lO-^M-IO-^M) was 
unable to stimulate ACTH secretion from permeabilised AtT-20 cells. No 
significant difference was observed between control secretion and 
secretion in response to every concentration of mas-17 investigated 
(Figure 40).
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Figure 38 Effect of GDP- p -S upon mastoparan-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated as described in the methods in standard permeabilisation 
medium for 30 min supplemented with the indicated concentration of 
mastoparan in the absence (■) or presence { ♦ )  of GDP- p -S (IQ-^M) and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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Figure 39 Effects of mastoparan and mas-7 upon ACTH secretion 
from permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
supplemented with the indicated concentration of mastoparan (■) or mas-7 
( ♦ )  and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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Figure 40 Effects of mastoparan and mas-17 upon ACTH secretion 
from permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
supplemented with the indicated concentration of mastoparan (■) or mas- 
17 ( ♦ )  and ACTH secretion measured by radioimmunoassay. The results 
are expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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The ability of GDP- p -S to reverse mastoparan-stimulated ACTH 
secretion from permeabilised AtT-20 cells would suggest that mastoparan 
stimulates secretion, at least partly, via activation of a GTP-binding protein. 
The GDP- p -S concentration of 1 0 '^  was chosen as this concentration of 
the guanine nucleotide completely reverses calcium- and GTP- y -S- 
stimulated ACTH secretion from permeabilised AtT-20 cells (Guild, 1991). 
Higher concentrations of GDP- p -S were unable to reverse mastoparan- 
stimulated ACTH secretion any further (data not shown). The ability of 
mas-7, the highly effective GTP-binding protein activator, to stimulate 
ACTH secretion to a greater extent than mastoparan coupled with the 
inability of mas-17, unable to activate GTP-binding proteins, to stimulate 
ACTH secretion is also consistent with mastoparan-stimulated ACTH 
secretion from permeabilised AtT-20 cells being mediated, at least partly, 
by activation of a GTP-binding protein.
The PKC inhibitor chelerythrine chloride was employed to determine 
whether mastoparan-stimulated ACTH secretion from permeabilised AtT- 
20 cells was mediated by this kinase. Mastoparan stimulated ACTH 
secretion in standard permeabilisation medium in a concentration- 
dependent manner becoming significantly greater than control secretion at 
concentrations of above lO'^M (figure 41). Chelerythrine chloride (lO'^M) 
had no significant effect upon control secretion or secretion in response to 
any concentration of mastoparan investigated (figure 36). ACTH secretion 
in response to lO'^M mastoparan was 321 ±  11 pg/105 cells/30 min in the 
absence of chelerythrine chloride (IQ-^M) and 307 ±  22 pg/10^ cells/30 min 
in the presence of chelerythrine chloride (lO'^M). Results from the present 
study indicate that chelerythrine chloride (10'^M) is capable of completely 
inhibiting the effects of PKC activators in AtT-20 cells under similar
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Figure 41 Effect of chelerythrine chloride upon mastoparan- 
stimulated ACTH secretion from permeabilised AtT-20 cells.
Permeabllised cells were incubated as described in the methods in 
standard permeabilisation medium for 30 min supplemented with the 
indicated concentration of mastoparan in the absence (■) or presence (♦ )  
of chelerythrine chloride (lO'^M) and ACTH secretion measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments. Absence of error bars indicate that they
lie within the symbol.
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conditions (a detailed account of this positive control can be found on p73). 
The inability of chelerythrine chloride to reverse the effects of mastoparan 
therefore suggest that mastoparan-stimulated ACTH secretion from 
permeabilised AtT-20 cells is not mediated by activation of PKC.
As demonstrated above cyclic AMP is unable to stimulate ACTH 
secretion from permeabilised AtT-20 cells. It can therefore be assumed 
that the effects of mastoparan upon ACTH secretion from permeabilised 
AtT-20 cells are not mediated by the generation of cyclic AMP. This was 
confirmed by investigating the effect of mastoparan upon cyclic AMP 
accumulation from permeabilised AtT-20 cells. Mastoparan had no 
significant effect upon cyclic AMP accumulation from permeabilised AtT-20 
cells over a 30 min incubation period. No significant difference was 
observed between control cyclic AMP accumulation and cyclic AMP 
accumulation from permeabilised cells in response to mastoparan (lO'^M) 
(figure 42). Cyclic AMP accumulation in the presence of mastoparan was 
1.5 dt. 10.1 pmol/IO^ cells/30 min compared to control cyclic AMP 
accumulation which was 1.4 ±  0.3 pmol/IO^ cells/30 min. Mastoparan was 
however able to stimulate ACTH secretion from the same cells under the 
same conditions (data not shown). This confirms that mastoparan- 
stimulated ACTH secretion from permeabilised AtT-20 cells is not mediated 
by generation of cyclic AMP and subsequent activation of PKA.
It therefore appears that mastoparan stimulates ACTH secretion 
from permeabilised AtT-20 cells by activation of a GTP-binding protein and 
that the effects of this peptide are not mediated by activation of either PKC 
or PKA. Mastoparan-stimulated ACTH secretion from permeabilised AtT-20 
cells therefore displays characteristics highly consistent with those of 
calcium ion- and GTP- y -S-stimulated secretion. Since mastoparan is an
CONTROL MASTOPARAN
Figure 42 Effect of mastoparan upon cyclic AMP accumulation 
from permeabilised AtT-20 cells. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
supplemented with IBMX (lO'^M) in the presence or absence of 
mastoparan (10'^M) as indicated and cyclic AMP accumulation measured 
by radioimmunoassay. The results are expressed as the mean ±  s.e. mean
from three separate experiments.
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activator of heterotrimeric GTP-binding proteins this may suggest that the 
GTP-binding protein which mediates calcium ion-stimulated ACTH 
secretion from AtT-20 cells is a heterotri meric GTP-binding protein.
Omitting ATP from the permeabilisation medium, normally present in 
the standard permeabilisation medium at a concentration of 5 x lO'^M, 
significantly reduced mastoparan-stimulated ACTH secretion from 
permeabilised AtT-20 cells. Mastoparan significantly stimulated ACTH 
secretion from permeabilised AtT-20 cells, in standard permeabilisation 
medium, in a concentration-dependent manner becoming significantly 
greater than control secretion at concentrations above 10 ^M (figure 43). 
Omitting ATP from the standard permeabilisation medium however 
reduced control secretion, although not statistically significant, and 
significantly reduced mastoparan (10 ^-10-5M)-stimulated ACTH secretion 
(figure 43). Secretion obtained in the absence of mastoparan was reduced 
from 31 ±  3 pg/IO^ cells/30 min to 13 ±  1 pg/10^ cells/30 min. ACTH 
secretion in response to lO'^M mastoparan was reduced from 274 ± 1 3  
pg/105 cells/30 min in the presence of ATP to 128 ±  11 pg/10^ cells/30 min 
in the absence of ATP. It should be noted however that mastoparan (10- 
^M)-stlmulated ACTH secretion in the absence of ATP was still significantly 
greater than control. This is consistent with previous results which 
demonstrated that calcium ion-stimulated ACTH secretion from 
permeabilised AtT-20 cells is similarly ATP-dependent (Guild, 1991).
(iii) Effects of pertussis toxin upon the late stages of the ACTH
secretory pathway of AtT-20 cells
The bacterial exotoxin pertussis toxin (PTX) from Bordetella 
pertussis possesses mono ADP-ribosyl transferase activity and has the
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Figure 43 Effect of mastoparan upon ACTH secretion from 
permeabilised AtT-20 ceiis in the presence and absence of ATP.
Permeabilised cells were incubated for 30 min as described in the 
methods supplemented with the indicated concentration of mastoparan 
either In standard permeabilisation medium containing ATP (5 x IQ-^M) {■) 
or permeabilisation medium containing no ATP {♦ )  and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments. Absence of error bars indicate
that they lie within the symbol.
iCalcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells in a concentration-dependent manner becoming significantly greater 
than control secretion at concentrations above lO’^M (figure 44). No 
significant difference was observed between calcium ion-stimulated ACTH 
secretion from control cells and from PTX (1pg ml“f, 16 h) pretreated cells 
(figure 44). Secretion in response to calcium ions (1 0 % ) from control cells 
was 132 + 10 pg/105 cells/30 min compared to 134 + 11 pg/IO^ cells/30 
min from PTX pretreated cells. GTP- y-S  stimulated ACTH secretion from 
permeabilised AtT-20 cells in a concentration-dependent manner, in 
standard permeabilisation medium, which became significantly greater 
than control secretion at a concentrations above of 10 %  (figure 45). No 
significant difference was observed between GTP- y -S-stimulated ACTH 
secretion from control cells and from PTX (Ipg ml \  16 h) pretreated cells 
(figure 45). Secretion in response to GTP- y-S  (10*%) from control cells 
was 145 ±  15 pg/105 cells/30 min compared to 151 + 1 5  pg/10  ^cells/30
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capacity to transfer the ADP-ribose moiety of the cofactor p-nicotinamide 
adenine dinucleotide (NAD) onto a specific cysteine residue of the a  
subunit of certain members of the G; subfamily of heterotrimeric GTP- 
binding proteins which prevents activation of these proteins by their 
endogenous activators (Yamane & Fung, 1993). PTX was therefore 
employed in the present study in an attempt to determine whether or not 
the GTP-binding protein which mediates calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells belongs to the G| subfamily of 4
heterotrimeric GTP-binding proteins. The abilities of calcium ions, GTP- y 1
-S and mastoparan to stimulate ACTH secretion were investigated using 
permeabilised AtT-20 cells which prior to permeabilisation were incubated 
for 16 h either in control growth medium or growth medium supplemented 
with Ipg ml-i PTX.
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Figure 44 Effect of PTX pretreatment upon calcium Ion-stimulated 
ACTH secretion from permeabllised AtT-20 cells. Control cells (■) and 
PTX pretreated cells (1 pg ml-i, 16 h, ♦ )  were permeabllised and 
incubated as described in the methods for 30 min in a series of calcium- 
EGTA buffers such that the indicated concentrations of free calcium 
resulted and ACTH secretion measured by radioimmunoassay. The results 
are expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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Figure 45 Effect of PTX pretreatment upon GTP- y-S-stlmufated 
ACTH secretion from permeabilised AtT-20 cells. Control cells (■) and 
PTX pretreated cells (1 |xg m| i, 16 h, ♦ )  were permeabilised and 
incubated as described in the methods for 30 min in standard 
permeabilisation medium containing the indicated concentrations of GTP- 
y -S and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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min from PTX pretreated cells. Mastoparan stimulated ACTH secretion 
from permeabilised AtT-20 cells in a concentration-dependent manner in 
standard permeabilisation medium becoming significantly greater than 
control secretion at concentrations above 10 ^M (figure 46). No significant 
difference was observed between mastoparan-stimulated ACTH secretion 
from control cells and from PTX (1pg m| f, 16 h) pretreated cells (figure 
46). Secretion in response to mastoparan (10'^M) from control cells was 
281 ±  35 pg/105 cells/30 min compared to 283 ±  16 pg/10^ cells/30 min 
from PTX pretreated cells.
Raising the extracellular calcium chloride concentration has been 
shown to result in an increase in the cytosolic calcium ion concentration of 
AtT-20 cells (Luini et a/., 1985). In the present study raising the 
extracellular concentration of calcium chloride from 1.8 mM (normally 
present in DMEM / BSA) to 4 mM and to 6 mM in both cases resulted in an 
increase in ACTH secretion over 2 h which was significantly greater than 
control secretion from intact AtT-20 cells (figure 47). No significant 
difference was observed between calcium chloride-stimulated ACTH 
secretion from control cells and from PTX pretreated cells (figure 47). 
Secretion in response to calcium chloride (6 mM) from control cells was 
411 ± 1 2  pg/well/2 h compared to 450 ±  33 pg/well/2 h from PTX 
pretreated cells (Ipg ml-i, 16 h). Forskolin (10-^M) stimulated ACTH 
secretion from intact AtT-20 cells over 2 h and was significantly greater 
than control secretion (figure 48). No significant difference was observed 
between forskolin-stimulated ACTH secretion from control cells and from 
PTX pretreated cells (figure 48). Secretion in response to forskolin from 
control cells was 817 ±  40 pg/well/2 h compared to 746 ±  43 pg/well/2 h 
from PTX pretreated cells.
§  =
5  5ÛC (O
Hila.
350
300
250
200
150
100
50
0 -8 -7 -6
[MASTOPARAN], (LOG M)
Figure 46 Effect of PTX pretreatment upon mastoparan-stimulated 
ACTH secretion from permeabilised AtT-20 cells. Control cells (■) and 
PTX pretreated cells (1 [ig m l'Tie h, ♦ )  were permeabilised and incubated 
as described in the methods for 30 min in standard permeabilisation 
medium containing the indicated concentrations of mastoparan and ACTH 
secretion measured by radioimmunoassay. The results are expressed as 
the mean ±  s.e. mean from three separate experiments. Absence of error 
bars indicate that they lie within the symbol.
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Figure 47 Effect of PTX pretreatment upon caicium chloride- 
stimulated ACTH secretion from Intact AtT-20 cells. Control cells (open 
columns) and PTX pretreated cells (1 pg ml T 16 h, shaded columns) were 
incubated as described in the methods for 2 h in DMEM/BSA 
supplemented with the indicated concentration of calcium chloride and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the column.
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Figure 48 Effect of PTX pretreatment upon forskoiin-stimuiated 
ACTH secretion and ID-trp®]-SRIF mediated inhibition of ACTH 
secretion from intact AtT-20 cells. Control cells (open columns) and PTX 
pretreated cells (1 pg m I'Tie h, shaded columns) were Incubated as 
Indicated as described in the methods for 2 h In DMEM/BSA supplemented 
with forskolin (IQ-^M, FSK), [D-trp®]-SRIF (SRIF, IQ-^M) and both forskolin 
and [D-trp®]-SRIF and ACTH secretion measured by radioimmunoassay. 
The results are expressed as the mean ± s.e. mean from three separate 
experiments. Absence of error bars indicate that they lie within the column.
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Thus it appears that caicium ion-, mastoparan- and GTP- y -S- 
stimulated ACTH secretion from permeabilised AtT-20 cells and calcium 
chloride- and forskolin-stimulated ACTH secretion from intact AtT-20 cells 
are all insensitive to PTX pretreatment suggesting that the GTP-binding 
protein which mediates calcium ion-stimulated ACTH secretion from AtT-20 
cells is not sensitive to PTX.
[D-trp®]-SRIF has previously been shown to inhibit forskolin- 
stimulated ACTH secretion from intact AtT-20 cells by a PTX-sensitive 
mechanism of action (Reisine & Guild, 1985). [D-trp®]-SRIF is employed in 
preference to SRIF itself as it is six to eight times more potent than the 
native peptide (Rlvier et a i, 1975). In order to confirm that in the present 
study the parameters adopted, a PTX pretreatment of Ipg ml-f for 16 h, 
were effective for inhibition of certain heterotrimeric GTP-binding proteins 
the effect of PTX upon [D-trp®]-SRIF-mediated inhibition of forskolin- 
stimulated ACTH secretion was investigated. [D-trp®]-SRIF (lO-^M) alone 
over 2 h had no significant effect upon ACTH secretion from control 
secretion from control cells or from PTX (1|xg m| f, 16 h) pretreated cells 
(figure 48). [D-trp®]-SRIF however significantly inhibited forskolin (lO'^M)- 
stimulated ACTH secretion from control cells (figure 48). This ACTH 
secretion in response to the combination of forskolin and [D-trp®]-SRIF was 
not significantly different from control secretion. In contrast [D-trp®]-SRIF 
had no significant effect upon forskolin-stimulated ACTH secretion from 
cells pretreated with PTX (1)ig m l-\ 16 h) (figure 48). ACTH secretion from 
control cells was 817 + 40 pg/well/2 h in the presence of forskolin (IQ-^M) 
and 271 + 32 pg/well/2h in the absence. ACTH secretion from PTX 
pretreated cells was 746 ±  43 pg/well/2 h in the presence of forskolin (10- 
^M) and 266 ±  34 pg/well/2 h in the absence. Therefore it appears that 
PTX pretreatment completely inhibited [D-trp®]-SRIF-mediated inhibition of
6 8
forskolin-stimulated ACTH secretion from intact AtT-20 cells. Thus it 
appears that the parameters adopted in the present study were highly 
effective with regard to inhibiting PTX-sensitive GTP-binding proteins.
(iv) Effects of cholera toxin upon the late stages of the ACTH 
secretory pathway of AtT-20 cells
The bacterial exotoxin CTX from Vibrio choleras possesses ADP- 
ribosyl transferase activity and is capable of transferring the ADP-ribose 
moiety from NAD to a particular arginine residue on the a  subunit of 
members of the Gs subfamily of heterotrimeric GTP-binding proteins 
resulting in a persistent activation of these proteins due to an inhibition of 
their intrinsic GTPase activity (Yamane & Fung, 1993). CTX was therefore 
employed in the present study to determine whether or not the GTP- 
binding protein which mediates calcium ion-stimulated ACTH secretion 
from AtT-20 cells belongs to the Gs subfamily of heterotrimeric GTP- 
binding proteins.
The effects of CTX were initially investigated upon ACTH secretion 
using intact AtT-20 cells in order to obtain a maximal CTX concentration. 
CTX stimulated ACTH secretion from intact AtT-20 cells in a concentration- 
dependent manner over 2 h becoming significantly greater than control 
secretion at concentrations above lO'^^M (figure 49). A maximal response 
was observed in response to 10'®M, a concentration which was therefore 
adopted as standard for further experiments in which the effects of CTX 
were being investigated. ACTH secretion in response to CTX (10'®M) was 
471 ± 3 7  pg/well/2 h compared to control secretion of 272 ±21 pg/well/2 h.
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Figure 49 Effect of CTX upon ACTH secretion from intact AtT-20 
ceiis. Intact cells were incubated as described in the methods for 2 h in 
DMEM/BSA supplemented with the indicated concentrations of CTX and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
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Having established a maximal CTX concentration using intact AtT- 
20 cells, the effects of CTX in permeabilised cells were investigated. In 
order to confirm that CTX was able to activate heterotrimeric GTP-binding 
proteins under these conditions the effects of CTX upon cyclic AMP 
accumulation, in the presence of the cofactor NAD, were initially 
investigated. The combination of CTX (IQ-^M) and NAD (lO'^M), in 
standard permeabilisation medium in the presence of IBMX (10-^M), 
stimulated cyclic AMP accumulation in a time-dependent manner becoming 
significantly greater than control cyclic AMP accumulation after a period of 
120 min (figure 50). The combination of CTX (10'SM) and a higher 
concentration of NAD (10"^M) stimulated cyclic AMP production above 
control cyclic AMP accumulation from permeabilised AtT-20 cells in a time- 
dependent manner becoming significantly greater than control cyclic AMP 
accumulation after a period of 90 min (figure 50). Control cyclic AMP 
accumulation after 120 min was 1.6 ±  0.4 pmol/IO^ cells compared to 3.3 ±  
0.5 pmol/105 cells in response to CTX (lO'^M) and NAD (10'^M) and 3.4 ±  
0.2 pmol/105 cells in response to CTX (IG'^M) and NAD (lO ^M). The 
ability of CTX, in combination with NAD, to stimulate cyclic AMP production 
from permeabilised AtT-20 cells suggests that the toxin is capable of ADP- 
ribosylation under these conditions.
Having established that CTX Is capable of ADP-ribosylation in 
permeabilised AtT-20 cells the effects of CTX, in combination with NAD, 
upon ACTH secretion from permeabilised AtT-20 cells were investigated. 
Control ACTH secretion became significant after 60 min (figure 51). No 
significant difference was observed between control secretion and 
secretion in response to CTX (10‘®M) in combination NAD (10 %  or 10- 
^M) (figure 51). Control ACTH secretion after 120 min was 189 + 15 pg/10^ 
cells compared to 188 ±  23 pg/10^ cells in response to CTX (10 ^M) and
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Figure 50 Effect of CTX and NAD upon cyclic AMP accumulation 
from permeabilised AtT-20 cells. Permeabilised cells were incubated for 
the indicated time period in standard permeabilisation medium 
supplemented with IBMX (1 O ^M) in the absence of CTX and NAD (■), 
presence of CTX (lO'^M) and NAD (10-5M) ( ♦ )  or in the presence of CTX 
(10‘®M) and NAD (1Q-^M) (#) and cyclic AMP accumulation measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments. Absence of error bars indicate that they
lie within the symbol.
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Figure 51 Effect of CTX and NAD upon ACTH secretion from 
permeabllised AtT-20 cells. Permeabilised cells were incubated for the 
indicated time period in standard permeabilisation medium in the absence 
of CTX and NAD (■), presence of CTX (lO-^M) and NAD (1 Q-^M) (♦ )  or in 
the presence of CTX (10"®M) and NAD (10‘^M) (• )  and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments.
70
NAD (10 % )  and 189 ±  19 pg/IO® cells in response to CTX (lO'^M) and 
NAD (1 0‘^M). It therefore appears that CTX has no effect upon ACTH 
secretion from permeabilised AtT-20 cells which therefore suggests that 
the GTP-binding protein that mediates calcium ion-stimulated ACTH 
secretion is not CTX sensitive.
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aAtiiNYESIlGAEQN INTO THE REGULATION OF ACTK5ECREILQN 
EROM-MI-ÜQ CELLS B.Y EBQIEiN. KINASE .C AND CYCLLC-AME: 
DEPENQEHI.PRGIEÜA KINASE AT A. LATE STAGE IN THE ACTH 
SECRETORY PATHWAY
(i) Effects of protein kinase 0  activators upon ACTH secretion 
from intact AtT-20 cells
The involvement of PKC in the ACTH stimulus-secretion coupling 
pathway of AtT-20 cells was investigated using the PKC activator phorbol 
12-myristate 13-acetate (PMA). The effects of PMA were initially 
investigated upon ACTH secretion using intact AtT-20 cells In order to 
obtain a suitable PMA concentration for further investigation. PMA 
stimulated ACTH secretion from intact AtT-20 cells in a concentration- 
dependent manner over 1 h becoming significantly greater than control 
secretion at concentrations above 10*^M (figure 52). ACTH secretion in 
response to PMA (lO-^M) was 1607 ±  102 pg/well/h compared to control 
secretion of 363 ±  30 pg/well/h. The DAG analogues 1 -oleoyl-2-acetyl-sn- 
glycerol (OAG, 1 0 '^ M^) and 1,2-dioctanoyI-sn-glycerol (DOG, 10 '% ) both 
significantly stimulated ACTH secretion from intact AtT-20 cells (figure 53) 
as did the phorbol esters phorbol 12, 13-didecanoate (PDD, 10’% )  and 
phorbol 12, 13-dibutyrate (PDBu, 1 0  % )  (figure 54). The inactive phorbol 
ester 4 a phorbol (10-7M) however had no significant effect upon ACTH 
secretion from intact AtT-20 cells (figure 54). These results suggest that 
PKC plays an important role in the regulation of ACTH secretion from AtT- 
20 cells. In order to determine whether PKC has a point of regulation distal 
to changes in the cytosolic free calcium ion concentration the effects of 
PMA were investigated upon permeabilised cells.
[PMA], (LOG M)
Figure 52 Effect of PMA upon ACTH secretion from Intact AtT-20 
cells. Intact cells were incubated as described in the methods for 1 h in 
DMEM/BSA supplemented with the indicated concentrations of PMA and 
ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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(ii) Effects of PMA upon the late stages of the ACTH secretory
pathway of AtT-20 cells
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells in a concentration-dependent manner (figure 55). This calcium ion- |
evoked secretion became significantly greater than control secretion at 
concentrations above 10 This stimulated secretion was enhanced at 
every free calcium ion concentration investigated by PMA (lO'^M) including 
in the effective absence of free calcium ions (figure 55). ACTH secretion in 
standard permeabilisation medium was 55 ±  5 pg/10  ^ cells/30 min in the 
absence of PMA compared to 108 ±  2 pg/10^ cells/30 min in the presence 
of PMA. ACTH secretion in response to a free calcium ion concentration of 
lO'^M was 215 ±  13 pg/10^ cells/30 min in the absence of PMA compared 
to 491 ±  27 pg/1 05 cells/30 min in the presence of PMA. The ability of PMA 
to enhance calcium ion-stimulated secretion suggests that PKC can 
stimulate a secretory response from AtT-20 cells by an action which Is 
unrelated to the elevation of the cytosolic free calcium ion concentration. In 
addition the ability of PMA to stimulate ACTH secretion in standard 
permeabilisation medium, which contains effectively no calcium ions, may 
also suggest that nPKC isozymes stimulate ACTH secretion from AtT-20 
cells by an action which is unrelated to calcium ion/Ge-stimulated 
secretion. Calcium ions and PMA however did interact in a synergistic 
manner indicating that there may be some kind of interaction between 
calcium ions and PKC with regard to ACTH secretion. One explanation is 
that in the presence of calcium ions cPKCs make an increasingly important 
contribution to the secretory response. As demonstrated in the present 
study AtT-20 cells contain both calcium ion-dependent cPKCs and calcium 
ion-independent nPKCs (see p74). At lower calcium ion concentrations 
PMA will activate only the nPKCs (Ryves et al., 1991) whereas at higher
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Figure 55 Effect of PMA upon calcium lon-stlmulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in a series of 
calcium/EGTA buffers such that the indicated cytosolic free calcium ion 
concentration resulted in the presence ( ♦ )  and absence (■) of PMA (10- 
7M) and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the symbol.
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calcium ion concentrations PMA will activate both nPKCs and cPKCs 
(Ryves et aL, 1991). It may be the case that cPKCs as well as nPKCs 
contribute to the ACTH secretory response by a mechanism which is 
independent of calcium ions and which therefore could account for this 
synergistic interaction.
The effect of chelerythrine chloride upon PMA-stimulated secretion 
was investigated in order to determine the effectiveness of this PKC 
inhibitor under the conditions employed in the present study. PMA (10'^M) 
significantly stimulated ACTH secretion from permeabilised AtT-20 cells in 
standard permeabilisation medium over 30 min (figure 56). This PMA- 
stimulated ACTH secretion was completely reversed by the PKC inhibitor 
chelerythrine chloride (lO'^M) (figure 56). Control secretion was 56 ±  1 
pg/IO® cells/30 min compared to PMA-stimulated secretion which was 129 
±  22 pg/105 cells/30 min. This PMA-stimulated secretion was reduced to 
74 ±  1 2  pg/105 cells/30 min in the presence of chelerythrine chloride. PMA 
(10*7M) also significantly stimulated ACTH secretion from permeabilised 
AtT-20 cells in a free calcium ion concentration of lO'^M over 30 min 
(figure 57). This PMA-stimulated ACTH secretion was also completely 
reversed by the PKC inhibitor chelerythrine chloride (1 0 ‘^M) (figure 57). 
Control secretion was 199 ±  26 pg/1 0  ^ cells/30 min compared to PMA- 
stimulated secretion which was 341 ±  30 pg/1 0  ^ cells/30 min. This PMA- 
stimulated secretion was reduced to 254 ± 1 9  pg/10  ^ cells/30 min in the 
presence of chelerythrine chloride. These findings suggest that 
chelerythrine chloride under the conditions employed in the present study 
is an effective inhibitor of PKC both in the presence and absence of 
calcium ions.
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Figure 56 Effect of chelerythrine chioride upon PMA-stimulated 
ACTH secretion from permeabilised AtT-20 cells in the effective 
absence of calcium ions. Permeabilised cells were incubated as 
described in the methods in standard permeabilisation medium for 30 min 
in the presence of PMA (1 0 -^M) as indicated and also in the presence of 
(shaded columns) or absence (open columns) of chelerythrine chloride (1 0 - 
5M) and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars indicate that they lie within the column.
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Figure 57 Effect of chelerythrine chloride upon PMA-stimulated 
ACTH secretion from permeabilised AtT-20 cells in the presence of 
calcium ions. Permeabilised cells were incubated as described in the 
methods in calcium/EGTA buffers such that a free calcium ion 
concentration of IQ-^M resulted for 30 min in the presence of PMA (IQ-^M) 
as indicated and also in the presence of (shaded columns) or absence 
(open columns) of chelerythrine chloride (10 '^M) and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments.
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Further studies indicate that PMA is also able to enhance secretion 
in response to GTP- y -S in the absence of calcium ions and also in the 
presence of a variety of free calcium ion concentrations. Calcium ions 
stimulated ACTH secretion from permeabilised AtT-20 cells in a 
concentration-dependent manner becoming significantly greater than 
control secretion at concentrations above 1 0 *^M (figure 58). As previously 
observed in standard permeabilisation medium, free calcium ion 
concentration of tO'^M, GTP- y - S (tO-^M) significantly stimulated ACTH 
secretion however was unable to enhance ACTH secretion observed in 
response to a free calcium ion concentration of lO'^M (figure 58). PMA (10’ 
^M) enhanced secretion in response to every concentration of calcium ions 
investigated both in the presence and absence of GTP- y -S (figure 58). 
PMA generally appeared to enhance GTP- y-S-stimulated secretion in an 
additive manner at every concentration of calcium Ions investigated. This 
finding seems to confirm that PKC is able to stimulate secretion by an 
action which is quite separate from calcium ion/Ge-stimulated secretion.
(iii) Effects of isozyme-selective protein kinase 0  activators upon
the late stages of the ACTH secretory pathway of AtT-20 cells
Having established that PKC has at least two points of regulation 
with regard to ACTH secretion from AtT-20 cells the possibility that 
different PKC isozymes regulate secretion at different points in the 
stimulus-secretion coupling pathway was investigated. PKC isoform 
I mmu no reactivity of whole AtT-20 cells, detected by Western analysis 
using isoform-specific antisera, revealed detectable amounts of PKCs a, p, 
e and Ç, however y, Ô and q could not be detected under the conditions 
employed although standards were readily detectable (figure 59).
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Figure 58 Effects of GTP- y-S and PMA upon calcium ion- 
stimuiated ACTH secretion from permeabilised AtT-20 ceils.
Permeabilised cells were incubated for 30 min as described in the methods 
in a series of calcium/EGTA buffers such that the indicated cytosolic free 
calcium ion concentration resulted in the absence of added secretagogues 
{■), presence of GTP- y-S  (1Q-5M, ♦ ) ,  presence of PMA (IQ-^M, #) and 
the presence of both GTP- y -S and PMA (A) and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments. Absence of error bars indicate
that they lie within the symbol.
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Particular PKC isozymes were activated by thymeleatoxin (TMX), 
reported to be selective for the cPKCs a, p and y isozymes, and 1 2 - 
deoxyphorbol 13-phenyl acetate 20-acetate (dPPA), reported to be 
selective for the pi-isozyme (Ryves et a i, 1991). TMX and dPPA both 
stimulated ACTH secretion from intact AtT-20 cells in a concentration- 
dependent manner over 1 h becoming significantly greater than control 
secretion in both cases at concentrations above 1 0 '^M in the case of TMX 
and 10‘QM in the case of dPPA (figure 60). In both cases 10 ^M was 
adopted as a standard concentration for further experimentation. ACTH 
secretion in response to TMX (10'^M) was 917 ±  143 pg/well/h compared 
to control secretion of 237 ±  22 pg/well/h. ACTH secretion in response to 
dPPA (10‘^M) was 631 ±  73 pg/well/h compared to control secretion of 265 
+ 46 pg/well/h. This finding may suggest that activation of the a and p 
isozymes or simply the Pi isozyme can stimulate ACTH secretion from 
intact AtT-20 cells. Whether the actions of these isozymes were proximal 
or distal to changes in cytosolic free calcium ion levels was subsequently 
investigated.
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells in a concentration-dependent manner becoming significantly greater 
than control secretion at concentrations above 1 0 '^M (figure 61). Calcium 
ion-stimulated ACTH secretion from permeabilised AtT-20 cells was not 
significantly different in the presence and absence of dPPA (1 0 ’^M) (figure 
61). ACTH secretion in response to a free calcium ion concentration of 10" 
5m was 1603 ±175  pg/105 cells/30 min in the absence of dPPA compared 
to 1340 ±147  pg/10^ cells/30 min in the presence of dPPA. The inability of 
dPPA to potentiate calcium ion-stimulated secretion indicates that the Pi 
isozyme does not contribute to secretion by an action distal to changes in
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Figure 60 Effect of protein kinase 0  activators upon ACTH 
secretion from intact AtT-20 cells. Intact cells were incubated as 
described in the methods for 1 h in DMEM/BSA supplemented with the 
indicated concentrations of dPPA (■) or TMX (♦ )  and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments. Absence of error bars indicate
that they lie within the symbol.
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Figure 61 Effect of dPPA upon calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in a series of 
calcium/EGTA buffers such that the indicated cytosolic free calcium ion 
concentration resulted in the presence ( ♦ )  and absence (■) of dPPA (10- 
7|VI) and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
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cytosolic free calcium ion concentrations and therefore may be at a point 
proximal to calcium ions in the stimulus-secretion coupling pathway.
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 
cells in a concentration-dependent manner becoming significantly greater 
than control secretion at concentrations above 1 0 ‘^M (figure 62). Calcium 
ion-stimulated ACTH secretion was significantly enhanced by TMX (10'^M) 
at every concentration of calcium ions investigated (figure 62). ACTH 
secretion in response to a free calcium ion concentration of 1 0  %  was 
2654 ±  150 pg/105 cells/30 min in the absence of TMX compared to 3897 
±  279 pg/105 cells/30 min in the presence of TMX. It therefore appears that 
TMX enhanced calcium ion-stimulated ACTH secretion from permeabilised 
cells in a manner similar to PMA. In particular the ability of TMX to 
stimulate ACTH secretion from permeabilised AtT-20 cells in the effective 
absence of calcium ions may suggest that this drug is not completely 
selective for cPKCs under these conditions.
There have been suggestions that dPPA is not completely selective 
for the PKC pi isozyme (Kiley et aL, 1994), a point which was investigated 
in the present study. The effects of concentrations of dPPA greater than 
10‘%  (shown to be supramaximal with regard to ACTH secretion from 
intact AtT-20 cells) upon control and calcium ion (10'%)-stimulated ACTH 
secretion were investigated. As previously demonstrated dPPA at a 
concentration of 1 0 "%  did not have any significant effect upon control or 
calcium ion stimulated ACTH secretion from permeabilised AtT-20 cells 
however dPPA at the higher concentration of lO’^M did significantly 
enhance calcium ion-stimulated secretion (table 4). Higher concentrations 
of dPPA also enhanced control ACTH secretion from permeabilised AtT-20 
cells although this proved not to be statistically significant. It appears that
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Figure 62 Effect of TMX upon calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in a series of 
calcium/EGTA buffers such that the indicated cytosolic free calcium ion 
concentration resulted in the presence (♦ )  and absence (■) of TMX (10- 
7M) and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean + s.e. mean from three separate experiments.
Absence of error bars indicate that they lie within the symbol.
[dPPA]
ACTH SECRETION (pg/IO® CELLS/30 MIN)
CONTROL CALCIUM (10-% )
0 373 ± 3 7 737 ± 6 8
10-7M 390 + 40 860 ± 9 5
1 0 -6 M 460 ±  46 1120±113
10-5M 490 ±16 1240 ±100
Table 4 Effect of higher concentrations of dPPA upon ACTH 
secretion from permeabilised AtT-20 cells In the presence and 
absence of calcium ions. Permeabilised cells were incubated for 30 min 
as described in the methods in calcium/EGTA buffers such that a cytosolic 
free calcium ion concentration of 1 0 ‘^M (control) or lO-^M resulted in the 
presence of the indicated concentration of dPPA and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean ±  
s.e. mean from three separate experiments.
■IÎ
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higher concentrations of dPPA may activate PKC in a non-selective 
manner however the concentration of 1 0 “^ M adopted in the present study 
as standard appears to have selective properties.
As can be seen figures 61 & 62 as well as table 4 indicate that in 
these particular experiments the absolute amount of ACTH released was 
relatively high in comparison to that from other experiments. This is thought 
to be due to variability within the assay and is therefore not likely to be 
physiologically important.
(iv) Effects of cyclic AMP upon the late stages of the ACTH 
secretory pathway of AtT-20 cells
Although cyclic AMP, in the absence of calcium ions and guanine 
nucleotides, is unable to stimulate ACTH secretion from permeabilised AtT- 
2 0  cells there is evidence to suggest that cyclic AMP can modulate calcium 
ion- and Gg-stimulated secretion (Guild, 1991). In the present study 
calcium ions (IO-^m) significantly stimulated ACTH secretion from 
permeabilised AtT-20 cells (figure 63). Cyclic AMP (10 % )  as previously 
observed had no significant effect upon secretion in the absence of calcium 
ions (free calcium ion concentration of 10’^M) however did significantly 
enhance secretion in response to a free calcium ion concentration of lO-^M 
(figure 63). Control secretion was 68.1 ±  10.9 pg/1 0  ^ cells/30 min in the 
absence of cyclic AMP and 90.4 ±15.8  pg/IO® cells/30 min in the presence 
of cyclic AMP (10 % ). Calcium ion-stimulated secretion was 268.3 ±  31.7 
pg/105 cells/30 min in the absence of cyclic AMP and 409.5 ±  23.1 pg/10  ^
cells/30 min in the presence of cyclic AMP (10 % ).
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Figure 63 Effect of cyclic AMP upon calcium ion-stimuiated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in calcium/EGTA buffers 
such that a cytosolic free calcium ion concentration of lO-^M (control) or 
IQ -%  (calcium ions) resulted in the presence (shaded columns) and 
absence (open columns) of cyclic AMP (10 % )  and ACTH secretion 
measured by radioimmunoassay. The results are expressed as the mean + 
s.e. mean from three separate experiments.
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GTP- 7  -S (1 0 '% ) significantly stimulated ACTH secretion from 
permeabilised AtT-20 cells (figure 64). Cyclic AMP (10 % )  had no 
significant effect upon secretion in the absence of GTP- 7  -S however did 
significantly enhance secretion in response to GTP- 7  -S (figure 64). 
Control secretion was 31.7 + 3.7 pg/1 0  ^ cells/30 min in the absence of 
cyclic AMP and 22.7 ±  6.0 pg/10  ^ cells/30 min in the presence of cyclic 
AMP (10‘% ). GTP- 7 -S-stimulated secretion was 125.2 ±  15.8 pg/10  ^
cells/30 min in the absence of cyclic AMP and 217.6 ± 21 .6  pg/105 cells/30 
min in the presence of cyclic AMP (lO’^M).
PMA (1 0 % ) significantly stimulated ACTH secretion from 
permeabilised AtT-20 cells (figure 65). Cyclic AMP (1Q-4M) had no 
significant effect upon secretion in the absence of PMA however did 
significantly enhance secretion in response to PMA (figure 65). Control 
secretion was 68.1 ±  10.9 pg/10  ^ cells/30 min in the absence of cyclic AMP 
and 90.4 + 15.8 pg/1 0  ^cells/30 min in the presence of cyclic AMP (10"%). 
PMA-stimulated secretion was 137.9 ± 1 1 .5  pg/10  ^ cells/30 min in the 
absence of cyclic AMP and 252.4 ±  29.6 pg/10  ^ cells/30 min in the 
presence of cyclic AMP (10 % ).
It therefore appears that cyclic AMP, in the absence of calcium ions 
and guanine nucleotides, is unable to stimulate ACTH secretion from 
permeabilised AtT-20 cells however does potentiate calcium ion and GTP- 
7  -S-stimulated ACTH secretion in a synergistic manner. This confirms 
previous studies which suggested that PKA is capable of modulating 
calcium ion/Gg-stimulated ACTH secretion from AtT-20 cells (Guild, 1991). 
The present study suggests that PKA may also have a similar modulatory 
role with regard to PKC-stimulated ACTH secretion from AtT-20 cells.
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Figure 64 Effect of cyclic AMP upon GTP- y -S-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in standard 
permeabilisation medium in the presence and absence of GTP- y-S (10“ 
^M) as indicated in the presence (shaded columns) and absence (open 
columns) of cyclic AMP (10“% )  and ACTH secretion measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments. Absence of error bars indicate that they
lie within the column.
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Figure 65 Effect of cyclic AMP upon PMA-stimulated ACTH 
secretion from permeabilised AtT-20 cells. Permeabilised cells were 
incubated for 30 min as described in the methods in standard 
permeabilisation medium in the presence and absence of PMA (10 % ) as 
indicated in the presence (shaded columns) and absence (open columns) 
of cyclic AMP (lO'^M) and ACTH secretion measured by 
radioimmunoassay. The results are expressed as the mean ±  s.e. mean 
from three separate experiments.
The effects of cyclic AMP upon calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells were compared to those of PMA, 
Calcium ions stimulated ACTH secretion from permeabilised AtT-20 cells in 
a concentration-dependent manner becoming significantly greater than 
control secretion at concentrations above 10*®M which was significantly 
enhanced by cyclic AMP (10 % )  and PMA (10 % ) with the characteristics 
previously described (figure 6 6 ). This data highlights important differences 
between PMA and cyclic AMP mediated enhancement of calcium ion- 
stimulated ACTH secretion. PMA is capable of stimulating ACTH secretion 
in the effective absence of calcium ions whereas cyclic AMP is not. In 
addition PKC is capable of enhancing calcium ion-stimulated ACTH 
secretion to a greater extent than cyclic AMP. Secretion in response to a 
cytosolic free calcium ion concentration of IO'^m was 268.3 ±  31.7 pg/1 0  ^
cells/30 min in the absence of PMA and cyclic AMP, 681.7 ±  44.7 pg/1 0  ^
cells/30 min in the presence of PMA and 409.5 ±  23.1 pg/1 0  ^cells/30 min 
in the presence of cyclic AMP. This observation highlights the fact that 
calcium ions can not elicit a full secretory response and that co-operation 
between calcium and PKA and in particular PKC is required to elicit what 
might be a maximal secretory response.
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Figure 66 Effects of cyclic AMP and PMA upon calcium lon- 
stimuiated ACTH secretion from permeablllsed AtT-20 cells.
Permeabilised cells were Incubated for 30 mln as described In the methods 
in a series of calclum/EGTA buffers such that the Indicated cytosolic free 
calcium ion concentration resulted In the absence of added secretagogues 
(■), presence of PMA (IQ-^M, ♦ )  and the presence of cyclic AMP (IQ-^M, 
• )  and ACTH secretion measured by radioimmunoassay. The results are 
expressed as the mean ±  s.e. mean from three separate experiments. 
Absence of error bars Indicate that they lie within the symbol.
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£RQIJEiMS,,MEPlAIlHja CALCIUM IQN-STiMULAIED ACTH
SECBEILQN ERQMAmaQ CELLS
(i) Effects of calcium ions upon the iate stages of the ACTH
secretory pathway of AtT-20 cells
Signal transduction mechanisms controlling exocytosis have been 
studied extensively in recent years using the technique of cell 
permeabillsatlon which overcomes the plasma membrane barrier and 
allows the manipulation of the Intracellular environment. The effects of 
calcium ions upon ACTH secretion and the mechanisms mediating calcium 
Ion-stimulated secretion were largely Investigated in the present study 
using AtT-20 cells permeabilised by the high voltage electric discharge 
technique. Electrical permeabillsatlon produces membrane breakdown 
which is predictable, highly selective for the plasma membrane and 
localised to certain areas of the plasma membrane (Knight & Baker, 1982). 
The resulting pores, which are generally 2-4 nm In diameter, are large 
enough to allow cytosolic dialysis and the Introduction of Ions and small 
molecules yet small enough to prevent leakage of cytosolic 
macromolecules and therefore allow the cell to retain a relatively Intact 
secretory response (Knight & Scruton, 1986). In contrast cells 
permeabilised using the detergent digitonin (Dunn & Holz, 1983; Wilson & 
Kirshner, 1983) or the protein streptolysln-O (Bader et al., 1988; Bader et 
a/., 1989), which are other commonly employed methods of cell 
permeabillsatlon, display a significant decay In the secretory response with 
time. In addition since both digitonin (Gogelein & Huby, 1984) and 
streptolysln-O (Bhakdl & Tranum-Jensen, 1987) facilitate cell 
permeabillsatlon by interacting with membrane cholesterol It is likely that
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these methods are not completely selective for the plasma membrane. This 
technique of electrical permeabillsatlon has previously been successfully 
employed to study calcium ion-stimulated ACTH secretion from AtT-20 
cells (Guild, 1991).
It was Douglas who first suggested that raising the concentration of 
calcium ions in the cytosol of specialised cells may result in exocytosis 
(Douglas, 1968 & 1974 b). Direct evidence for this theory was
subsequently obtained when It was demonstrated that raising the 
concentration of free calcium Ions In the cytosol of permeabilised adrenal 
medullary cells to the micromolar range resulted in catecholamine 
secretion (Baker & Knight, 1978). This has since been shown to be the 
case In a variety of other permeabilised secretory cell types (Gomperts,
1990; Knight & Scrutton, 1986; Llndau & Gomperts, 1991). In the present |
study it was demonstrated that raising the concentration of free calcium |
1Ions in the permeabillsatlon medium stimulated ACTH secretion from j
electrically-permeabllised AtT-20 cells In a concentration-dependent 
manner with a threshold of 1 0 '^M reaching a maximal stimulation by 1 0 '
®M. This data Is highly consistent with previous studies Investigating 
calcium ion-stimulated ACTH secretion from electrically-permeabllised 
(Guild, 1991) and digitonln-permeablllsed (Lulnl & DeMattels, 1988) AtT-20 
cells and also with a variety of other cell types (Knight & Scrutton, 1986). It 
therefore appears that permeablllsing AtT-20 cells by means of the high 
voltage electric discharge technique does not Impair their ability to undergo 
evoked exocytosis and that electrically-permeabllised AtT-20 cells serve as 
a useful model system for the Investigation of calcium lon-stlmulated ACTH 
secretion.
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(ii) Effects of GTP- y-S upon the iate stages of the ACTH secretory 
pathway of AtT-20 cells
Using permeabilised neutrophils Gomperts and co-workers {
observed that guanine nucleotides participate in the stimulus-secretion 
coupling pathway at two distinct points (Barrowman et a/., 1986). The first 
was thought to be the GTP-blnding protein Gq, now well established as 
being responsible for the activation of PLC (Smrcka et a/., 1991 ; Taylor et 
al., 1991) which results in the generation of DAG and subsequent 
activation of PKC (Nishlzuka, 1995). The other was thought to be a second 
GTP-blnding protein which was involved at a stage in the stimulus- 
secretion coupling pathway distal to changes in the cytosolic free calcium 
ion concentration and was also independent of PKC activation. Since this 
second GTP-blnding protein represented a more direct means of regulating 
exocytosis it was subsequently termed G@ (Gomperts eta!., 1986). Using a 
variety of permeabillsatlon techniques guanine nucleotides have since 
been shown to stimulate secretion from a variety of specialised secretory 
cell types. In addition evidence exists to suggest that a similar Ge-like 
GTP-blnding protein Is present In a variety of specialised cell types 
(Gomperts, 1990; Llndau & Gomperts, 1991).
A number of studies have suggested that a similar mechanism 
operates In the ACTH stimulus-secretion coupling pathway of AtT-20 cells.
The stable GTP analogue GTP- y -S has been shown to be capable of 
stimulating ACTH secretion Independently of changes in the cytosolic free 
calcium ion concentration from both electrically-permeabllised (Guild, ^
1991) and digitonln-permeablllsed (Lulnl & DeMattels, 1988 & 1990) AtT- 
20 cells. This was confirmed In the present study with the observation that 
GTP- y -S stimulated ACTH secretion from permeabilised AtT-20 cells In a I
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concentration-dependent manner in the effective absence of calcium ions. 
Since any changes in the cytosolic free calcium Ion concentration Induced 
by GTP- 7  -8 would have been buffered by the calcium/EGTA buffers, 
designed to establish and maintain the required cytosolic free calcium ion 
concentration which In the case of this particular set of experiments was 
10'^M (effectively zero), it can be assumed that this guanine nucleotide- 
evoked secretion Is Independent of changes In the cytosolic free calcium 
ion concentration. This observation Is therefore consistent with the findings 
of previous studies (Guild, 1991; Lulnl & DeMattels, 1988 & 1990) which 
first suggested that a GTP-blnding protein (or proteins) is involved In the 
ACTH stimulus-secretion coupling pathway of AtT-20 cells at a stage distal 
to changes In cytosolic free calcium Ion concentrations.
The finding that the stable GDP analogue GDP- p -8 Inhibits calcium 
lon-stlmulated ACTH secretion from permeabilised AtT-20 cells (Guild,
1991) may suggest that this GTP-blnding protein Involved In the stimulus- 
secretion coupling pathway at a stage distal to calcium Ions in fact 
mediates the effects of calcium Ions upon the secretory response of this 
cell line. This was confirmed In the present study by Investigating the 
effects of calcium ions and GTP- y -8 In combination upon ACTH secretion 
from permeabilised AtT-20 cells. Although GTP- y -8 was able to stimulate 
ACTH secretion from permeabilised AtT-20 cells In the absence of calcium 
Ions this stable GTP analogue was unable to enhance secretion In 
response to a free calcium Ion concentration of lO'^M which is maximal 
with regard to ACTH secretion. The Inability of GTP- y -8  to enhance 
calcium lon-stlmulated ACTH secretion from permeabilised AtT-20 cells 
would suggest that calcium ions and GTP- y -8 are stimulating secretion 
via a common mechanism. 8ince the effects of GTP- y -8 are not mediated 
by raising the cytosolic free calcium Ion concentration It Is likely that the
. . I
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effects of calcium ions upon ACTH secretion from AtT-20 cells are 
mediated by activation of a GTP-blnding protein (or proteins). This 
observation is again consistent with a previous study which observed a 
similar interaction between GTP- y -S and calcium Ions with regard to 
evoked ACTH secretion from AtT-20 cells (Guild, 1991) as well as studies 
carried out In permeabilised chromaffin cells (Bittner & Holz, 1986) and 
RlNmSF cells (Valler et al., 1987).
It can therefore be concluded from the findings of the present and 
previous (Guild, 1991; Lulnl & DeMattels, 1988 & 1990) studies that a 
GTP-blnding protein mediates calcium ion-stimulated ACTH secretion from 
AtT-20 cells. This finding is consistent with the model for the late stages of 
the stimulus-secretion coupling pathway proposed by Gomperts and co­
workers in which a GTP-blnding protein, Ge, plays a similar role 
(Gomperts, 1990; Gomperts & Llndau, 1991). As a result the GTP-blnding 
protein present In AtT-20 cells which mediates calcium lon-stlmulated 
ACTH secretion will subsequently be referred to as Ge-
(iii) Mechanisms mediating calcium ion- and Ge-stimuiated ACTH
secretion from AtT-20 cells
There Is evidence to suggest that both PKA (Guild, 1991) and PKC 
(Guild & Relslne, 1987; Relslne 1989), In addition to raising cytosolic free 
calcium Ion levels, may regulate ACTH secretion from AtT-20 cells by an 
action in the stimulus-secretion coupling pathway distal to changes In the 
cytosolic free calcium Ion concentration. Therefore the possibility that 
calcium ion- and Ge-stlmulated ACTH secretion from AtT-20 cells was 
mediated by activation of either PKA or PKC was considered.
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The possibility that calcium ion- and Ge-stlmulated ACTH secretion 
from AtT-20 cells Is mediated via activation of PKC was Investigated using 
the naturally occurring alkaloid chelerythrine chloride which appears to be 
a potent (IC5 0  of 6.6 x 10*^M) Inhibitor of PKC (Herbert et a i, 1990). In 
addition chelerythrine chloride has been shown to be without effect upon a 
variety of other enzymes (Cohen et al., 1978; Herbert et al., 1990) and 
from the information available to date It appears that chelerythrine chloride 
displays a high degree of selectivity towards Inhibition of PKC. 
Chelerythrine chloride, at the concentration used in this study, has been 
shown In the present study to be an effective PKC Inhibitor in AtT-20 cells 
by completely inhibiting the effects of the PKC activator PMA. This 
attenuation was demonstrated In both the absence and presence of 
calcium ions Indicating that chelerythrine chloride under the present 
conditions may inhibit both cPKCs and nPKCs present in this cell line. 
Calcium ions and GTP- y-S  were both able to stimulate ACTH secretion 
from permeabilised AtT-20 cells to the same extent In the presence or 
absence of chelerythrine chloride (lO’^M). The inability of chelerythrine 
chloride to inhibit calcium ion- and GTP- y -S-stimuIated ACTH secretion
from permeabilised AtT-20 cells therefore suggests that the effects of 
calcium Ions and G@ upon secretion are not mediated by PKC. This finding 
rules out the possibility that activation of Gq (or another GTP-blnding 
protein responsible for PLC activation), generation of DAG and subsequent 
PKC activation contributes to secretion from AtT-20 cells under these 
conditions.
Previous studies using the Walsh PKA Inhibitor (PKI) (Walsh et a i, 
1971) also argues against the suggestion that PKA may mediate calcium 
Ion-stimulated ACTH secretion from AtT-20 cells. The calcium lonophore 
lonomycin has been shown to raise the cytosolic free calcium Ion
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concentration of AtT-20 cells which in turn results in an ACTH secretory 
response (Guild & Reisine, 1987). Introduction of the PKA inhibitor by 
means of a targeted liposome technique had no effect upon this 
ionomycln/calcium ion-induced secretory response (Guild & Reisine, 1987). 
Since PKI Is an effective Inhibitor of PKA in AtT-20 cells (Miyazaki et a/.,
1984) this finding suggests that calcium lon-stlmulated ACTH secretion 
from this cell line is not mediated by PKA.
A number of observations from the present study also suggest that 
PKA does not contribute to ACTH secretion from permeabilised AtT-20 
cells In the absence of calcium ions. The present study demonstrated that 
cyclic AMP was unable to stimulate ACTH secretion from permeabilised 
AtT-20 cells In the absence of calcium Ions, a result consistent with a 
previous study (Guild, 1991). In addition agents known to stimulate cyclic 
AMP, namely CRF-41 and forskolln, were unable to stimulate ACTH 
secretion from permeabilised AtT-20 cells In the absence of calcium Ions. It 
therefore appears that activation of PKA does not result In ACTH secretion 
from AtT-20 cells under these conditions. Since GTP- y -8  was able to 
stimulate ACTH secretion from permeabilised AtT-20 cells In the effective 
absence of calcium Ions It seems that calcium ion/Ge-stlmulated ACTH 
secretion from AtT-20 cells Is not mediated by activation of PKA. This 
observation rules out the possibility that activation of Gg, the GTP-blnding 
protein responsible for adenylate cyclase activation and subsequent cyclic 
AMP generation (lyenger, 1993), contributes to ACTH secretion from AtT- 
20 cells under these conditions.
The possibility that a kinase may mediate calcium ion- and Ge- 
stlmulated ACTH secretion from AtT-20 cells was further Investigated by 
omitting ATP from the permeabillsatlon medium. ATP Is included In the
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standard permeabilisation medium as initial studies reported that calcium 
ion-stimulated ACTH secretion from permeabilised AtT-20 cells was almost 
completely dependent upon the presence of ATP (Guild, 1991; LuinI & 
DeMattels, 1988). The present study indicates that GTP- y -S-stimulated 
ACTH secretion from permeabilised AtT-20 cells can still proceed when 
ATP is omitted from the permeabilisation medium. Since ATP is a 
requirement for kinase activation (Goldsmith & Cobb, 1994; Pawson, 1994; 
Taylor et al., 1993) this would suggest that GTP- y -S-stimulated ACTH 
secretion from permeabilised AtT-20 cells and therefore the actions of Ge 
are not mediated by kinase activation.
It therefore appears that calcium lon-stlmulated ACTH secretion 
from permeabilised AtT-20 cells Is ATP-dependent (Guild, 1991; Lulnl & 
DeMattels, 1988) whereas GTP- y -S-stlmulated secretion Is ATP- 
Independent. This apparent contradiction could Indicate that calcium Ions 
and Ge stimulate ACTH secretion from AtT-20 cells via different 
mechanisms, however this may not be the case. Calcium Ions stimulate 
ACTH secretion from AtT-20 cells via activation of a GTP-blnding protein, 
therefore a requirement for this evoked secretion must be GTP In order for 
activation of Ge to occur. The standard permeabillsatlon medium employed 
In the present study contains no GTP yet calcium ions are capable of 
stimulating ACTH secretion from permeabilised AtT-20 cells under these 
conditions. It Is possible that ATP, via conversion by the ubiquitous enzyme 
nucleoside diphosphate kinase, provides a source of GTP which would 
allow calcium lon-stlmulated ACTH secretion to proceed (Gomperts, 1990). 
Since GTP- y -S Is Itself a source of GTP, If this hypothesis was correct,
ACTH secretion from permeabilised AtT-20 cells In response to this 
guanine nucleotide would not be expected to be dependent upon ATP. 
This was Indeed shown to be the case In the present study, therefore It
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appears that calcium ion-stimulated ACTH secretion from AtT-20 cells is 
dependent upon ATP to provide a source of GTP in order to allow 
activation of the GTP-binding protein Ge.
Protein dephosphorylation is now known to play an equally 
important role in signal transduction to that of phosphorylation (for review 
see Hunter, 1995) therefore having established that a kinase does not 
mediate calcium ion/Ge-stimulated ACTH secretion from AtT-20 cells the 
possibility that a phosphatase does was considered. It has already been 
postulated that protein dephosphorylation may well be a step mediating the 
effects of Ge upon secretion (Gomperts, 1990; Llndau & Gomperts, 1991) 
following the observation that ATP retards the onset of secretion in 
permeabilised mast cells (Tatham & Gomperts, 1989). In addition studies 
carried out In AtT-20 cells have also observed a dephosphorylation of a 14 
kDa protein which shows a significant correlation with evoked secretion 
(Bishop et al., 1987).
Previous studies carried out in AtT-20 cells have Indicated that 
approximately 60 % of the total phosphatase activity of this cell line can be 
attributed to type 1 or 2A serlne/threonlne specific phosphatases (Antoni et 
a i,  1993). The physiological relevance of this observation Is however 
unclear therefore the possibility that a type 1 or 2A phosphatase mediates 
the effects of changes In the cytosolic free calcium Ion concentration and 
also of Ge upon ACTH secretion from AtT-20 cells was therefore 
investigated. This was achieved using calyculln A, originally Isolated from 
the marine sponge Discodermia calyx {KaXeo et ai, 1986), now established 
as an Inhibitor of type 1 and type 2A serlne/threonlne specific 
phosphatases (Ishlhara et al., 1989). Calyculln A inhibits type 2A 
phosphatases with a similar potency (IC50  of 10-io-10*9M) to okadaic acid,
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however calyculln A Is some 20- to 300-fold more potent than okadaic acid 
with regard to inhibition of type 1 phosphatases (Ishlhara et al., 1989). 
Therefore In certain cases calyculln A represents a more practical 
alternative to okadaic acid and was adopted as a phosphatase Inhibitor in 
the present study.
Calcium Ion- and GTP-y-S-stlmulated ACTH secretion from 
permeabilised AtT-20 cells were both completely Inhibited by calyculln A at 
every concentration of these secretagogues Investigated. This Indicates 
that dephosphorylation, perhaps by a type 1 or 2A phosphatase, plays an 
Important role in the ACTH stimulus-secretion coupling pathway of AtT-20 
cells and is Involved In regulating the effects of calcium ions and Ge upon 
ACTH secretion from these cells. This finding Is consistent with a study 
carried out in permeabilised pancreatic acinar cells (Wagner etal., 1992) In 
which the late stages of the amylase secretory pathway also appear to 
Involve a calcium lon/Ge mechanism which is mediated by a calyculln A- 
sensitlve phosphatase.
(iv) Summary
Initial results from the present study are highly consistent with a 
number of other studies Investigating calcium lon-stlmulated ACTH 
secretion from permeabilised AtT-20 cells (Guild, 1991; Lulnl & Guild, 1988 
& 1990). It appears that the effects of calcium Ions upon ACTH secretion 
from AtT-20 cells are mediated by a GTP-blnding protein (or proteins) 
which has been shown to perform a similar function In a variety of 
specialised cells and has been dubbed G@ (Gomperts, 1990; Llndau & 
Gomperts, 1991). Previous studies have Indicated that calcium ion- 
stimulated ACTH secretion from permeabilised AtT-20 cells Is highly
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dependent upon the presence of ATP in the permeabilisation medium 
(Guild, 1991; Luini & DeMattels, 1988). Results from the present study 
indicate that ATP may be required as a source of GTP, a requirement for 
Ge activation, and may account for the ATP dependency of calcium ion- 
stimulated ACTH secretion from AtT-20 cells.
Both PKA (Guild, 1991) and PKC (Guild & Reisine, 1987; Reisine, 
1989) have been implicated in the regulation of ACTH secretion from AtT- 
20 cells at a stage distal to changes in the cytosolic free calcium ion 
concentration. Results from the present study suggest that the effects of 
calcium ions and Ge upon ACTH secretion from AtT-20 cells are 
independent of activation of PKA, PKC or any other kinase. In contrast 
studies carried out using the phosphatase inhibitor calyculln A Indicate that 
calcium ion/Ge-stlmulated secretion Is In fact mediated by a phosphatase. 
A schematic diagram outlining a proposed model for the mechanisms 
mediating calcium lon-stlmulated ACTH secretion from AtT-20 cells Is 
displayed In figure 67.
FREE CALCIUM 
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ATP
IDPK
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GTP-BINDING
PROTEIN
GDP
PHOSPHATASE
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Figure 67 Schematic diagram showing the mechanisms postulated 
to mediate calcium ion-stimulated ACTH secretion from AtT-20 cells.
ATP, adenosine 5'-triphosphate; GDP, guanosine 5 -diphosphate; GTP, 
guanosine 5'-triphosphate; NDPK, nucleoside diphosphate kinase.
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2 AN INVESTIGATION INTO THE NATUJ^E QF THE GTP^iNDlNG  
PROTEIN MEDIATING CALCIUM IQN-STiMULATED ACTK.SECRET1QN 
FROM. AtT:2Q CELLS
GTP-binding proteins represent a large and diverse family of 
transducing proteins which are involved in a variety of cellular functions (for 
reviews see Bourne etal., 1990 & 1991; Kaziro etal., 1991). Many of these 
GTP-binding proteins have been implicated in various aspects of the 
secretory process, both as part of the secretory apparatus itself and also 
as part of the signal-transduction pathways regulating secretion (for 
reviews see Ferro-Novick & Novick, 1993; Nuoffer & Balch, 1994; Pfeffer,
1992). Having established that a GTP-binding protein mediates the effects 
of calcium ions upon ACTH secretion from AtT-20 cells (Guild, 1991 ; Luini 
& DeMattels, 1988 & 1990 & present study) the aim of this section of the 
present study was therefore to further characterise this protein Ge-
Results already obtained using AtT-20 cells may give some 
indication of the nature of Ge in this particular cell type. Many organelles 
involved in intracellular protein transport have at least one monomeric 
GTP-binding protein on their cytoplasmic surface and these proteins have 
been implicated in the regulation of both the constitutive and regulated 
secretory pathways (Ferro-Novick & Novick, 1993; Nuoffer & Balch, 1994; 
Pfeffer, 1992). In particular monomeric GTP-binding proteins belonging to 
the rab subfamily are thought to be associated with the ACTH containing 
secretory vesicles of AtT-20 cells (Ngsee et al., 1993) and as a result 
represent a candidate for Ge- These small molecular weight GTP-binding 
proteins which participate in membrane traffic are postulated to cycle 
between a GTP and a GDP bound state (Pfeffer, 1992) therefore the non- 
hydrolysable GTP analogue GTP- y -S would arrest this cycle in the GTP
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bound conformation and result in an inhibition of this process in contrast to 
heterotrimeric GTP-binding proteins which upon binding GTP- y -S become 
persistently activated (Gilman, 1987; Taylor, 1990). The ability of GTP-y-S  
to stimulate ACTH secretion from permeabilised AtT-20 cells by an action 
upon Ge (Guild, 1991; Luini & DeMatteis, 1988 & 1990 & present study) 
does not rule out the possibility that Ge present in AtT-20 cells is a 
monomer however it does suggest that this GTP-binding protein does not 
function in a similar manner to these monomeric GTP-binding proteins 
which are already known to participate in vesicular traffic.
Heterotrimeric GTP-binding proteins are also thought to regulate 
intracellular protein transport (Ferro-Novick & Novick, 1993; Nuoffer & 
Balch, 1994; Pfeffer, 1992) and have been located on intracellular 
membranes including those of chromaffin (Toutant et a i, 1987) and p 
(Konrad etal., 1995) cell secretory granules. In addition an inhibitory form 
of Ge, designated Gei, has been identified in AtT-20 cells as a pertussis 
toxin-sensitive heterotrimeric GTP-binding protein (Luini & DeMatteis, 1988 
& 1990). Heterotrimeric GTP-binding proteins therefore also represent a 
possible candidate for Ge and as a result the possibility that Ge, which 
mediates calcium ion-stimulated ACTH secretion from AtT-20 cells, 
displays characteristics consistent with it also belonging to the 
heterotrimeric rather than the monomeric subfamily of GTP-binding 
proteins was investigated.
(i) Effects of aluminium fluoride upon the iate stages of the ACTH
secretory pathway of AtT-20 ceils
AIF(3 -5) does not activate monomeric GTP-binding proteins (Kahn,
1991) but does however activate heterotrimeric GTP-binding proteins by
i
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binding to GDP and mimicking the y -phosphory! group of GTP and hence 
shifting the GTP-binding protein into the active conformation (Higashijima 
et aL, 1991), AIF(3 .5 ) is therefore a useful pharmacological tool which can 
be used to discriminate between heterotrimeric and monomeric GTP- 
binding protein involvement in cellular functions. The effect of AIF(3 .5) upon 
the GTP-binding protein Ge, present in AtT-20 cells, was therefore 
investigated in the present study In an attempt to determine whether this 
protein belongs to the heterotrimeric family of GTP-binding proteins.
The effect of A1F{3.5) upon cyclic AMP production from 
permeabilised AtT-20 cells was initially investigated in order to obtain 
parameters which were capable of GTP-binding protein activation. AIF(3_5), 
provided by aluminium chloride in combination with potassium fluoride, 
evoked cyclic AMP production presumably via activation of Gs, or a similar 
GTP-binding protein, and subsequent activation of adenylate cyclase and 
cyclic AMP production (lyenger, 1993). Of all the conditions investigated 
the combination of 2 x lO'^M potassium fluoride and 5 xIO'^M aluminium 
chloride stimulated cyclic AMP production to the greatest extent and as a 
result were adopted as a standard concentrations for further 
experimentation. The effect of AIF(a.5 ) upon ACTH secretion from 
permeabilised AtT-20 cells was subsequently investigated and it was 
discovered that this heterotrimeric GTP-binding protein activator was 
unable to stimulate secretion under these conditions. In fact potassium 
fluoride inhibited control ACTH secretion from permeabilised AtT-20 cells, 
an inhibition that AIF(3_s) was unable to overcome.
The inability of this heterotrimeric GTP-binding protein activator to 
stimulate ACTH secretion from permeabilised AtT-20 cells would seem to 
suggest that in this particular cell type G@ is not a heterotrimeric GTP-
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binding protein. However the possibility that AIF(3-5 ) has additional actions 
which may inhibit Ge-stimulated exocytosis from AtT-20 cells was 
investigated. GTP- y -S-stimulated ACTH secretion from AtT-20 cells, 
previously shown to be due to a direct activation of Ge (Guild, 1991 ; Luini & 
DeMatteis, 1988; 1990 & present study), was partially inhibited by 
potassium fluoride and completely inhibited in the presence of AIF(3-5 ). It is 
therefore clear that under these conditions activation of Ge does not result 
in ACTH secretion.
It may well be the case that AIF(3 -5 ) is indeed activating Ge however 
this activation does not result in a secretory response due to additional 
actions of this heterotrimeric GTP-binding protein activator. It has been 
demonstrated that potassium fluoride in addition to contributing to GTP- 
binding protein activation is capable of inhibiting a number of enzymes 
including phosphatases (Chabre, 1990). Since results from the present 
study demonstrate that a phosphatase mediates calcium ion/Ge-stimulated 
ACTH secretion from AtT-20 cells one possibility is that the ability of AIF(3 _ 
5) to inhibit Ge-stimulated secretion is due to a phosphatase inhibition. In 
addition the inhibitory equivalent to Ge designated Gei, which is known to 
be a heterotrimeric GTP-binding protein (Luini & DeMatteis, 1988 & 1990), 
will be activated by AIF{3 -5 ) and may also contribute to an inhibition of Ge- 
stimulated ACTH secretion. It may be the case that additional actions of 
AIF(3 -5 ) unrelated to activation of GTP-binding proteins, perhaps a 
phosphatase inhibition, coupled with activation of an inhibitory 
heterotrimeric GTP-binding protein result in a complete inhibition of Ge- 
stimulated ACTH secretion from AtT-20 cells. In the present study AIF(3-5) 
therefore did not prove to be a useful tool in the characterisation of Ge in 
AtT-20 cells.
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AIF(3-5) does however stimulate histamine secretion from digitonin- 
(Sorimachi et al., 1988) and streptolysin-0- (Aridor et al., 1993) 
permeabilised rat mast cells, amylase secretion from streptolysin-O- 
permeabilised rat pancreatic acini (Morrison etal., 1994) and noradrenaline 
secretion from streptolysin-O-permeabilised bovine chromaffin cells (Vitale 
eta l., 1994) indicating the involvement of heterotrimeric GTP-binding 
proteins in the late stages of the secretory pathways of these cell types.
The ability of AIF(3 -5 } to stimulate a secretory response from these cell 
types may indicate that there are important differences in the intracellular 
mechanisms regulating secretion from AtT-20 cells and other secretory cell ^
types.
(ii) Effects of mastoparan upon the late stages of the ACTH 
secretory pathway of AtT-20 ceils
Mastoparan is an amphiphilic tetradecapeptide (lle-Asn-Leu-Lys- 
Ala-Leu-AIa-Ala-Leu-Ala-Lys-Lys-lle-Leu-NHa) toxin originally isolated from 
wasp venom which has been noted for its ability to stimulate histamine 
secretion from mast cells (Argiolas & Pisano, 1984; Bueb et al., 1990; 
Mousli et al., 1989) and it is after this action that the peptide is named. 
Mastoparan is now known to stimulate secretion from a number of other 
cell types including catecholamines from chromaffin cells (Kuroda et al., 
1980), insulin from pancreatic islets (Komatsu et al., 1992; Yokokawa et 
al., 1989) and the RINmSF p-cell line (Komatsu etal., 1993), prolactin from 
anterior pituitary lactotrophs (Kurihara, et al., 1986; Mau et al., 1994), 
serotonin from platelets (Ozaki etal., 1990) and surfactant from pulmonary 
alveolar cells (Joyce-Brady et al., 1991). Results from the present study 
indicate that ACTH secretion from intact AtT-20 cells can also be added to 
this list.
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When mastoparan binds to a phospholipid bilayer it forms an a helix 
that lies parallel to the plane of the membrane (Higashijima et al., 1983; 
Wakamatsu etal., 1983) a structure which is mimicked by some GTP- 
binding protein linked receptors at an area near the inner surface of the 
membrane which is important for GTP-binding protein activation (Ross, 
1989). This prompted speculation that the effects of mastoparan upon 
secretion may be mediated by GTP-binding protein activation which has 
indeed recently been shown to be the case with the finding that 
mastoparan activates heterotrimeric GTP-binding proteins by an action at 
the carboxyl terminus of Ga an area of the GTP-binding protein which
interacts with agonist-bound receptors (Higashijima et al., 1988 & 1990; 
Higashijima & Ross, 1991; Weingarten et al., 1990). The possibility that 
mastoparan was capable of stimulating ACTH secretion from AtT-20 cells 
by an action on the postulated GTP-binding Ge was investigated in the 
present study. If mastoparan was capable of stimulating secretion by such 
a mechanism it would be consistent with this GTP-binding protein being a 
heterotrimeric GTP-binding protein.
In order however to determine whether mastoparan was capable of 
stimulating ACTH secretion by an action upon Ge the effects of this peptide 
were investigated using permeabilised AtT-20 cells which allow a direct 
manipulation of the intracellular environment. Mastoparan stimulated ACTH 
secretion from permeabilised AtT-20 cells in a concentration-dependent 
manner in the effective absence of calcium ions. Any changes in the 
cytosolic free calcium ion concentration induced by mastoparan would 
have been buffered by the calcium/EGTA buffers designed to establish and 
maintain the required cytosolic free calcium ion concentration which in the 
case of this particular set of experiments was 10"^M (effectively zero), 
therefore mastoparan evoked ACTH secretion from permeabilised AtT-20
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cells is independent of changes in the cytosolic free calcium ion 
concentration which is therefore consistent with this peptide evoking a 
secretory response by a G@-like mechanism of action.
Previous results from the present study have indicated that calcium 
ion/Ge-stimulated ACTH secretion from AtT-20 cells is not mediated by the 
activation of PKC. Therefore if mastoparan-stimulated secretion is 
mediated by activation of Ge this secretory response should be similarly 
PKC-independent. This hypothesis was tested using the PKC inhibitor 
chelerythrine chloride (Herbert, etal., 1990). Mastoparan was able to 
stimulate ACTH secretion from permeabilised AtT-20 cells to the same 
extent in the presence or absence of chelerythrine chloride. Mastoparan is 
therefore able to stimulate ACTH secretion from AtT-20 cells independently 
of PKC which is once again consistent with this peptide evoking a 
secretory response by a Ge-like mechanism of action.
Activation of PKA by cyclic AMP is also known to stimulate ACTH 
secretion from permeabilised AtT-20 cells however this evoked secretion 
does not occur in the absence of either calcium ions or guanine 
nucleotides (Guild, 1991). Since mastoparan stimulated secretion in the 
absence of guanine nucleotides and the effective absence of calcium ions 
it is probable that activation of PKA by means of cyclic AMP generation 
does not contribute to these actions of mastoparan. This point however 
was confirmed by investigating the effects of mastoparan upon cyclic AMP 
accumulation from permeabilised AtT-20 cells. Mastoparan under 
conditions which result in ACTH secretion was unable to stimulate cyclic 
AMP accumulation. It can therefore be concluded that mastoparan 
stimulated ACTH secretion from permeabilised AtT-20 cells does not
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proceed via cyclic AMP generation again consistent with this peptide 
evoking a secretory response by a Ge-like mechanism of action.
Mastoparan however has been reported to have a number of 
actions which may not be mediated by heterotrimeric GTP-binding 
proteins. These include non-specific cell lysis in chromaffin cells (Wilson, 
1989); binding to calmodulin (Malenick & Anderson, 1983); direct activation 
of phospholipase Aa (Argiolas & Pisano, 1983) or PLC (Wallace & Carter,
1989); stimulation of nucleoside diphosphate kinase (Kikkawa etal., 1992; 
Kowluru etal., 1995); inhibition of PKC, calcium/calmodulin kinase II, Na-K 
ATPase and the Na pump (Raynor etal., 1991). Some of these actions will 
not be relevant in the permeabilised cell system employed here where 
changes in the cytosolic free calcium ion concentrations, calmodulin 
activity, membrane bound ion channels and pumps are circumvented. In 
addition results from the present study indicate that the actions of 
mastoparan are not mediated by activation of PLC and subsequent 
activation of PKC. It was however important to establish whether the 
effects of mastoparan In AtT-20 cells were due to GTP-binding protein 
activation or to a non GTP-binding protein-mediated event.
The stable GDP analogue GDP- p -S, which inhibits GTP activation 
of GTP-binding proteins by means of competitive antagonism, partially 
inhibited mastoparan-evoked ACTH secretion from permeabilised AtT-20 
cells. Mastoparan-stimulated ACTH secretion from AtT-20 cells is therefore 
mediated, at least partly, by a GTP-binding protein. This is consistent with 
calcium ion-evoked ACTH secretion from permeabilised AtT-20 cells which 
is similarly inhibited by GDP- p -S (Guild, 1991). In addition mas-17, an 
analogue of mastoparan unable to activate GTP-binding proteins 
(Higashijima etal., 1990), was unable to stimulate ACTH secretion from
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permeabilised AtT-20 cells. This is in contrast to the mastoparan analogue 
mas-7, a highly active GTP-binding protein activator (Higashijima et al.,
1990), which stimulated ACTH secretion to an even greater extent than 
mastoparan. This again suggests that the ability of mastoparan to stimulate 
ACTH secretion from permeabilised AtT-20 cells independently of changes 
in calcium and PKC is, at least partly, due to a direct activation of a GTP- 
binding protein.
The ability of mastoparan to stimulate ACTH secretion from 
permeabilised AtT-20 cells independently of calcium ions, of PKC and of 
PKA suggests that this peptide is acting via a Ge-like mechanism of action 
which may suggest that this GTP-binding protein may belong in this 
particular cell line to the heterotrimeric family of GTP-binding proteins. 
These findings are consistent with a number of studies which demonstrate 
that mastoparan stimulates a secretory response by directly activating Ge 
in a variety of specialised cells including pancreatic p-cells (Jones et al.,
1993), mast cells (Aridor etal., 1990) and platelets (Wheeler-Jones etal.,
1992).
The characteristics of mastoparan-stimulated ACTH secretion from 
permeabilised AtT-20 cells were further investigated in order to compare 
them to that of calcium ion- and GTP- y -S-stimulated ACTH secretion. 
Mastoparan-evoked ACTH secretion from permeabilised AtT-20 cells was 
significantly, but not completely, reduced when ATP was omitted from the 
permeabilisation medium. This is again consistent with calcium ion-evoked 
ACTH secretion from permeabilised AtT-20 cells which also displays a 
dependency upon ATP (Guild, 1991) however is in contrast to GTP- y -S - 
stimulated secretion which displays little or no ATP dependency. This 
finding may suggest that calcium ions and mastoparan activate G@ by a
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similar mechanism which Is different to that of GTP- y -S. Mastoparan may 
therefore provide a useful alternative to GTP- y -S as a means of directly 
activating Ge with the advantage that it activates this GTP-binding protein 
in a manner more analogous to calcium ions.
Although mastoparan and calcium ions stimulate ACTH secretion 
from permeabilised AtT-20 cells by similar mechanisms important 
differences do exist between secretory responses to these two 
secretagogues which are consistent with mastoparan having an additional 
action which contributes to ACTH secretion. Calcium ion-stimulated ACTH 
secretion from permeabilised AtT-20 cells is almost completely inhibited in 
the presence of the GTP-binding protein inhibitor GDP- p -S (Guild, 1991) 
whereas it should be noted that the present study demonstrates that this 
guanine nucleotide can only partially inhibit ACTH secretion in response to 
mastoparan. A similar observation was made using pancreatic p-cells in 
which mastoparan-stimulated secretion from permeabilised cells was only 
partially inhibited by GDP- p -S (Jones etal., 1993). Calcium ion-stimulated 
ACTH secretion from permeabilised AtT-20 cells is also almost completely 
dependent upon the presence of ATP in the permeabilisation medium 
(Guild, 1991; Luini & DeMatteis, 1988) in contrast to mastoparan- 
stimulated ACTH secretion which is only partially attenuated by the 
omission of ATP from the permeabilisation medium. These important 
differences between calcium ion- and mastoparan-stimulated ACTH 
secretion from permeabilised AtT-20 cells point towards mastoparan 
having an additional site of action in the stimulus-secretion coupling 
pathway regulating ACTH release. This point of regulation would in 
common with Ge be distal to changes in cytosolic free calcium ion levels, 
independent of PKC activation and of PKA activation however may not be 
mediated by a GTP-binding protein.
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One possibility which cannot be ruled out is that mastoparan may 
activate the enzyme phospholipase A2 . As previously mentioned 
mastoparan, in addition to its ability to stimulate GTP-binding proteins, may 
also have a direct stimulatory action upon phospholipase A2 (Argiolas & 
Pisano, 1983). Evidence exists to suggest that activation of phospholipase 
A2 and subsequent release of arachadonic acid and related metabolites 
may result in ACTH secretion from both the normal corticotroph (Abou- 
Samra et al., 1986; Won & Orth, 1994) and from AtT-20 cells (Luini & 
Axelrod, 1985). It is therefore a possibility that activation of phospholipase 
A2 is involved at some stage of the stimulus-secretion coupling pathway of 
AtT-20 cells and is an important trigger to exocytosis therefore this enzyme 
must be a likely candidate for the second site of action of mastoparan with 
regard to ACTH secretion from this cell line.
In addition the effects of a number of secretagogues including CRF- 
41 , forskolin, membrane permeant cyclic AMP analogues, potassium and 
phorbol esters upon ACTH secretion from AtT-20 cells have been shown to 
be attenuated to some extent by agents which interfere with phospholipase 
A2 activity and subsequent arachadonic acid metabolism (Luini & Axelrod,
1985). This diverse array of secretagogues stimulate ACTH secretion from 
AtT-20 cells by a variety of actions however one common feature is the fact 
that their effects are mediated to a greater or lesser extent by an elevation 
in the cytosolic free calcium ion concentration (Guild et al., 1986, Guild & 
Reisine, 1987; Luini etal., 1985; Reisine & Guild, 1985; Reisine, 1989). 
Therefore one possibility is that the effects of calcium ion- and Ge- 
stimulated ACTH secretion from AtT-20 cells may be mediated by 
activation of phospholipase A2 . Such a mechanism whereby the effects of 
a diverse variety of secretagogues are all mediated, to some extent, by a 
common mechanism would provide a convenient point of regulation for
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inhibitory influences. Since glucocorticoids, which are the main inhibitory 
influence upon ACTH secretion from anterior pituitary corticotrophs 
(Aguilera, 1994; Antoni, 1986; Jones & Gillham, 1988), are known to inhibit 
phospholipase A2 (Flowers, 1985) it is tempting to speculate that this is 
indeed the case.
(Hi) Effects of pertussis toxin upon the iate stages of the ACTH 
secretory pathway of AtT-20 cells
PTX-sensitive heterotrimeric GTP-binding proteins have been 
implicated in the late stages of the ACTH secretory pathway of AtT-20 
cells. The inhibitory form of Ge (GeO which mediates SRIF-regulated 
inhibition of ACTH secretion from AtT-20 cells is known to be PTX- 
sensitive (Luini & DeMatteis, 1988 & 1990). Since many of the actions of 
mastoparan, now known to activate Ge in AtT-20 cells, have been 
attributed to the activation of PTX-sensitive heterotrimeric GTP-binding 
proteins (Higashijima et al., 1988) the possibility that the stimulatory form of 
Ge present in AtT-20 cells is similarly PTX-sensitive was investigated.
Calcium ions, mastoparan and GTP- y -S all stimulated ACTH 
secretion from permeabillsed AtT-20 cells, at least party, by a direct action 
upon Ge (Luini & DeMatteis, 1988 & 1990; Guild, 1991 & present study). 
Pretreatment with PTX did not inhibit calcium ion-, mastoparan- or GTP- y 
-S-stimulated ACTH secretion from permeabillsed AtT-20 cells. It can 
therefore be concluded that in permeabillsed AtT-20 cells calcium ion-, 
mastoparan- and GTP- y -S-stimulated ACTH secretion are not PTX- 
sensitive. As mastoparan is generally thought to act through activation of 
PTX-sensitive GTP-binding proteins (Higashijima et a!., 1988) this 
observation would seem to contradict previous findings of the present
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Study suggesting that mastoparan stimulates ACTH secretion from 
permeabillsed AtT-20 cells, at least partly, by an action upon a GTP- 
binding protein, namely G@. Several studies however have shown that 
mastoparan has been implicated in the activation of PTX-insensitive GTP- 
binding proteins (Nakahata etaL, 1990; Vitale etal., 1994; Wheeler-Jones 
et a i, 1992; Mau et a i, 1994).
Calcium chloride- and forskolin-stimulated secretion from intact AtT- 
20 cells also proved to be PTX-insensitive. The addition of calcium chloride 
to the extracellular medium of AtT-20 cells has been shown to raise 
cytosolic calcium ion concentrations (Luini et a i, 1985). Raising the 
extracellular calcium chloride concentration resulted in ACTH secretion 
from intact AtT-20 cells which was insensitive to PTX pretreatment. 
Forskolin is known to stimulate ACTH secretion from intact AtT-20 cells by 
raising the intracellular cyclic AMP content of the cell which in turn results 
in an elevation of the cytosolic calcium ion concentration (Luini et ai, 1985; 
Reisine & Guild, 1985; Guild et ai, 1986; Guild & Reisine, 1987). Forskolin- 
stimulated ACTH secretion from intact AtT-20 cells was also insensitive to 
PTX pretreatment.
PTX pretreatment was however able to inhibit the effects of SRI F 
upon AtT-20 cells. Forskolin stimulated ACTH secretion from intact AtT-20 
cells was inhibited by SRIF. This SRIF-mediated inhibition was completely 
reversed by PTX pretreatment. This confirms previous reports suggesting 
that the effects of SRIF in AtT-20 cells are mediated by a PTX-sensitive 
GTP-binding protein (Luini et a i, 1986; Luini & DeMatteis, 1988 & 1990; 
Reisine & Guild, 1985; Reisine et a i, 1988) and also suggests that PTX 
was highly effective under the conditions empioyed in this study. PTX 
pretreatment was therefore unable to inhibit evoked ACTH secretion by a
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variety of stimuli from both intact or permeabilised AtT-20 cells. It can 
therefore be concluded that in AtT-20 cells Ge is not a PTX-sensitive GTP- 
binding protein. PTX has been shown to inhibit the secretion, mediated by 
activation of G@, of histamine from streptolysin-O-permeabilised rat mast 
cells (Aridor et al., 1993) and noradrenaline secretion from streptolysin-O- 
permeabilised bovine chromaffin cells (Vitale etal., 1994) suggesting that 
in these cell types Ge is PTX-sensitive and may belong to the Gj subfamily 
of GTP-binding proteins. Again this seems to indicate that there are 
important differences between the intracellular mechanisms regulating 
secretion from these cells and AtT-20 cells.
(iv) Effects of cholera toxin upon the late stages of the ACTH
secretory pathway of AtT-20 cells
Mastoparan has been reported to activate purified PTX-sensitive 
GTP-binding proteins, namely Gj and Go, however is unable to stimulate 
Gs to the same extent (Higashijima et al., 1988). It has however been 
reported that under more physiological conditions mastoparan is able to 
generate cyclic AMP indicating a possible action upon G$ (Higashijima et 
al., 1988; Wheeler-Jones et al., 1992). In addition kinetic studies carried 
out in permeabilised rat mast cells suggested that Ge displayed the 
characteristics consistent with those of a heterotrimeric GTP-binding 
protein and of heterotrimers of which the kinetics are understood these 
characteristics most resemble those of Gs (Lillie & Gomperts, 1993). To 
determine whether Ge present in AtT-20 cells belongs to the G$ subfamily 
of heterotrimeric GTP-binding proteins the effects of CTX upon ACTH 
secretion were investigated.
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CTX stimulated ACTH secretion from intact AtT-20 cells in a 
concentration-dependent manner indicating that a member of the Gs 
subfamily was involved at some stage of the stimulus-secretion coupling 
pathway of AtT-20 cells. However activation of Gs is known to generate 
cyclic AMP (lyenger, 1993) and agents known to elevate cellular cyclic 
AMP levels in AtT-20 cells are known to stimulate ACTH secretion from 
intact AtT-20 cells (Axelrod & Reisine, 1984; Heisler & Reisine, 1984; Litvin 
et a/., 1984; Miyazaki ef a/., 1984). Therefore to distinguish between the 
actions of CTX upon the GTP-binding protein associated with cyclic AMP 
production and Ge a permeabilised cell preparation was employed. The 
effects of CTX, in the presence of the cofactor NAD, upon both cyclic AMP 
production and ACTH secretion from permeabilised AtT-20 cells were 
investigated. CTX in combination with NAD stimulated cyclic AMP 
production from permeabilised AtT-20 cells but did not stimulate ACTH 
secretion under similar conditions. It can be concluded that CTX was 
effective under the conditions employed in this study and that in AtT-20 
cells Ge is insensitive to CTX. These results from permeabilised cells 
suggest that CTX-stimulated secretion from intact AtT-20 cells can be 
attributed to the generation of cyclic AMP and that Ge appears not belong 
to the Gs subfamily of heterotrimeric GTP-binding proteins. CTX has been 
shown to stimulate amylase secretion from streptolysin-O-permeabilised 
rat pancreatic acini (Morrison et a/., 1994) prompting the suggestion that in 
these cells Ge may belong to the Gs subfamily of GTP-binding proteins and 
again highlights the fact that different secretory cell types appear to have 
differences in the intracellular mechanisms regulating secretion from 
different cell types.
In AtT-20 cells Ge is therefore insensitive to both PTX and CTX. 
This study appears to be most consistent with studies carried out in the
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insulin-secreting RINmSF (3-cell line. Calcium ions and GTP- y-S (Valler et 
a!., 1987) as well as mastoparan (Komatsu etal., 1993) stimulate secretion 
from RINmSF cells by a Ge-like mechanism of action. It also appears that 
in the RINmSF cell line Ge is insensitive to PTX (Valler et al., 1987; 
Komatsu etal., 1993) and to CTX (Valler etal., 1987).
(v) Summary
In conclusion in AtT-20 cells the nature of Ge remains elusive. 
Despite the inability of AIF(3 -s) to stimulate ACTH secretion by an action 
upon Ge this GTP-binding protein does however still display characteristics 
consistent with it belonging to the heterotrimeric family of GTP-binding 
proteins. The results of this study would also suggest that in AtT-20 cells 
Ge is insensitive to both PTX and CTX. Studies carried out in some 
specialised secretory cell types, including the present study, have 
proposed a number of different candidates for Ge. The present study is 
highly consistent with results obtained using the RINmSF (3-cell line in 
which Ge is also insensitive to both PTX and CTX (Valler et al., 1987; 
Komatsu et al., 1993). However it contrasts with work carried out in mast 
cells (Aridor et ai, 1993) and chromaffin cells (Vitale et a!., 1994) in which 
Ge appears to be PTX-sensitive and also with studies carried out in the 
exocrine pancreas in which Ge appears to be CTX-sensitive (Morrison et 
al., 1994), Studies to date therefore would suggest that Ge present in a 
peptide secreting endocrine cell is insensitive to both PTX and CTX (Valler 
et a i, 1987; Komatsu et ai, 1993). This contrasts with amine secreting 
endocrine cells in which Ge appears to be PTX sensitive (Aridor et a i, 
1993; Vitale et a i, 1994) and also to exocrine cells in which Ge may be 
CTX sensitive (Morrison et a i, 1994). It may therefore be the case that the 
identity of Ge in a particular cell type depends upon the nature of secretion
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for which that ceil is specialised and that Ge may share a common identity 
between different cell types specialised for similar forms of secretion.
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a AN imESTlGAUQN iNTQ THE REGULATION Of  ACTH SECRËliQH
FR0M.AII-2Q,-CELLS BY PRQIEIN KLMASE C AND CXQIIC AMP-
DEPENDENT PROTEIN KINASE AI  A LAT£,.SIAQE IN.IHE ACIH
SECRETQRY PATHWAY
(i) Effects of protein kinase C activators upon ACTH secretion 
from intact AtT-20 ceils
As already discussed in detail the effects of AVP are thought to be 
largely mediated by the activation of PLC (Jard et al., 1987) and 
subsequent generation of DAG leading to activation of PKC (Bllezikjian et 
al., 1987a & b; Guillon etal., 1987; Oki etal., 1990; Raymond etal., 1985). 
As a result the involvement of PKC in the ACTH stimulus-secretion 
coupling pathway has been the focus of a number of studies. The phorbol 
ester PMA stimulates ACTH secretion from both the normal corticotroph 
(Abou-Samra et a i, 1986) and AtT-20 cells (Reisine & Guild, 1987; 
Reisine, 1989) confirming that PKC plays an important role in the ACTH 
stimulus-secretion coupling pathway. Initial results from the present study 
were consistent with this suggestion with the observation that the phorbol 
esters PMA, PDD and PDBu all stimulated ACTH secretion from intact AtT- 
20 cells. The ability of diacylglycerol analogues to stimulate ACTH 
secretion coupled with the inability of 4 a phorbol, an inactive phorbol
ester, to stimulate a similar secretory response suggests that the effects of 
these phorbol esters upon ACTH secretion are mediated by activation of 
PKC and are not due to a simple biophysical effect.
Previous studies have suggested that the ability of PKC to stimulate 
ACTH secretion from AtT-20 cells is due to an elevation of the cytosolic 
free calcium ion concentration (Reisine & Guild, 1987; Reisine, 1989). This
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rise in the cytosolic calcium ion concentration is however a transient one in 
contrast to the resultant hormone release which is sustained, an 
observation which lead to speculation that PKC may have additional points 
of regulation in the ACTH stimulus-secretion coupling pathway which are 
unrelated to the elevation of cytosolic free calcium ion levels (Reisine & 
Guild, 1987). Using the permeabilised cell preparation, in which the 
cytosolic free calcium ion concentration can be controlled, it was one aim 
of this study to determine whether this hypothesis was in fact the case.
(li) Effects of PMA upon the late stages of the ACTH secretory 
pathway of AtT-20 cells
The present study demonstrated that PMA enhances calcium ion- 
stimulated ACTH secretion from permeabilised AtT-20 cells. Since any 
changes in cytosolic free calcium ion concentrations would be 
counteracted by the calcium/EGTA buffers employed in the present study it 
appears that PKC is indeed able to stimulate ACTH secretion from 
permeabilised AtT-20 cells by an action which is unrelated to an elevation 
of the cytosolic free calcium ion concentration. Therefore it can be 
concluded that PKC has at least two sites of action with regard to 
stimulated ACTH secretion from AtT-20 cells. This second site of action 
uncovered in the present study could account for the sustained nature of 
PKC-stimulated secretion from these cells (Reisine & Guild, 1987). Having 
established that PKC has more than one point of regulation in the ACTH 
stimulus-secretion coupling pathway the nature of this second site of action 
was considered.
PMA was shown to stimulate ACTH secretion from permeabilised 
AtT-20 cells in the effective absence of calcium ions (free calcium ion
1
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concentration of lO'^M) and in the absence of guanine nucleotides. This 
may suggest that this second site of action of PKC is one which is capable 
of stimulating secretion by a mechanism which is independent of calcium 
ion/Ge-stimulated secretion. PKC is known to represent a family of 
isozymes comprising in part of cPKCs and nPKCs (Ohno et al., 1991), 
both of which are now known to be present in AtT-20 cells. In the absence 
of calcium ions PMA is therefore only able to activate nPKCs (Ryves et al.,
1991) and it can be concluded that secretion from permeabilised AtT-20 
cells observed in response to PMA in the effective absence of calcium ions 
is due to activation of these calcium independent isozymes of PKC.
The present study aiso indicates that calcium ions and PMA interact 
in a synergistic manner with regard to ACTH secretion from permeabilised 
AtT- 2 0  cells. It may be the case that cPKCs, which can be activated by 
PMA only in the presence of calcium ions (Ryves et al., 1991), also 
stimulate secretion from AtT-20 cells by a pathway which is independent of 
calcium ion/Ge-stimulated secretion in a manner similar to nPKCs. 
Activation of these additional isozymes may result in an enhanced 
secretory response and could therefore account for the observed synergy 
between calcium ions and PMA. Consistent with this argument is the 
finding that there appears to be no interaction between PMA and GTP- y-S  
with regard to evoked ACTH secretion from permeabilised AtT-20 cells. In 
the absence of calcium ions PMA and GTP- y -S stimulated ACTH 
secretion from AtT-20 cells in an additive manner indicating no interaction 
between nPKCs and Ge and therefore confirming that nPKCs stimulate 
secretion by an action which is independent of calcium ion/Ge-stimulated 
secretion. In addition PMA and GTP- y -S also stimulated ACTH secretion 
in an additive manner at every free calcium ion concentration investigated 
indicating that there is also no interaction between cPKCs and Ge which is
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therefore consistent with cPKCs also stimulating secretion by an action 
which is independent of calcium ion/Ge-stimulated ACTH secretion. These 
findings therefore suggest that cPKCs as well as nPKCs may contribute to 
an ACTH secretory response from AtT-20 cells which is independent of 
calcium ion/Ge-stimulated secretion.
It therefore appears that at a late stage in the ACTH stimulus- 
secretion coupling pathway of AtT-20 cells two distinct parallel pathways 
can be distinguished both of which appear to require calcium ions in some 
capacity. The first is that of Ge-stimulated secretion which is directly 
activated by calcium ions and the second is that of PKC-stimulated 
secretion. This PKC-stimulated secretion can proceed in the absence of 
calcium ions, however since both cPKCs and nPKCs appear to contribute 
to this pathway the presence of calcium ions greatly enhances the 
secretory response mediated by this route. A schematic diagram outlining 
a proposed model for the involvement of PKC in the ACTH stimulus- 
secretion coupling pathway of AtT-20 cells is displayed in figure 6 8 . The 
ability of PKC to stimulate a secretory response in a calcium ion- 
independent manner from AtT-20 cells is consistent with a number of 
studies carried out in GH3 cells (Ronning & Martin, 1986), mammary 
epithelial cells (Turner et aL, 1992), natural killer cells (Ting et al., 1992), 
neutrophils (Barrowman et al., 1986; DiVirgilio et al., 1984) and RINmSF 
cells (Valler etal., 1987).
The above model predicts that secretagogues which produce a 
sustained elevation of the cytosolic free calcium ion concentration, such as 
CRF-41 (Axelrod & Reisine, 1984; Miyazaki et al., 1984), should be 
capable of evoking a significant ACTH secretory response from anterior 
pituitary corticotrophs. In contrast agents the effects of which are mediated
PKA FREE CALCIUM IONS PKC
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Figure 68 Schematic diagram showing a possible model for the 
Involvement of protein kinase C In the late stages of the ACTH 
stimulus-secretion coupling pathway of AtT-20 cells.
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by activation of PKC, such as AVP (Oki et a i, 1990), will produce in a 
relatively poor secretory response. This model however also predicts that 
this poor secretory response will be largely potentiated by agents such as 
CRF-41 which raise the cytosolic free calcium ion concentration. In rats, 
primates and humans this is indeed the case with CRF-41 being the 
dominant regulator of ACTH secretion from the anterior pituitary 
corticotroph. In contrast AVP is a weak stimulator of ACTH release, 
however this hormone can markedly potentiate CRF-41-stimulated 
secretion (Aguilera, 1994; Antoni, 1986). Although CRF-41 (Abou-Samra et 
a/., 1987; Antoni, 1986) and AVP (Oki etal., 1990) may have actions which 
are unrelated to elevation of the cytosolic free calcium ion concentration 
and to the activation of PKC respectively, the proposed model does seem 
consistent with the general patterns of hormone release observed in 
response to these two major regulators of ACTH secretion.
(Hi) Effects of Isozyme-selective protein kinase 0  activators upon
the late stages of the ACTH secretory pathway of AtT-20 cells
To date the family of PKC isozymes is known to comprise 12 closely 
related polypeptides (Dekker & Parker, 1994). Western blot analysis 
revealed that AtT-20/D16-16 cells, employed in the present study, contain 
a variety of these isozymes including the cPKC a and p isozymes, the 
nPKC e isozyme and the atypical PKC Ç isozyme, a profile identical to that 
of the AtT-20/D16v cell line (Dr D.J. Mac Ewan, personal communication). 
Since it has been demonstrated that particular isozymes of PKC have 
distinct roles in signal-transduction, stimulus-secretion coupling and growth 
(Akita etal., 1990; Housay et al., 1988; Kiley et al., 1992; Leli etal., 1992; 
Naor et al., 1989; Pai et al., 1991 ; Sharma et al., 1991) the present study 
attempted to establish physiological roles for some of the isozymes present
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in AtT-20 cells and in particular establish whether some of these isozymes 
contribute to PKC-stimulated ACTH secretion by interacting with the 
calcium ion messenger system (Reisine & Guild, 1987; Reisine, 1989) or 
by an action which is independent of calcium ion/Ge-stimulated secretion.
This problem was approached in the present study using a number 
of substances thought to selectively activate particular isozymes of PKC. 
PMA, employed extensively in the present study, is regarded as a general 
activator of PKC isozymes although calcium ions are required for maximal 
activation of cPKCs (Ryves et al., 1991). It should also be noted that 
certain isozymes, including the Ç isozyme present in AtT-20 cells, do not 
appear to be regulated by phorbol esters or DAG (Akimoto et al., 1994; 
Nishizuka, 1988; Selbie et al., 1993) and therefore these isozymes will be 
unaffected by PMA. TMX is reported to be a selective activator of the a, p 
and Y isozymes (Ryves et al., 1991) and was employed in the present 
study in order to activate the a  and p isozymes present in AtT-20 cells. 
Another phorbol ester dPPA was employed in the present study as an 
activator of the p isozyme for which it is has been reported to be selective 
(Ryves et al., 1991). The effects of these activators were originally 
investigated in intact AtT-20 cells from which PMA, dPPA and TMX all 
stimulated ACTH secretion, a result which appears to suggest that general 
activation of PKC isozymes, activation of the a and p isozymes or simply 
activation of the p isozyme may evoke a secretory response.
In order to determine whether these isozymes participate in the 
stimulus-secretion coupling pathway by raising the cytosolic free calcium 
ion concentration or by a calcium ion/Ge-independent site of action the 
effects of these agents upon ACTH secretion were investigated using the 
permeabilised cell preparation in which the cytosolic free calcium ion
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concentration can be controlled. The p isozyme activator dPPA, in contrast 
to PMA, was unable to enhance calcium ion-stimulated ACTH secretion 
from permeabilised AtT-20 cells. This finding may therefore suggest that 
dPPA and therefore that the p isozyme does not contribute to the calcium 
ion/Ge-independent site of action by PKC. Experiments carried out in intact 
AtT-20 cells however demonstrated that dPPA is capable of evoking a 
secretory response indicating that the p isozyme does play a role in the 
regulation of ACTH secretion. The role of the p isozyme may therefore be 
at an early stage in the stimulus-secretion coupling pathway where PKC 
has been shown to stimulate calcium ion entry into the cell across the 
plasma membrane (Reisine & Guild, 1987; Reisine, 1989). It may therefore 
be the case that the calcium-dependent a  isozyme and the calcium- 
independent e isozyme may contribute to the regulated secretory response 
in a calcium ion/Ge-independent manner.
As previously suggested the relative contributions of these PKC 
isozymes to the secretory response will be determined to a certain extent 
by the availability of calcium ions. At lower calcium ion concentrations the e 
isoform may be dominant in AtT-20 cells contributing to ACTH secretion by 
the calcium ion/Ge-independent pathway. At higher calcium ion 
concentrations however the a  and p isoforms will also contribute to the 
ACTH secretory response, the a  isozyme perhaps by a mechanism similar 
to that of the e Isozyme and the p isozyme perhaps by raising the cytosolic 
free calcium ion concentration. These findings from the present study are 
consistent with investigations into the role of PKC in the regulation of 
prolactin secretion from the GHg anterior pituitary cell line which adopted a 
similar approach and proposed a similar role for the p isozyme in the 
stimulus-secretion coupling pathway (MacEwan & Mitchell, 1991 ; 
MacEwan et ai, 1991; Thomson et ai, 1993). In addition this involvement
1 1 6
of both cPKCs and nPKCs in the regulation of exocytosis has been shown 
to be the case in both rat basophilic RBL-2H3 cells (Ozawa et aL, 1992) 
and GH4 C 1 rat anterior pituitary cells (Akita et al., 1990).
The ability of TMX to stimulate ACTH secretion from permeabilised 
AtT-20 cells in the absence of calcium ions in a similar manner to PMA was 
surprising since TMX has been reported to be a selective activator of 
cPKCs (Ryves etal., 1991). This may therefore suggest that TMX is not as 
selective as previously anticipated, further evidence for which comes from 
the finding that this PKC activator is capable of binding to the e isozyme, 
although TMX was 10-20 fold less potent in this regard in comparison to its 
effects upon the a  or p isozymes (Kazanietz etal., 1993). Although binding 
of TMX to the e isozyme does not give any indication of activation it may 
suggest that caution is required when attributing selective properties to 
these agents and in particular to TMX.
Similar doubts have been expressed over the selectivity of dPPA 
with recent findings suggesting that dPPA may activate PKC isozymes in a 
non-selective manner (Kiley eta l., 1994). This non-selective action 
however required a dPPA concentration in excess of 10‘^M which was the 
concentration employed in the present study. In addition dPPA has been 
demonstrated in vitro to require a concentration in excess of 2  x IQ-^M for 
non-specific PKC activation to occur whereas activation of the p isozyme 
occurs at a concentrations of 2  x lO’^M (Ryves et al., 1991). These 
findings indicate that dPPA may well facilitate a non-selective activation of 
PKC isozymes however this action requires a relatively high concentration 
of this PKC activator. These same studies also suggest that when 
employed at an appropriate concentration, including the concentration of 
10'^M adopted in the present study, dPPA is in fact selective for activation
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of the p isozyme of PKC. Consistent with these findings are results from 
the present study which suggest that dPPA is capable of stimulating ACTH 
secretion from permeabilised AtT-20 cells both in the presence and 
absence of calcium ions only at concentrations of IQ-^M and above 
indicating that dPPA may activate other PKC isozymes only when present 
in relatively large quantities. Results from the present study also indicate 
clearly that PMA and TMX display different characteristics from dPPA with 
regard to ACTH secretion which would not be the case if these agents 
were all non-selective in their activation of PKC isozymes. It therefore does 
appear that dPPA can be employed as a selective activator of the p 
isozyme of PKC.
In conclusion it appears that different isozymes of PKC contribute to 
the ACTH secretory response by actions at distinct points in the stimulus- 
secretion coupling pathway of AtT-20 cells. In particular the p isozyme may 
interact with the calcium ion messenger system at an early stage in the 
stimulus-secretion coupling pathway perhaps by facilitating calcium ion 
entry into the cell across the plasma membrane. Other PKC isozymes, 
perhaps the a  and e isozymes, may regulate ACTH secretion from AtT-20 
cells by an action which is not due to an interaction with the calcium ion 
messenger system. The involvement of different isozymes at different 
points in the ACTH stimulus-secretion coupling pathway of AtT-20 cells 
may go some way to explaining the need for the variety of PKCs now 
known to be present in these cells.
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(iv) Effects of cyclic AMP upon the iate stages of the ACTH 
secretory pathway of AtT-20 cells
Elevation of the intracellular cyclic AMP content of both AtT-20 cells 
and the normal corticotroph induced by a number of agents, including 
CRF-41, has been demonstrated to result in ACTH secretion (Aguilera et 
al., 1983; Axelrod & Reisine, 1984; Heisler & Reisine, 1984; Litvin et al., 
1984; Miyazaki etal., 1984) indicating that PKA is an important part of the 
stimulus-secretion coupling pathway of these cells. Evidence exists to 
suggest that PKA stimulates ACTH secretion from AtT-20 cells by 
interacting with the calcium ion messenger system by producing a 
sustained elevation of the cytosolic free calcium ion concentration (Luini et 
al., 1985; Guild & Reisine, 1987). More recently it has also been suggested 
that PKA has a second point of regulation by which it is capable of 
modulating the effects of changes in the cytosolic free calcium ion 
concentration, including those evoked by PKA Itself, upon ACTH secretion 
from AtT- 2 0  cells by an action in the stimulus-secretion coupling pathway 
distal to calcium ions (Guild, 1991). This modulatory action of PKA was 
confirmed in the present study with the demonstration that cyclic AMP, 
although incapable of stimulating ACTH secretion from permeabilised AtT- 
2 0  cells itself, can interact in a synergistic manner with both calcium ions 
and GTP- y -S to elicit a secretory response. These findings suggest that 
PKA is capable of modulating calcium ion/Ge-stimulated secretion by an 
action in the stimulus-secretion coupling pathway which is distal to both 
calcium ions and to Ge and are consistent with previous results obtained 
using this cell line (Guild, 1991).
The possibility that PKA may also have a similar modulatory role 
with regard to calcium ion/Ge-independent PKC-stimulated ACTH secretion
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from permeabilised AtT-20 cells was subsequently investigated. PMA- 
stimulated ACTH secretion from permeabilised AtT-20 cells was enhanced 
by cyclic AMP in a similar way to that of calcium ion- and GTP- y -S- 
stimulated secretion. Cyclic AMP enhanced PMA-stimulated ACTH 
secretion from permeabilised AtT-20 cells in a synergistic manner 
indicating that PKA may play a modulatory role with regard to calcium 
ion/Ge-independent PKC-stimulated secretion. It therefore appears that 
PKA is capable of enhancing ACTH secretion by two distinct pathways, 
that of calcium ion/Ge-stimulated secretion and that of PKC-stimulated 
ACTH secretion. A schematic diagram displaying a possible model for the 
involvement of PKA in the late stages of the ACTH secretory pathway of 
AtT-20 cells is displayed in figure 69. Whether this modulatory action of 
PKA is due to a single point of regulation by PKA which for instance may 
enlarge a readily releasable pool of stored hormone making more ACTH 
available for stimulated secretion (Dannies, 1982) or by a separate point of 
regulation on each pathway is unclear from the present study.
(v) Summary
Results from the present study indicate that both PKC and PKA, in 
addition to raising cytosolic free calcium ion levels (Luini etal., 1985; Guild 
& Reisine, 1987; Reisine, 1989), contribute to the ACTH secretory 
response of AtT-20 cells by an action at a late stage in the stimulus- 
secretion coupling pathway. It appears however that these kinases 
contribute at this late stage in quite different ways, PKC providing a direct 
stimulus to secretion in contrast to PKA which is unable to stimulate 
secretion by itself but which can modulate both calcium ion/Ge- and PKC- 
stimulated secretion. Although the present study demonstrates that PKC is 
capable of stimulating ACTH secretion from AtT-20 cells in the effective
PKA FREE CALCIUM 
IONS
-  PKC
I
GTP-BINDING
PROTEIN
PKA
ACTH SECRETION
Figure 69 Schematic diagram showing a possibie model for the 
involvement of cyclic AMP-dependent protein kinase in the iate 
stages of the ACTH stimulus-secretion coupling pathway of AtT-20
cells.
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absence of calcium ions the secretory response evoked by this route is 
greatly enhanced by the presence of calcium ions. It therefore appears that 
calcium ions can still be regarded as the central intracellular regulator of 
ACTH release from AtT-20 cells however co-operation with PKA and PKC 
is required to uncover what might be a maximal secretory response.
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4 CQNCmDlNfiLREMARKS
In conclusion it appears that the mechanisms mediating calcium ion- 
stimulated ACTH secretion from AtT-20 cells can be separated into two 
distinct pathways. The first is mediated by the GTP-binding protein Ge the 
effects of which are mediated in turn by a phosphatase. This pathway is 
activated by calcium ions and represents the mechanism by which these 
ions directly stimulate ACTH secretion. In contrast the second pathway 
which is mediated by PKC is not dependent upon calcium ions but is 
enhanced to a large extent by their presence. Although it is now clear that 
calcium ions are not an absolute requirement for ACTH secretion they can 
still be regarded as the central intracellular regulator of ACTH secretion 
since this ’calcium-independent' secretory response is relatively small. How 
two pathways mediated by opposing cellular actions, namely a 
dephosphorylation and a phosphorylation, result in the same physiological 
response remains puzzling however one possibility is that two pools of 
readily releasable ACTH exist, one sensitive to the actions of a 
phosphatase and the other to a kinase. It is also clear from the present 
study that PKC contributes to the regulation of ACTH secretion from AtT-20 
cells by quite a different mechanism from PKA which appears to be a 
largely modulatory with regard to both calcium ion/Ge- and PKC-stimulated 
secretion. It may be the case that PKA may play a regulatory role at this 
late stage controlling the availability of readily releasable pools of ACTH 
from a more long term storage pool (Dannies, 1982).
Both PKC and PKA have been shown in AtT-20 cells to have a wide 
variety of target proteins, some distinct and some shared (Bishop et al., 
1987; Rougon etal., 1989). It is therefore likely that both of these kinases 
have additional points of regulation with regard to the control of ACTH
1i
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secretion, that the stimulus-secretion coupling pathways in this cell line are 
only partially understood and that the models proposed in the present 
discussion represent an oversimplification. In addition whether these post­
calcium ion mechanisms do indeed represent the 'late stages of the ACTH 
secretory pathway' or simply an intermediate stage remains to be 
elucidated.
The present study also indicates that Ge, the GTP-binding protein 
mediating calcium ion-stimulated ACTH secretion, displays characteristics 
consistent with it being heterotrimeric in AtT-20 cells. Further studies, 
perhaps adopting a more molecular biological approach, are required to 
confirm this hypothesis and to establish the identity of this GTP-binding 
protein which may in turn give indications as to possible effector proteins 
for Ge. In addition GTP-binding proteins are known to be regulated by 
phosphorylation (Yamane & Fung, 1993) therefore the possibility that Ge 
may be a target for a number of kinases could also be investigated. Having 
established the existence of Ge in AtT-20 cells these follow-up studies may 
determine the importance of this GTP-binding protein in the stimulus- 
secretion coupling pathway and suggest why calcium ion-stimulated 
secretion should be mediated by a GTP-binding protein.
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